0001731122-19-000476.txt : 20190814 0001731122-19-000476.hdr.sgml : 20190814 20190814142014 ACCESSION NUMBER: 0001731122-19-000476 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 50 CONFORMED PERIOD OF REPORT: 20190630 FILED AS OF DATE: 20190814 DATE AS OF CHANGE: 20190814 FILER: COMPANY DATA: COMPANY CONFORMED NAME: XG SCIENCES INC CENTRAL INDEX KEY: 0001435375 STANDARD INDUSTRIAL CLASSIFICATION: PLASTICS, MATERIALS, SYNTH RESINS & NONVULCAN ELASTOMERS [2821] IRS NUMBER: 000000000 STATE OF INCORPORATION: MI FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 333-209131 FILM NUMBER: 191025352 BUSINESS ADDRESS: STREET 1: 3101 GRAND OAK DRIVE STREET 2: SUITE 212 CITY: LANSING STATE: MI ZIP: 48911 BUSINESS PHONE: 517-203-1110 MAIL ADDRESS: STREET 1: 3101 GRAND OAK DRIVE STREET 2: SUITE 212 CITY: LANSING STATE: MI ZIP: 48911 10-Q 1 e1451_10q.htm FORM 10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington D.C. 20549

 

FORM 10-Q

 

  x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended: June 30, 2019

or

  ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ______to______.

 

    XG SCIENCES, INC.    
    (Exact name of registrant as
specified in its
charter)
   

 

Michigan   333-209131   20-4998896
(State or other jurisdiction of
incorporation or organization)
  (Commission File No.)   (I.R.S. Employer Identification
No.)

 

3101 Grand Oak Drive

Lansing, MI 48911

 

(Address of principal executive offices) (zip code)

 

(517) 703-1110

(Issuer Telephone number)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No ¨

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes No ¨

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company filer. See definition of “accelerated filer” and “large accelerated filer” in Rule 12b-2 of the Exchange Act (Check one):

 

Large accelerated filer ¨ Accelerated filer ¨
Non-accelerated filer ¨ Smaller reporting company þ
(Do not check if a smaller
reporting company)
  Emerging growth company þ

 

 

If an emerging growth company, indicate by checkmark if the registrant has not elected to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. þ

 

Indicate by check mark whether the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act. Yes  No

 

Securities registered pursuant to Section 12(b) of the Act: N/A

 

As of August 14, 2019, there were 4,011,943 shares of the registrant’s common stock outstanding.

 

 1 

 

 

 

XG SCIENCES, INC.

FORM 10-Q

June 30, 2019

INDEX

 

 

 

PART I  
     
ITEM 1. FINANCIAL STATEMENTS 4
     
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 16
     
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK 27
     
ITEM 4. CONTROLS AND PROCEDURES 27
     
PART II  
     
ITEM 1. LEGAL PROCEEDINGS 28
     
ITEM 1A. RISK FACTORS 28
     
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS 28
     
ITEM 3. DEFAULTS UPON SENIOR SECURITIES 28
     
ITEM 4. MINE SAFETY DISCLOSURES 28
     
ITEM 5. OTHER INFORMATION 28
     
ITEM 6. EXHIBITS 29
     
SIGNATURES 30

 

 

 2 

 

 

 

FORWARD-LOOKING STATEMENTS

 

The information in this Quarterly Report on Form 10-Q contains “forward-looking statements” and information within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) relating to XG Sciences, Inc., a Michigan corporation and its subsidiary, XG Sciences IP, LLC, a Michigan limited liability company (collectively referred to as “we”, “us”, “our”, “XG Sciences”, “XGS”, or the “Company”), which are subject to the “safe harbor” created by those sections. These forward-looking statements include, but are not limited to, statements concerning our strategy, future operations, future financial position, future revenue, projected costs, prospects and plans and objectives of management. The words “anticipates,” “believes,” “estimates,” “expects,” “intends,” “may,” “plans,” “projects,” “will,” “would” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. We may not actually achieve the plans, intentions or expectations disclosed in our forward-looking statements and you should not place undue reliance on our forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties that could cause our actual results, performance or achievements to differ materially from those expressed or implied by the forward-looking statements, including, without limitation, the risks set forth beginning on page 12 under the section entitled “Risk Factors” in our annual report on Form 10-K/A as filed with the Securities and Exchange Commission (the “SEC”) on April 3, 2019. 

 

 3 

 

 

ITEM 1 - FINANCIAL STATEMENTS

 

XG SCIENCES, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS  
(U.S. Dollars)
    June 30, 2019    December 31, 2018 
ASSETS    (Unaudited)      
CURRENT ASSETS          
Cash  $1,735,721   $4,703,834 
Accounts receivable, less allowance for doubtful accounts of $26,000 at June 30, 2019 and $85,000 at December 31, 2018   269,539    859,054 
Inventories   965,578    660,217 
Other current assets   110,937    114,453 
Total current assets   3,081,775    6,337,558 
LONG-TERM ASSETS          
Property, Plant and Equipment, Net   4,123,286    4,223,650 
           
Restricted Cash for Letter of Credit   —      190,140 
           
Lease Deposit   59,440    20,156 
           
Intangible Assets, Net   733,056    690,646 
           
Right of Use Asset   1,767,269    —   
Total Long-Term Assets   6,683,051    5,124,592 
TOTAL ASSETS   9,764,826    11,462,150 
           
LIABILITIES AND STOCKHOLDERS' EQUITY          
CURRENT LIABILITIES          
Accounts payable   666,718    1,102,910 
Other current liabilities   513,034    429,573 
Deferred revenue   —      832 
Current portion of long-term debt   —      196,723 
Current portion of lease liabilities   461,603    3,613 
Total current liabilities   1,641,355    1,733,651 
LONG-TERM LIABILITIES          
Long-term portion of lease liabilities   1,411,749    11,914 
Long term debt   4,323,953    4,725,866 
Total long-term liabilities   5,735,702    4,737,780 
TOTAL LIABILITIES   7,377,057    6,471,431 
           
STOCKHOLDERS' EQUITY          
Series A convertible preferred stock, 3,000,000 shares authorized, 1,890,354 shares issued and outstanding, liquidation value of $22,684,248 at June 30, 2019 and December 31, 2018   22,307,480    22,307,480 
Common stock, no par value, 25,000,000 shares authorized, 4,011,943 and 3,760,268 shares issued and outstanding at June 30, 2019 and December 31, 2018, respectively   32,301,876    30,268,476 
Additional paid-in capital   8,280,579    8,101,923 
Accumulated deficit   (60,502,166)   (55,687,160)
Total stockholders' equity   2,387,769    4,990,719 
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY   9,764,826    11,462,150 

 

See notes to unaudited condensed consolidated financial statements

 

 4 

 

 

XG SCIENCES, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS 

(U.S. Dollars, except Share data)

(Unaudited)

 

 

 

For the 3 Months
Ended June 30,

  For the 6 Months
Ended June 30,
   2019  2018  2019  2018
REVENUE            
Product Sales   247,069    850,854    1,104,346    1,737,191 
Total revenue  $247,069   $850,854   $1,104,346   $1,737,191 
COST OF GOODS SOLD                    
Direct costs   196,411    563,260    877,564    1,031,451 
Unallocated manufacturing expenses   599,745    542,689    1,093,214    1,289,272 
Total cost of goods sold   796,156    1,105,949    1,970,778    2,320,723 
GROSS LOSS   (549,087)   (255,095)   (866,432)   (583,532)
OPERATING EXPENSES                    
Research and development   384,767    287,082    770,013    564,146 
Sales, general and administrative   1,486,380    1,147,794    2,907,301    2,334,473 
Total operating expenses   1,871,147    1,434,876    3,677,314    2,898,619 
OPERATING LOSS   (2,420,234)   (1,689,971)   (4,543,746)   (3,482,151)
OTHER INCOME (EXPENSE)                    
Interest expense, net   (78,277)   (83,805)   (154,941)   (168,974)
Government incentives, net                 3,253 
Total other expense   (78,277)   (83,805)   (154,941)   (165,721)
NET LOSS  $(2,498,511)  $(1,773,776)  $(4,698,687)  $(3,647,872)
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING -                    
Basic and diluted (in shares)   3,990,038    2,644,522    3,883,053    2,549,943 
Net Loss Per Share - Basic and diluted (in dollars per share)  $(0.63)  $(0.67)  $(1.21)  $(1.43)

 

 

See notes to unaudited condensed consolidated financial statements

 

 5 

 

 

XG SCIENCES, INC. 

CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS’ EQUITY

(U.S. Dollars)

(Unaudited)

 

For the 6 Months Ended June 30, 2019
   Preferred stock (A)  Common stock  Additional
paid-in
  Accumulated   
   Shares  Amount  Shares  Amount  capital  deficit  Total
Balances, December 31, 2018   1,890,354   $22,307,480    3,760,268   $30,268,476   $8,101,923   $(55,687,160)  $4,990,719 
Stock issued for cash   —      —      251,675    2,013,400    —      —      2,013,400 
Stock issuance fees and expenses   —      —      —      (20,000)   —      —      (20,000)
Transition adjustment for adoption of new lease standard   —      —      —      —      —      (116,319)   (116,319)
Stock-based compensation   —      —      —      40,000    178,656    —      218,656 
Net loss   —      —      —      —      —      (4,698,687)   (4,698,687)
                                    
Balances, June 30, 2019   1,890,354   $22,307,480    4,011,943   $32,301,876   $8,280,579   $(60,502,166)  $2,387,769 

 

 

For the 6 Months Ended June 30, 2018
   Preferred stock (A)  Common stock  Additional
paid-in
  Accumulated   
   Shares  Amount  Shares  Amount  capital  deficit  Total
Balances, December 31, 2017   1,857,816   $21,917,046    2,353,350   $19,116,012   $7,831,958   $(47,767,544)  $1,097,472 
Stock issued for cash   —      —      493,175    3,945,400    —      —      3,945,400 
Stock issuance fees and expenses   —      —      —      (66,598)   —      —      (66,598)
Preferred stock issued to pay capital lease obligations   14,280    171,343    —      —      —      —      171,343 
Stock-based compensation   —      —      —      40,000    134,231    —      174,231 
Net loss   —      —      —      —      —      (3,647,872)   (3,647,872)
                                    
Balances, June 30, 2018   1,872,096   $22,088,389    2,846,525   $23,034,814   $7,966,189   $(51,415,416)  $1,673,976 

 

 

For the 3 Months Ended June 30, 2019
   Preferred stock (A)  Common stock  Additional
paid-in
  Accumulated   
   Shares  Amount  Shares  Amount  capital  deficit  Total
Balances, March 31, 2019   1,890,354   $22,307,480    3,811,518   $30,682,476   $8,190,211   $(58,003,655)  $3,176,512 
Stock issued for cash   —      —      200,425    1,603,400    —      —      1,603,400 
Stock issuance fees and expenses   —      —      —      (4,000)   —      —      (4,000)
Stock-based compensation   —      —      —      20,000    90,368    —      110,368 
Net loss   —      —      —      —      —      (2,498,511)   (2,498,511)
                                    
Balances, June 30, 2019   1,890,354   $22,307,480    4,011,943   $32,301,876   $8,280,579   $(60,502,166)  $2,387,769 

 

 

For the 3 Months Ended June 30, 2018
   Preferred stock (A)  Common stock  Additional
paid-in
  Accumulated   
   Shares  Amount  Shares  Amount  capital  deficit  Total
Balances, March 31, 2018   1,864,956   $22,002,717    2,555,275   $20,741,574   $7,899,722   $(49,641,639)  $1,002,374 
Stock issued for cash   —      —      291,250    2,330,000    —      —      2,330,000 
Stock issuance fees and expenses   —      —      —      (56,760)   —      —      (56,760)
Preferred stock issued to pay capital lease obligations   7,140    85,672    —      —      —      —      85,672 
Stock-based compensation   —      —      —      20,000    66,467    —      86,467 
Net loss   —      —      —      —      —      (1,773,776)   (1,773,776)
                                    
Balances, June 30, 2018   1,872,096   $22,088,389    2,846,525   $23,034,814   $7,966,189   $(51,415,415)  $1,673,977 

 

 

See notes to unaudited condensed consolidated financial statements

 

 6 

 

 

XG SCIENCES, INC. 

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS 

(U.S. Dollars)

(Unaudited)

 

   For the Six Months Ended June 30,
   2019  2018
CASH FLOWS FROM OPERATING ACTIVITIES           
Net loss  $(4,698,687)  $(3,647,872)
Depreciation   388,110    442,231 
Amortization of intangible assets   31,716    26,434 
Provision for bad debts   26,000    5,000 
Stock-based compensation expense   218,656    174,231 
Non-cash interest expense   39,584    170,311 
Non-cash equipment rent expense   —      106,164 
Changes in current assets and liabilities:          
Accounts receivable   563,515    (207,620)
Inventory   (305,361)   (72,173)
Other current and non-current assets   (46,002)   (101,249)
Accounts payable and other liabilities   (353,563)   755,506 
NET CASH USED IN OPERATING ACTIVITIES   (4,136,032)   (2,349,037)
           
CASH FLOWS FROM INVESTING ACTIVITIES          
Purchases of property and equipment   (287,746)   (1,707,364)
Purchases of intangible assets   (74,127)   (72,731)
NET CASH USED IN INVESTING ACTIVITIES   (361,873)   (1,780,095)
           
CASH FLOWS FROM FINANCING ACTIVITIES          
Repayments of capital lease obligations   (15,528)   (10,661)
Repayments of long-term loan debt   (638,220)   —   
Proceeds from issuance of common stock   2,013,400    3,945,400 
Common stock issuance fees and expenses   (20,000)   (66,598)
NET CASH PROVIDED BY FINANCING ACTIVITIES   1,339,652    3,868,141 
           
NET CHANGE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH   (3,158,253)   (260,991)
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, BEGINNING OF PERIOD   4,893,974    3,041,590 
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, END OF PERIOD   1,735,721    2,780,599 
           
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:          
Cash paid for interest   64,626    430 
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:            
Value of preferred stock issued for AAOF capital lease obligations   —      171,343 

  

*For reporting purposes, restricted cash was included with Cash and Cash Equivalents beginning in April 2018. It has been included in the 2018 Cash and Cash Equivalents amount for the first six months of 2018 for comparable purposes.

 

See notes to unaudited condensed consolidated financial statements

 

 7 

 

 

XG SCIENCES, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS  

 

NOTE 1 – NATURE OF BUSINESS AND BASIS OF PRESENTATION

 

XG Sciences, Inc., a Michigan company located in Lansing, Michigan and its subsidiary, XG Sciences IP, LLC (collectively referred to as “we”, “us”, “our”, or the “Company”) manufactures graphene nanoplatelets made from graphite, using two proprietary manufacturing processes to split natural flakes of crystalline graphite into very small and thin particles, which we sell as xGnP® graphene nanoplatelets. We sell our nanoplatelets in the form of bulk powders or dispersions to other companies for use as additives to make composite and other materials with specialty engineered characteristics. We also manufacture and sell integrated, value-added products containing these graphene nanoplatelets such as greases, composites, thin sheets, inks and coating formulations that we sell to other companies. Additionally, we have licensed our technology to other companies in exchange for royalties and other fees.

 

Basis of Presentation

 

The accompanying interim condensed consolidated financial statements are unaudited and have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and the instructions to Form 10-Q and do not include all of the information and footnotes required by GAAP for complete financial statements. All intercompany transactions have been eliminated in consolidation.

 

Certain information and footnote disclosures normally included in our annual audited consolidated financial statements and accompanying notes have been condensed or omitted in these interim condensed consolidated financial statements. Accordingly, the unaudited condensed consolidated financial statements included herein should be read in conjunction with the audited consolidated financial statements for the year ended December 31, 2018, as filed with the Securities and Exchange Commission (“SEC”) on Form 10-K/A on April 3, 2019.

 

The results of operations presented in this quarterly report are not necessarily indicative of the results of operations that may be expected for any future periods. In the opinion of management, these unaudited condensed consolidated financial statements include all adjustments and accruals, consisting only of normal recurring adjustments that are necessary for a fair statement of the results of all interim periods reported herein.

 

Use of Estimates

 

The preparation of our condensed consolidated financial statements in conformity with GAAP requires us to make estimates, judgments and assumptions that affect the reported amounts of assets, liabilities, revenue and expenses, together with amounts disclosed in the related notes to the financial statements. Actual results and outcomes may differ from our estimates, judgments and assumptions. Significant estimates, judgments and assumptions used in these condensed consolidated financial statements include, but are not limited to, those related to revenue, accounts receivable and related allowances, inventory valuations, contingencies, useful lives and recovery of long-term assets, including intangible assets, income taxes, and the fair value of stock-based compensation. These estimates, judgments, and assumptions are reviewed periodically and the effects of material revisions in estimates are reflected in the financial statements prospectively from the date of the change in estimate.

 

 

NOTE 2 – UPDATES TO SIGNIFICANT ACCOUNTING POLICIES

 

Revenue Recognition

 

Revenues are recognized at a point in time, typically when control of the promised goods is transferred to customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods. The Company does not recognize revenue in cases where collectability is not probable, and defers the recognition until collection is probable or payment is received.

 

The Company generally expenses sales commissions when incurred because the amortization period would have been one year or less. These costs are recorded within selling, general and administrative expenses. Customer deposits, deferred revenue and other receipts are deferred and recognized when the revenue is realized and earned.  

 

Revenue related to licensing agreements is recorded upon substantial performance of the terms of the licensing contract. In the case of licensing arrangements that involve up-front payments, revenue is recorded when management determines that the appropriate terms of the contract have been fulfilled. For example, this may occur when technology has been transferred via written documents or, if training is involved, whenever all contracted training has occurred. In the case of licenses where product delivery is also embedded in the deliverable, a portion of revenue would be recognized when products are delivered.

 

We have also out-licensed certain intellectual property to licensees under terms and conditions of license agreements that specify the   intellectual property licensed, the territory, and the type of license. In exchange for these licenses, we have recorded revenues associated with the initial granting of the license and expect to receive royalties based on sales of products produced under these licenses. License revenues are recorded to reflect our performance of requirements under these license agreements. In addition, we record royalty revenues from licensees at the time they are earned.

 

 

 8 

 

 

XG SCIENCES, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS  

 

Grant contract revenue is recognized over the life of the contracts as the services are performed or as milestones are met.

 

Amounts received in excess of revenues earned are recorded as deferred revenue.

  

Liquidity

 

We have historically incurred recurring losses from operations and we may continue to generate negative cash flows as we implement our business plan. Our consolidated financial statements are prepared using GAAP as applicable to a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business.

  

As of August 12, 2019, we had cash on hand of $2,680,604. We believe our cash is sufficient to fund our operations through August 31, 2020 after taking into account various sources of funding and cash received from continued commercial sales transactions. Our primary means for raising funds since 2016 has been through our offering of shares of common stock at a fixed price of $8.00 per share to the general public in a self-underwritten offering (the “Offering” or our “IPO”) and under a draw loan note and agreement with The Dow Chemical Company (the “Dow Facility”). On April 12, 2019, we completed the Offering, after selling 2,615,425 shares under the Registration Statement at a price of $8.00 per share for total proceeds of $20,923,400. On July 8, 2019 we borrowed $2 million under the draw loan note and agreement with The Dow Chemical Company (the “Dow Facility”). We have $3 million of proceeds from the Dow Facility available to us, which we intend to be our primary source of liquidity at this time (See Note 3).  

 

There has been no public market for our securities and a public market may never develop, or, if any market does develop, it may not be sustained. Our common stock is not currently quoted on or traded on any exchange or on any over-the-counter market. In the event we are unable to fund our operations from existing cash on hand, operating cash flows, additional borrowings or raising equity capital, we may be forced to reduce our expenses, slow down our growth rate, or discontinue operations. Our condensed consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should we be unable to continue as a going concern.  

 

 

 9 

 

 

XG SCIENCES, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

 

Inventory  

 

The following amounts were included in inventory at the end of the period:   
   June 30,  December 31,
   2019  2018
Raw materials  $66,395   $48,371 
Consumables   160,630    188,764 
Finished goods   738,553    423,082 
Total  $965,578   $660,217 

 

 

Recent Accounting Pronouncements

 

In February 2016, the FASB issued Accounting Standards Update No. 2016-02, Leases (“ASU 2016-02”). The new standard establishes a right-of-use (“ROU”) model that requires a lessee to record a ROU asset and a lease liability on the balance sheet for all leases with terms longer than 12 months. Leases will be classified as either finance or operating, with classification affecting the pattern of expense recognition in the income statement. The new standard must be adopted using a modified retrospective transition and requires application of the new guidance at the beginning of the earliest comparative period presented.   We adopted ASU 2016-02 as of January 1, 2019.

 

 

Adoption of Lease Accounting Policy    

 

We applied ASU 2016-02 and all related amendments (“ASC 842”) using the modified retrospective method by recognizing the cumulative effect of adoption as an adjustment to the opening balance of retained earnings at January 1, 2019. Therefore, the comparative information has not been adjusted and continues to be reported under prior leasing guidance. As a result, in the first quarter of 2019 we recorded ROU assets of $1,871,366. We also recorded lease liabilities of $1,981,795. The decrease to retained earnings was $116,319, reflecting the cumulative impact of the accounting change. The standard did not have a material effect on consolidated net income or cash flows.

 

Right-of-use assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. As our leases do not provide an implicit rate, we used our incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. Lease expense for lease payments is recognized on a straight-line basis over the lease term.

 

We do not record a ROU asset or lease liability for leases with an expected term of 12 months or less. The comparative information has not been adjusted and continues to be reported under prior leasing guidance.

 

 10 

 

 

XG SCIENCES, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

  

NOTE 3 –FINANCING AGREEMENT

 

Dow Facility

 

In December 2016, we entered into the Dow Facility which provides us with up to $10 million of secured debt financing at an interest rate of 5% per year, drawable at our request under certain conditions. We received $2 million at closing and an additional $1 million on July 18, 2017, September 22, 2017 and December 4, 2017, respectively.

 

The Dow Facility is senior to our other debt and is secured by all of our assets. It matures on December 1, 2021 (subject to certain mandatory prepayments based on our equity financing activities). When we raise a cumulative amount of equity capital exceeding $15 million, we are required to prepay an amount equal to 30% of the amount raised over $15 million, but less than $25 million. We began these prepayments on equity raised as of September 10, 2018. Interest was payable beginning January 1, 2017, although we had elected, per the Dow facility, to capitalize the interest as part of the outstanding debt through January 1, 2019. Beginning April 1, 2019, current interest is payable in cash on the first day of each quarter, and accordingly, has been paid on April 1, 2019 and July 1, 2019 in the amounts of $64,626 and $59,709, respectively.

 

Dow received warrant coverage of one share of common stock for each $40 in loans received by us, equating to 20% warrant coverage, with an exercise price of $8.00 per share for the warrants issued at closing of the initial $2 million draw. After the initial closing, the strike price of future warrants issued is subject to adjustment if we sell shares of common stock at a lower price. As of June 30, 2019, we had issued 125,000 warrants to Dow, which are exercisable on or before the expiration date of December 1, 2023. 

 

The aforementioned warrants meet the criteria for classification within stockholders’ equity. Proceeds were allocated between the debt and the warrants at their relative fair value. The total debt discount on the Dow Facility was approximately $372,372. The debt discount is being amortized to interest expense using the effective interest method over the term of the loans using an average effective interest rate of 7.67%. During the six months ended June 30, 2019, we recognized $163,919 of amortization expense consisting of $124,335 interest expense and $39,584 of amortization from debt discount accretion related to the Dow Facility. We have repaid $816,710 of outstanding principal on the debt, resulting in a carrying value of $4,323,953 for the Dow Facility as of June 30, 2019.

 

The Dow Facility entitles Dow to appoint an observer to our Board. Dow will maintain this observation right until the later of December 1, 2019 or when the amount of principal and interest outstanding under the Dow Facility is less than $5 million.

 

 

 11 

 

 

XG SCIENCES, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 4 – STOCK WARRANTS ACCOUNTED FOR AS EQUITY INSTRUMENTS

 

The following table summarizes the warrants (including the warrants previously accounted for as derivatives) outstanding at June 30, 2019, which are accounted for as equity instruments, all of which are exercisable: 

 

Date Issued   Expiration Date  

Indexed

Stock

  Exercise Price     Number of 
Warrants
 
07/01/2009   07/01/2019   Common   $ 8.00       6,000  
10/08/2012   10/08/2027   Common   $ 12.00       5,000  
01/15/2014 - 12/31/2014   01/15/2024   Series A Convertible Preferred   $ 6.40       972,720  
04/30/2015- 05/26/2015   04/30/2022   Common   $ 16.00       218,334  
06/30/2015   06/30/2022   Common   $ 16.00       6,563  
12/31/2015   12/31/2020   Common   $ 8.00       20,625  
03/31/2016   03/31/2021   Common   $ 10.00       10,600  
04/30/2016   04/30/2021   Common   $ 10.00       895  
12/14/2016   12/01/2023   Common   $ 8.00       50,000  
07/18/2017   12/01/2023   Common   $ 8.00       25,000  
09/22/2017   12/01/2023   Common   $ 8.00       25,000  
12/04/2017   12/01/2023   Common   $ 8.00       25,000  
                      1,365,737  

  

Each warrant indexed to Series A Convertible Preferred Stock is currently exercisable and exchangeable into 1.875 shares of common stock.

 

NOTE 5 – STOCKHOLDERS’ EQUITY (DEFICIT)

 

Common Stock

 

The Company is authorized to issue 25,000,000 shares of common stock, no par value per share of which 4,011,943 and 3,760,268 shares were issued and outstanding as of June 30, 2019 and December 31, 2018, respectively.

 

During the six months ended June 30, 2019 the Company issued 251,675 shares of common stock pursuant to the Offering. During the six months ended June 30, 2018 the Company issued 493,175 shares of common stock pursuant to the Offering. Upon its completion on April 12, 2019, the Company had sold 2,615,425 shares of common stock in its IPO at a price of $8.00 per share for gross proceeds of $20,923,400.  

 

Potentially dilutive securities consist of shares potentially issuable pursuant to stock options and warrants as well as shares that would result from full conversion of all outstanding convertible securities. These potentially dilutive securities were 3,013,987 and 2,903,987 as of June 30, 2019 and 2018, respectively, and are excluded from diluted net loss per share calculations because they are anti-dilutive.

 

Series A Convertible Preferred Stock

 

The Company is authorized to issue up to 3,000,000 shares of Series A Convertible Preferred Stock (the “Series A Preferred”). Each share of the Series A Preferred, which has a liquidation preference of $12.00 per share, is convertible at any time, at the option of the holder, into one share of common stock at the lower of: (a) $12.00 per share, or (b) 80% of the price at which the Company sells any equity or equity-linked securities in the future. The Series A Preferred also contains typical anti-dilution provisions that provide for adjustment of the conversion price to reflect stock splits, stock dividends, or similar events. The Series A Preferred is subject to mandatory conversion into common stock upon the listing of the Company’s common stock on a Qualified National Exchange. However, the Series A Preferred is not subject to the mandatory conversion until all outstanding convertible securities are also converted into common stock. The Series A Preferred ranks senior to all other equity or equity equivalent securities of the Company other than those securities which are explicitly senior or pari passu in rights and liquidation preference to the Series A Preferred and pari passu with the Company’s Series B Preferred Stock.

 

The Company issued 1,456,126 shares of Series A Preferred in connection with the conversion of certain convertible notes on December 31, 2015.

 

In December 2015, the conversion price of the Series A Preferred was reduced from $12.00 to $6.40 (80% of $8.00), and thus, each share of Series A Preferred Stock is convertible into 1.875 shares of common stock. During the period from May 17, 2016 through December 31, 2018 the Company issued shares of Series A Preferred Stock to Aspen Advanced Opportunity Fund, LP (“AAOF”) as payment for lease financing obligations under the terms of a Master Leasing Agreement.

 

As of June 30, 2019, and December 31, 2018, the Company had 1,890,354 shares of Series A Preferred Stock issued and outstanding which is currently convertible into 3,544,414 shares of our common stock.

 

 

 12 

 

 

XG SCIENCES, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

  

NOTE 6 – EQUITY INCENTIVE PLAN  

 

We previously established the 2007 Stock Option Plan (the “2007 Plan”), which was scheduled to expire on October 30, 2017 and under which we granted key employees and directors options to purchase shares of our common stock at not less than fair market value as of the grant date. On May 4, 2017, the Board approved the 2017 Equity Incentive Plan (the “2017 Plan”) to replace the 2007 Plan, which became effective upon the approval of the stockholders holding a majority of the voting power in the Company on July 18, 2017. The 2017 Plan replaces the 2007 Plan and authorizes us to issue awards (stock options and restricted stock) with respect of a maximum of 1,200,000 shares of our common stock, which equals the number of shares authorized under the 2007 Plan.   

 

On July 24, 2017, certain stock options from the 2007 Plan were cancelled and replacement stock options were awarded. The replacement stock option awards have an exercise price of $8.00 per share, a seven-year term, are vested 50% on date of grant with the remaining vesting over a 4-year period from the date issued and are subject to certain other terms. Each option holder received options equal to 150% of the number of cancelled stock options. The cancellation and reissuance of the stock options were treated as a modification under ASC 718, Compensation-Stock Compensation. Incremental compensation cost of approximately $1,015,758 was measured as the excess of the fair value of the modified award over the fair value of the original award immediately before the terms were modified. Compensation cost of approximately $501,071 was recorded on the date of cancellation for awards that were vested on the date of the modification. For unvested awards, compensation cost of approximately $514,687 will be recorded over the remaining requisite service period. 

 

On September 30, 2018 and August 10, 2017, the Company granted each Board member 2,500 stock options and 2,500 shares of restricted stock for their Board services. The options were granted at a price of $8.00 per share and vest ratably over a four-year period beginning on the one-year anniversary. The options had an aggregate grant date fair value of $29,580 and $26,120 on September 30, 2018 and August 10, 2017, respectively. The restricted stock issued to the Board members has an aggregate fair value of $160,000 and vest ratably in arrears over four quarters on the last day of each fiscal quarter following the grant date. As of June 30, 2019, 20,000 of the 20,000 shares of restricted stock issued had vested, resulting in compensation expense of $20,000 for the period ended June 30, 2019.

 

During the three months ended June 30, 2019, the Company granted 20,000 employee stock options. The options were granted at a price of $8.00 per share and had an aggregate grant date fair value of $61,644. The options vest ratably over a four-year period beginning on the one-year anniversary. The fair value of the options granted was estimated on the date of grant using the Black Scholes option-pricing model using the following assumptions: Stock price: $8.00, Exercise Price: $8.00, Expected Term: 4.75 years, Volatility: 42.71%, Risk free rate: 1.76%, Dividend rate: 0%.

 

All options granted thus far under the 2017 Plan have an exercise price of $8.00 per share and vesting of the options ranges from immediate to 25% per year, with most options vesting 25% per year beginning on the one-year anniversary of the grant date. The options expire seven years from the date of grant.

 

Stock-based compensation expense was $110,368    for the three months ended June 30, 2019. As of June 30, 2019, there was approximately $632,744 in unrecognized compensation cost related to the options granted under the 2017 plan. We expect to recognize these costs over the remaining vesting terms, ranging from 3 to 4 years.

 

A summary of the stock options available as of June 30, 2019 is as follows:

 

      Weighted
   Number  Average
   Of  Exercise
   Options  Price
Options outstanding at March 31, 2019   805,375   $8.00 
Changes during the period:          
Expired   —      8.00 
New Options Granted – at market price   20,000    8.00 
Options outstanding at June 30, 2019   825,375   $8.00 
Options exercisable at June 30, 2019   384,025   $8.00 

 

 

 13 

 

  

 

XG SCIENCES, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 7 – LEASES

 

Right of Use Asset and Leased Liability:

 

Estimated Lease Life – Lease term through December 2022

 

Right-of-use lease assets- operating as of March 31, 2019  $1,871,366 
Less: Accumulated amortization   (104,097)
Right-of-use lease assets- operating as of June 30, 2019  $1,767,269 
      
Lease liability-operating as of March 31, 2019  $1,981,795 
Less: Accumulated Amortization   (108,443)
Lease liability operating-as of June 30, 2019  $1,873,352 
      
Operating lease expense for the three months ended June 30, 2019  $150,557 
Actual remaining lease payments  $2,214,410 
Present value of remaining payments  $1,873,352 

  

Supplemental cash flow information related to leases:

 

   Leases
   Three months
   ended
   June 30, 2019
Cash paid for amounts included in the measurement of lease liabilities:     
    Operating cash flows from operating leases  $154,903 
Weighted average remaining lease term- operating leases (in months)   40 
Weighted average discount rate- operating leases (annual)   9.98%
Maturities of leases liabilities were as follows:     
  Year ending December 31, 2019 (excluding the three months ended June 30, 2019)  $309,806 
  Year ending December 31, 2020   622,878 
  Year ending December 31, 2021   638,178 
  Year ending December 31, 2022   643,547 
       Total Lease payments   2,214,409 
Less imputed interest   (341,057)
    Total  $1,873,352 

 

With the exception of the standards discussed above, we believe there have been no new accounting pronouncements issued that would have a material impact, to our Consolidated Financial Statements.

  

 

 14 

 

 

XG SCIENCES, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 8 – RELATED PARTY TRANSACTIONS

 

We have a licensing agreement for exclusive use of patents and pending patents with Michigan State University (“MSU”), a shareholder of the Company via the MSU Foundation. During the three months ended June 30, 2019 and 2018 we recorded licensing expense of $12,500 per quarter.  

 

We have also entered into product licensing agreements with certain other shareholders. No royalty revenue or expenses have been recognized related to these agreements during the three and six months ended June 30, 2019 or the three and six months ended June 30, 2018.

 

During the three months ended June 30, 2019 we did not issue any Series A Preferred stock. For the six months ended June 30, 2018, we issued 7,140 shares of Series A Preferred stock to AAOF as payment for lease financing obligations under the terms of the Master Lease Agreement, dated March 18, 2013.

 

 15 

 

 

ITEM 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

Forward-Looking Statements

 

In this Quarterly Report on Form 10-Q, unless otherwise indicated, the words “we”, “us”, “our”, “XG”, “XGS”, “XG Sciences” or the “Company” refer to XG Sciences, Inc. and its wholly owned subsidiary, XG Sciences IP, LLC, a Michigan limited liability company.

 

Introduction

 

The following discussion and analysis should be read in conjunction with the unaudited condensed consolidated financial statements, and the notes thereto included herein. The information contained below includes statements of the Company’s or management’s beliefs, expectations, hopes, goals and plans that, if not historical, are forward-looking statements subject to certain risks and uncertainties that could cause actual results to differ materially from those anticipated in the forward-looking statements. For a discussion on forward-looking statements, see the information set forth in the introductory note to this quarterly report on Form 10-Q under the caption “Forward-Looking Statements”, which information is incorporated herein by reference.

 

Overview of our Business

 

XG Sciences was formed in May 2006 for the purpose of commercializing certain technology to produce graphene nanoplatelets and integrated, value-added products containing graphene nanoplatelets. First isolated and characterized in 2004, graphene is a single layer of carbon atoms configured in an atomic-scale honeycomb lattice. Among many noted properties, monolayer graphene is harder than diamonds, lighter than steel but significantly stronger, and conducts electricity better than copper. Graphene nanoplatelets are particles consisting of multiple layers of graphene. Graphene nanoplatelets have unique capabilities for energy storage, thermal conductivity, electrical conductivity, barrier properties, lubricity and the ability to impart physical property improvements when incorporated into plastics, metals or other matrices.

 

We believe the unique properties of graphene and graphene nanoplatelets will enable numerous new product applications and the market for such products will quickly grow to be a significant market opportunity. Our business model is to design, manufacture and sell advanced materials we call xGnP® graphene nanoplatelets and value-added products incorporating xGnP® nanoplatelets. We currently have hundreds of customers trialing our products for numerous applications, including, but not limited to lithium ion batteries, lead acid batteries, thermally conductive adhesives, composites, thermal management and heat transfer, inks and coatings, printed electronics, construction materials, cement, and in a range of other industrial uses. We believe our proprietary processes have enabled us to be a low-cost producer of high-quality, graphene nanoplatelets and value-added integrated products containing graphene nanoplatelets and that we are well positioned to address a wide range of end-use applications.  

 

Our Customers

 

We sell products to customers around the world and have sold materials to over 1,300 customers in 47 countries since 2008. Some of these customers are research organizations and some are commercial organizations. Our customers have included well-known automotive and OEM suppliers around the world (Ford, Johnson Controls, Magna, Honda Engineering), global-scale lithium ion battery manufacturers in the U.S., South Korea and China (Samsung SDI, LG Chemical, Lishen, A123) and diverse specialty material companies (3M, BASF, Henkel, Dow Chemical, DuPont), as well as leading research centers such as Lawrence Livermore National Laboratory and Oakridge National Laboratory. We have also licensed some of our base manufacturing technology to other companies. Our licensees include POSCO, the fifth largest steel manufacturer in the world by 2018 tonnage output, and Cabot Corporation (“Cabot”), a leading global specialty chemicals and performance materials company. These licensees further extend our technology through their customer networks. Ultimately, we believe we will benefit in terms of royalties on sales of xGnP® nanoplatelets produced and sold by our licensees. As can be seen in the below bar chart, the cumulative number of customers has steadily grown over the last ten years.

 

 16 

 

 

 

 

Cumulative Customers, By Year

 

We believe average order size is an early indicator of commercial traction. The majority of our customers are still ordering in smaller quantities consistent with their development and engineering qualification work. As can be seen in the chart below, our quarterly average order size was relatively modest until the second half of 2017, when a number of customers reached commercial status with different product applications. The data below represents orders shipped in the respective quarter and exclude no charge orders targeted mainly for R&D purposes. Despite the average order size decreasing during the three months ended June 20, 2019, we believe that it will continue to increase as more customers commercialize products using our materials. In the three months ended June 30, 2019 the average order size was $4,575, a decrease of 60% from $11,345 for the three months ended June 30, 2018. In the 3 months ended June 30, 2019 we shipped 4.1 MT of product, primarily in the form of dry powder, a decrease of 63% over the 3 months ended March 31, 2019.

 

 17 

 

 

Our Products

XG Sciences is a manufacturer of graphene nanoplatelets marketed under the brand xGnP® and value-added products that contain graphene nanoplatelets. The term “graphene” is used widely in the literature and the popular press to cover a variety of specific forms of the material. We generally think about two broad classes of graphene materials: 

  1. One-atom thick films of carbon commonly referred to as monolayer graphene, manufactured typically from gases by assembling molecules to form relatively large, transparent sheets of material. These materials have been characterized by their performance attributes that differentiate them from other advanced materials and that may include: 200 times stronger than steel, flexible and able to stretch up to 25% of its original length, optically transparent, more electrically conductive than copper, more thermally conductive than any other known material and atomic-level barrier properties. XG Sciences does not manufacture these films and does not participate in the markets for these films and believes that in general, the markets for these films do not compete with those for graphene nanoplatelets.

 

  2. Ultra-thin particles of carbon that consist of layers of graphene sheets ranging in thickness from a few layers to many layers – that are commonly referred to as graphene nanoplatelets (“GNP” or “GNPs”). Because GNPs are thin and can be manufactured in a range of diameters, they are useful for a wide variety of applications. XG Sciences manufactures GNPs that range in thickness from a few nanometers and up to 10-20 nanometers and with diameters ranging from less than 1 micron and up to 100 microns. The manufacture of these graphene particles is our main area of expertise, and their use in practical applications is the focus of our sales, marketing and development activities.

 

 18 

 

  

The well-publicized isolation and characterization of graphene in 2004 at the University of Manchester, has spawned a new class of 2D materials based on layers of carbon atoms arranged in a hexagonal array and each carbon having lone pair electrons. The unique characterization and related performance of this new class of materials is derived from their two-dimensional nature and their composition of sp2 carbon atoms arranged in a hexagonal array. The ability of any new material to be exploited in industrial applications will depend on its fit-for-performance. In the case of graphene nanoplatelets, the fit-for-performance is very much related to their aspect ratio (among other factors) such that the diameter is greater than the thickness and is what differentiates the material from bulk graphite of high crystallinity and purity. We classify nanoplatelets consisting of largely basel planes of carbon atoms packed in a hexagonal array (i.e., graphene) as graphene nanoplatelets so long as their aspect ratio may be classified as two-dimension and are thus in the form of platelets. Such a definition implies that the thickness is nanoscale – GNPs having a thickness in the range from generally 0.6 nanometers and up to many 10’s of nanometers. We have chosen to utilize the definitions as set out by the Carbon Journal editorial team (Carbon, volume 65, pp.1-6) and Fullerex (Bulk Graphene Pricing Report, 2019) which provides classification for the various material types which provide meaningful descriptions of commercially available graphene.

 

Graphene Product Thickness Definitions Based on Thickness

  Number of Layers   Product Description
  1   Graphene (monolayer)
  1-3   Very Few Layer Graphene (vFLG)
  2-5   Few Layer Graphene (FLG)
  2-10   Multilayer Graphene (MLG)
  >10   Graphene Nanoplatelets (GNP)

 

Bulk Materials. We sell bulk materials under the trademarked brand name of xGnP® graphene nanoplatelets. These materials are produced in various grades, which are analogous to average particle thickness, and average particle diameters. There are three commercial grades (Grades H, M & R), each of which is offered in three standard particle sizes and a fourth, C Grade, which is offered in three standard surface areas. We also have access to other development grades (Grade T, for example), but which are not yet made available commercially and have been used internally for those products containing graphene nanoplatelets. These bulk materials, which normally ship in the form of a dry powder, are especially applicable for use as additives in polymeric or metallic composites, or in coatings or other formulations where particular electrical, thermal or barrier applications are desired by our customers. We also offer our material in the form of dispersions of nanoplatelets in liquids such as water, alcohol, or organic solvents, or mixed into resins or polymers such as thermoplastics or thermosets. We use two different commercial processes to produce these bulk materials:

 

Grade H/M/R/T materials are produced through chemical intercalation of natural graphite followed by thermal exfoliation using a proprietary process developed by us. The “grade” designates the thickness and surface characteristics of the material, and each grade is available in various average particle diameters. Surface area, calculated by the Brunauer, Emmet, and Teller (BET) Method, is used as a convenient proxy for thickness, so each grade of products produced through chemical intercalation is designated by its average surface area, which ranges from 50 to 150 m2/g of material. We are able to extend the surface area higher (250 m2/g for T Grade) but are not yet producing these materials in metric-ton quantities. As the market need emerges for this class of materials, we will scale them as needed. For example, we introduced a new Grade of xGnP® powders, R-Grade, with improved electrical conductivity targeting use in applications for electrically and thermally conductive ink and composites and have scaled R-Grade to metric-ton quantities. 

 

Grade C materials are produced through a high-shear mechanical exfoliation using a proprietary process and equipment that we invented, designed, constructed and patented. The Grade C materials are smaller particles than those grades produced through chemical exfoliation, and Grade C materials are designated by their BET surface area, which ranges from 300 to 800 m2/g. We are able to produce other surface areas and may make those available commercially as needed by our customers.

The following graphic depicts xGnP® graphene nanoplatelets as a function of both layer thickness and aspect ratio (thickness by diameter), two key parameters which will influence their performance in a range of industrial applications.

 19 

 

 

XG Sciences’ Graphene Nanoplatelet Product Portfolio and Versus Graphite

 

Composites. These consist of compositions of specially designed xGnP® graphene nanoplatelets formulated in pre-dispersed mixtures that can be easily incorporated in various polymers. Our integrated composites portfolio includes pre-compounded resins derived from a range of thermoplastics as well as master batches of resins and xGnP® nanoplatelets and their combination with resins and fibers for use in various end-use applications that may include industrial, automotive and sporting goods and which have demonstrated efficacy in standard injection molding, compression molding, blow molding and 3-D processes, to name but a few. Our current product portfolio of polymer resins containing various forms of our xGnP® graphene nanoplatelets and in varying concentration includes polyurethane (XGPU), polypropylene (XGPP), polyethylene terephthalate (XGPET), vinyl ester (XGVE), polyetherimide (XGPEI) and high-density polyethylene (XGHDPE). Others polymers may be added over time depending on the end-market and customer needs. In addition, we offer various bulk materials with demonstrated efficacy in plastic composites to impart improved physical performance to such matrices, which may be supplied as dry powders or as aqueous or solvent-based dispersions or cakes as described above. We have also targeted use of our graphene nanoplatelets as an additive in cement mixtures, which we believe results in improved barrier resistance, durability, toughness and corrosion protection. Our GNP® Concrete Additive promotes the formation of more uniform and smaller grain structure in cement. This fine-grain and uniform structure gives the concrete improvements in flexural and compressive strength. In addition, the embedded graphene nanoplatelets will stop cracks from forming and retard crack propagation, should any cracks form – the combination of which will improve lifetime and durability of cement.

Inks and Coatings. These consist of specially-formulated dispersions of xGnP® together with solvents, binders, and other additives to make electrically or thermally conductive products designed for printing or coating and which are showing promise in diverse customer applications such as advanced packaging, electrostatic dissipation and thermal management. We also offer a set of standardized ink formulations suitable for printing. These inks offer the capability to print electrical circuits or antennas and may be suitable for other electrical or thermal applications. All of these formulations can be customized for specific customer requirements.

Energy Storage Materials. These consist of specialty advanced materials that have been formulated for specific applications in the energy storage segment. We offer various bulk materials for use as conductive additives for cathodes and anodes in lithium-ion batteries, as an additive to anode slurries for lead-carbon batteries, as a component in coatings for current collectors in lithium-ion batteries and we are investigating the use of our materials as part of other battery components.

 

Thermal Management Materials.  These consist mainly of various thermal interface materials (“TIM”) in the form of custom greases or pastes. Our custom XG TIM® greases and pastes are also designed to be used in various high temperature environments. Additionally, we offer various bulk materials for use as active components in adhesives, liquids, coatings and plastic composites to impart improved thermal management performance to such matrices.


Our Focus Areas

 

We believe we are a “platform play” in advanced materials, because our proprietary processes allow us to produce varying grades of graphene nanoplatelets that can be mapped to a variety of applications and in many market segments. However, we are prioritizing our efforts in specific areas and with specific customers that we believe represent opportunities for either relatively near-term revenue or especially large and attractive markets. At this time, we are focused on four key vertical markets: Automotive, Sporting Goods, Packaging and Industrial. The following graphic provides examples of target applications within each of the four key verticals where XG Sciences has either commercial sales or is in development with one or more customers.

 

 

 20 

 

 

XGS Market/Application Focus Areas

 

 

Addressable Markets

 

The markets for our materials are large and growing. As one example, the 2019 North American packaging market for plastic bottles and containers is estimated to be more than $34 billion (Mordor Intelligence). Further, Mordor estimates the 2019 global market for PET water bottles at 543.8 billion units. XG Sciences is engaged in the commercial supply of xGnP® graphene nanoplatelets for use in water bottles manufactured initially in North America and we are expanding our market activities into other geographies. If each water bottle produced in 2019 were to incorporate just 1 milligram of xGnP® graphene nanoplates, the total revenue available to XG Sciences may range from $200 to $300 million, depending on product form.

 

Commercialization Process

 

Because graphene is a new material, most of our customers are still developing applications that use our products. Commercialization is a process, the exact timing of which is often difficult to predict. It starts with our own internal R&D to validate performance for an identified market or customer-specific need. Our customers then validate the performance of our materials and determine whether our products can be incorporated into their manufacturing processes. This is initially done at pilot production scale levels. Our customers then have to introduce products that incorporate our materials to their own customers to validate performance. After their customers have validated performance, our customers will then move to commercial scale production. Every customer goes through the same process, but will do so at varying speeds, depending on the customer, the product application and the end-use market. Thus, we are not always able to predict when our customers will begin ordering commercial volumes of our materials or predict their expected volumes over time. However, as customers move through the process, we generally receive feedback and gain greater insights regarding their commercialization plans. According to our respective customers, the following are examples where our products are providing value to our customers at levels that are either in commercial production or we believe will warrant their use on a commercial basis.

 

·In 2018, Callaway Golf Company introduced new dual-core Chrome Soft and Chrome Soft X golf balls incorporating our xGnP® graphene nanoplatelets into the outer core, resulting in a new class of golf ball that enables higher driving speeds, greater distance and increased control, which is allowing Calloway to command a premium price for their golf balls in the marketplace, and in 2019 Callaway expanded the use of our technology to incorporate our xGnP® into the ERC Soft line of golf balls;

 

·The Ford Motor Company, after having demonstrated a 17 percent reduction in noise, a 20 percent improvement in mechanical properties and a 30 percent improvement in heat endurance properties compared with that of polyurethane foam used without graphene  is now incorporating our graphene nanoplatelets for polyurethane based foam parts in over ten under hood components on the Ford F-150 and Mustang with initial production in 2018.

 

·Light emitting diode module and product company demonstrated approximately 50% improvement in thermal management capability when compared to existing commercial thermal management products, translating into a 15% improvement in thermal management at the device level;

 

·Lead acid battery manufacturers incorporating our materials in the commercial supply of batteries demonstrating improvements in measured cycle life, capacity and charge acceptance;

 

·U.S. bottling company adopting commercial use of our graphene nanoplatelets in PET water bottles to improve modulus (10% with minimal affect to color and up to 200% with color change), shelf life and energy savings during processing;

 

·Plastics composite part manufacturer demonstrating 7-30% improvement in strength and 40% improvement in modulus when used in sheet molding compound; and

 

·Plastic composite parts manufacturer demonstrating 25% increase in tensile strength and 15% improvement in flex modulus for a high-density polyethylene composite, and Plastics manufacturer demonstrating up to 25% increase in tensile modulus, 15% increase in tensile strength and 8x increase in puncture impact for nylon-based thermoplastics.

 

 21 

 

 

The process of “designing-in” new materials is relatively complex and involves the use of relatively small amounts of the new material in laboratory and engineering development for an extended period of time. Following successful development, customers that incorporate our materials into their products will then order much larger quantities of material to support commercial production. Although, our customers are under no obligation to report to us on the usage of our materials, some have indicated that they have introduced or will soon introduce commercial products that use our materials. Thus, while many of our customers are currently purchasing our materials in kilogram (one or two pound) quantities, some are now ordering at multiple ton quantities and we believe many will require tens of tons or even hundreds of tons of material as they commercialize products that incorporate our materials. We also believe that those customers already in production will increase their order volume as demand increases and others will begin to move into commercial volume production as they gain more experience in working with our materials and engage new customers. For example, in 2017 we shipped 19.3 metric tons of product for various end-use customers. In 2018, we shipped 59.9 metric tons of products comprising 48.3 metric tons of dry powders and approximately 11.6 metric tons of additional product in the form of slurry, cake or other integrated products. This demand profile is further evidence that we are transitioning into higher-volume commercial production.

 

Commercialization Trends

 

We are tracking the commercial and development status of more than 75 different customer applications using our materials with some customers pursuing multiple applications. As of June 30, 2019, we had twenty specific customer applications where our materials are incorporated into our customers’ products and such customers are actively selling these products to their own customers. In addition, we have another eighteen customer applications where our customers have indicated that they expect to begin shipping product incorporating our materials in the next 3 – 6 months and have another twenty-six customer applications where our customers have indicated an intent to commercialize in the next 6 – 9 months. We are also working with numerous additional customers that have not yet indicated an exact date for commercialization, but we believe have the potential to contribute to revenue in 2019. The following graphic demonstrates the commercialization trends over the past 8 fiscal quarters as an increasing number of customers indicate their intent to commercialize applications and move into actively selling or promoting products for future sales. We believe that the average order size for these customers will increase throughout 2019 as their demand grows. As a result, we believe we will begin shipping significantly greater quantities of our products, and thus continue scaling revenue through 2019.

 

 

 

(a)  Customer applications where our materials are used in customer products and they are actively selling them to their customers.

(b) Customer applications where our customers are indicating that they expect to begin shipping products incorporating our materials in the next 3-6 months.

(c)   Customer applications where our customers are indicating an intent to commercialize in the next 6-9 months.

 Additional 10’s of customers demonstrating efficacy and moving through qualification process.

 

Manufacturing Capacity

 

We completed the first phase of expansion in our newest 64,000 square-foot facility in the first half of 2018. The expansion has added 90 metric tons of graphene nanoplatelet production capacity, bringing the total capacity of the facility up to approximately 180 metric tons of dry powder. Phase two of the expansion was partially complete by year-end 2018 and resulted in up to ~270 metric tons of total graphene nanoplatelet output capacity at the facility. We expect to complete the last portion of this phase two expansion in the first half of 2019, resulting in up to ~400 metric tons of total graphene nanoplatelet output capacity. Our total graphene nanoplatelet output capacity across both of our manufacturing facilities, as of June 30, 2019, exceeded 300 metric tons per year and will increase to an approximate 450 metric tons by year-end. The expansions support our mission to continue commercializing the use of graphene in customer products across diverse industries. XG’s increasing capacity will support the growing demand for our products over the next several fiscal quarters. However, additional manufacturing capabilities for certain value-added products and certain bulk materials remain to be developed and may require the acquisition of additional facilities. In particular, the production processes for certain integrated products will require additional capital and may require additional facilities to meet expected future customer demand.

 

Some of the Company’s products are new products that have not yet been fully developed and for which manufacturing operations have not yet been fully scaled. Although we believe we will continue to scale our production capability and revenue rapidly in 2019, we have not yet demonstrated the capability to produce sufficient materials to generate the ongoing revenues necessary to sustain our operations in the long-term.

 

 22 

 

 

Our Intellectual Property

 

Some of our proprietary manufacturing processes were developed at Michigan State University (MSU) and licensed to us in 2006. We license three U.S. patents and patent applications from MSU. On August 8, 2016, we signed an agreement acquiring an exclusive license to Metna’s background IP for use of graphene nanoplatelets as additives to concrete mixtures. For purposes of the agreement, Metna’s background IP relates to the U.S. Patent 8,951,343. Also, on August 8, 2016, we entered into a second agreement for an exclusive license related to all Metna’s background technology and foreground technology, including any jointly-owned foreground technology where the end use is known to be any graphite additive dispersed in concrete mixtures. Over time, our scientists and engineers have made many further discoveries and inventions that are embodied in the form of (and as of June 30, 2019): fifteen (15) additional U.S. patents, eighteen (18) foreign patents, ten (10) additional U.S. patent applications and numerous trade secrets. For many of the applications filed in the U.S., additional filings are made in other countries such as the European Union, Japan, South Korea, China, Taiwan or other applicable countries. As of June 30, 2019, we maintained twenty (20) international patent applications. These filings and analyses are made on a case-by-case basis. Typically, patents that are defensive in nature are not filed abroad, while those that are protective of active XGS products or applications are filed in relevant countries abroad. Our general IP strategy is to keep as trade secrets those manufacturing processes that are difficult to enforce should they be disclosed and to seek patent coverage for other manufacturing processes, materials derived from those processes, unique combinations of materials and end uses of materials containing graphene nanoplatelets. We believe that the combination of our rights under the MSU license, our patents and patent applications, and our trade secrets create a strong intellectual property position.

   

Operating Segment

 

We have one reportable operating segment that manufactures xGnP® graphene nanoplatelets and value-added products produced therefrom, conducts research on graphene nanoplatelets and related products, and licenses our technology as appropriate. As of June 30, 2019, we shipped products on a worldwide basis, but all of our assets were located within the United States.

 

Results of Operations for the Three and Six Months Ended June 30, 2019 Compared with the Three and Six Months Ended June 30, 2018

 

Summary Income Statement  For the Three Months Ended June 30,     For the Six Months Ended June 30,   
   2019  2018  Change  2019  2018  Change
Total Revenues  $247,069   $850,854   $(603,785)  $1,104,346   $1,737,191    (632,845)
Cost of Goods Sold   796,156    1,105,949    (309,793)   1,970,778    2,320,723    (349,945)
Gross Loss   (549,087)   (255,095)   (293,992)   (866,432)   (583,532)   (282,900)
Research & Development Expense   384,767    287,082    97,685    770,013    564,146    205,867 
Sales, General & Administrative Expense   1,486,380    1,147,794    338,586    2,907,301    2,334,473    572,828 
Total Operating Expense   1,871,147    1,434,876    436,271    3,677,314    2,898,619    778,695 
Operating Loss   (2,420,234)   (1,689,971)   (730,263)   (4,543,746)   (3,482,151)   (1,061,595)
Other Expense   (78,277)   (83,805)   5,528    (154,941    (165,721)   10,780 
Net Loss  $(2,498,511)  $(1,773,776)  $(724,735)  $(4,698,687)  $(3,647,872)  $(1,050,815)

 

Revenue

 

Revenues for the three months and six months ended June 30, 2019 and 2018, by category, are shown below.

 

   For the Three Months Ended June 30,     For the Six Months Ended June 30,   
   2019  2018  Change  2019  2018  Change
Product Sales  $247,069   $850,854   $(603,785)  $1,104,346   $1,737,191   $(632,845)
Total  $247,069   $850,854   $(603,785)  $1,104,346   $1,737,191   $(632,845)

 

 

 23 

 

 

The decrease in Product sales for the three months ended June 30, 2019 versus the same period last year, is primarily the result of a large customer pre-buying their inventory needs in quarter 4 of the prior year and, partially, in quarter 1 of the current year. This customer, although delaying reorders, continues to use our product in their manufacturing processes. We have a very strong customer pipeline and continue to establish a robust baseline of customers who are nearing commercial status. We believe that once these customers reach commercial status with products that incorporate our products, each will begin to order from us on a regular basis, which will help to mitigate the quarter to quarter revenue variability.

 

Product sales consist of two broad categories: (1) material sold to customers for research or development purposes; and (2) production orders for customers. Typically, the order sizes for the first category are relatively small, however we expect orders in the second category to be much larger in the future. For the three months ended June 30, 2019, product sales decreased by $603,785, or 71% from the comparable period in the prior year and for the six months ended June 30, 2019, product sales decreased by $632,845, or 36% from the comparable period in the prior year. The drop in revenue for the three months ended June 30, 2019 is due to our largest customer suspending orders during the period. The customer has not stopped using our products, but rather, is working down material pre-ordered in the latter half of 2018 and currently held in inventory and being used to produce their products. In the three months ended March 31, 2019, this customer purchased $565,946 of our product, representing 94% of the revenue decrease for the three months ended June 30, 2019 and 90% of the revenue decrease for the six months ended June 30, 2019. This customer continues to ship their products incorporating our material and we expect they will work down existing inventory, and over the next several quarters will resume purchasing our products at historical levels. Customers are moving through development programs towards commercialization, requiring larger quantities of our materials for advanced testing, pilot production and commercial-scale production activities. We believe that those customers already in production will increase their order volume as demand increases and others will begin to move into commercial volume production as they gain more experience in working with our materials and engage their own customers.

 

We ship our products from our Lansing, MI manufacturing facilities to customers around the world. During the six months ended June 30, 2019, we shipped materials   to customers in 20 countries, as compared to 22 countries during the same period in 2018. For the six months ended June 30, 2019, sales to one country, South Korea, accounted for more than 10% of revenue. For the six months ended, June 30, 2018, no product sales to any one country accounted for more than 10% of product sales. During the three months ended June 30, 2019, we shipped materials to customers in 17 countries, as compared to 17 countries during the same period in 2018. For the three months ended June 30, 2019, sales to one country, South Korea, accounted for more than 10% of revenue. For the three months ended, June 30, 2018, no product sales to any one country accounted for more than 10% of product sales.

 

Order Summary

The table below shows a comparison of domestic and international orders fulfilled (excluding orders for free samples). The table also includes the average order size for product sales. The average order size for product revenue during the three months and six months ended June 30, 2019 decreased by 60% and 21%, respectively, as compared to the same period in 2018. The relatively small average order size means that the majority of our customer base remains active with research and development projects that only use limited amounts of our material. We expect our average order size to increase significantly as more customers reach commercial status.

 

Order Summary  For the Three Months Ended June 30,     For the Six Months Ended June 30,   
(unaudited)  2019  2018  Change  2019  2018  Change
                   
Number of orders - domestic   26    47    (21)   51    82    (31)
Number of orders - international   28    28    —      54    49    5 
Number of orders - total   54    75    (21)   105    131    (26)
Average order size for product sales recorded in our Statement of Operations  $4,575   $11,345   $(6,770)  $10,518   $13,261   $(2,743)
 % change             (60%)             (21%)

 

Cost of Goods Sold

 

We use a standard cost system to estimate the direct costs of products sold. Direct costs include estimates of raw material costs, packaging, freight charges net of those billed to customers, and an allocation for direct labor and manufacturing overhead. Because of the nature of our production processes, there is a substantial fixed manufacturing expense requirement that represents the ongoing cost of maintaining production facilities that are not directly related to products sold, so we use a “full capacity” allocation of overhead based on an estimate of what product costs would be if the manufacturing facilities were operating on a full-time basis and producing products at the designed capacity.

 

 24 

 

 

The following table shows the relationship of direct costs to product sales for the three months and six months ended June 30, 2019 and 2018:

 

Gross Profit Summary  For the Three Months Ended June 30,    

For the Six Months Ended June 30,

   
   2019  2018  Change  2019  2018  Change
                   
Product Sales  $247,069   $850,854   $(603,785)  $1,104,346   $1,737,191   $(632,845)
Direct Costs   196,411    563,260    (366,849)   877,564    1,031,451    (153,887)
Direct Cost Margin  $50,658   $287,594   $(236,936)  $226,782   $705,740   $(478,958)
% of Sales   20.5%   33.8%        20.5%   40.6%     
Unallocated Manufacturing Expense   599,745    542,689    57,056    1,093,214    1,289,272    (196,058)
Gross Loss on Product Sales  $(549,087)  $(255,095)  $(293,992)  $(866,432)  $(583,532)  $(282,900)

 

 

We believe that the fluctuations in gross loss on product sales and direct cost from period to period are not indicative of future margins because of the relatively small size of our sales in comparison to our future expectations. Direct costs vary depending on the size of an order, the specific products being ordered, and other factors like shipping destination (which on small orders can represent a significant percentage of the cost).

 

The remaining “non-direct” costs of operating our manufacturing facilities are recorded as unallocated manufacturing expenses. These expenses include personnel costs, rent, utilities, indirect supplies, depreciation, and related indirect expenses. Unallocated manufacturing expenses are expensed as incurred. We allocate these costs to direct product costs based on the proportion of these expenses that would be representative of direct product costs if we were operating our factory at full capacity.

 

For the three months ended June 30, 2019, unallocated manufacturing expenses increased by 11% to $599,745 as compared to $542,689 in 2018. The increase of $57,056 is largely due to increased production personnel at the Mason, MI facility which opened in mid-2018.

 

For the six months ended June 30, 2019, unallocated manufacturing expenses decreased by 15% to $1,093,214 as compared to $1,289,272 in 2018. The decrease of $196,058 is largely due to lower equipment rental costs.

 

Sales, General and Administrative Expenses 

 

During the three months ended June 30, 2019, we incurred selling, general and administrative expenses (SG&A) of $1,486,380. This is an increase of approximately $338,586 or 29.5% from the same period in 2018. This increase in SG&A expense is related to an increased hiring of skilled personnel to respond to customer needs and to promote growth. Professional fees increased due to the change in auditors that occurred toward the end of 2018. As we continue to grow and gain traction in the marketplace, we expect that our SG&A expenses will increase, but should stabilize and become more fixed in nature as we achieve economies of scale.

 

During the six months ended June 30, 2019 we incurred selling, general and administrative expenses (SG&A) of $2,907,301. This is an increase of $572,828 from the same period in 2018, primarily due to increases in personnel costs as our sales team expands.

  

Research and Development Expenses

 

During the three months ended June 30, 2019, we incurred research and development expenses (R&D) of $384,767. This is an increase of $97,685 or 34% from the same period in 2018. This increase in R&D is primarily due to additional utilization of external testing services and other increased activities in our research and development area as we continue to commercialize and expand our sales reach.

 

Research and development expenses for the six months ended June 30, 2019 were $770,013 as compared to $564,146 for the same period in 2018, an increase of $205,867.

 

 25 

 

 

 

Other Income (Expense)

 

The following table shows a comparison of other income and expense by major expense component for the three and six months ended June 30, 2019 and 2018:

   For the Three Months Ended June 30,     For the Six Months Ended June 30,   
   2019  2018  Change  2019  2018  Change
Interest expense, net  $(78,277)  $(83,805)  $5,528   $(154,941)  $(168,974)  $14,033 
Government incentives, net   —      —      —      —      3,253    (3,253)
Total  $(78,277)  $(83,805)  $5,528   $(154,941)  $(165,721)  $10,780 

 

 26 

 

 

 

Liquidity and Capital Expenditures

 

Liquidity

 

We have historically incurred recurring losses from operations and we may continue to generate negative cash flows as we implement our business plan. Our consolidated financial statements are prepared using GAAP as applicable to a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business.

  

As of August 12, 2019, we had cash on hand of $2,680,604. We believe our cash is sufficient to fund our operations for at least twelve months after taking into account various sources of funding and cash received from continued commercial sales of our products. Our primary means for raising funds since 2016 has been through our offering of shares of common stock at a fixed price of $8.00 per share to the general public in a self-underwritten offering (the “Offering” or our “IPO”) and under a draw loan note and agreement with The Dow Chemical Company (the “Dow Facility”). On April 12, 2019, we completed the Offering, after selling 2,615,425 shares under the Registration Statement at a price of $8.00 per share for total proceeds of $20,923,400. On July 8, 2019 we borrowed $2 million under the draw loan note and agreement with The Dow Chemical Company (the “Dow Facility”). We have $3 million of proceeds from the Dow Facility available to us, which we intend to use as our primary source of liquidity in the event we need more funding (See Note 3).  

 

There has been no public market for our securities and a public market may never develop, or, if any market does develop, it may not be sustained. Our common stock is not currently quoted on or traded on any exchange or on any over-the-counter market. In the event we are unable to fund our operations from existing cash on hand, operating cash flows, additional borrowings or raising equity capital, we may be forced to reduce our expenses, slow down our growth rate, or discontinue operations. Our condensed consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should we be unable to continue as a going concern.

 

Critical Accounting Policies

 

In preparing the condensed consolidated financial statements in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”), we have adopted various accounting policies. Our most significant accounting policies are disclosed in Note 2 to the consolidated financial statements included in our Form 10-K/A for the year ended December 31, 2018.

 

The preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires us to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Our estimates and assumptions, including those related to inventories, intangible assets, property, plant and equipment, legal proceedings, research and development, warranty obligations, product liability, fair valued liabilities, sales returns and discounts, going concern, and income taxes are updated as appropriate, which in most cases is at least quarterly. We base our estimates on historical experience, or various judgements about the reported values of assets, liabilities, revenue and expenses. Actual results may materially differ from these estimates.

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

Smaller reporting companies are not required to provide this information.

 

ITEM 4. CONTROLS AND PROCEDURES

 

(a) Evaluation of disclosure controls and procedures. We maintain disclosure controls and procedures designed to ensure that information required to be disclosed in reports filed under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating our disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives.

As required by SEC Rule 15d-15, our management carried out an evaluation, under the supervision and with the participation of our principal executive officer and principal financial officer, of the effectiveness of our disclosure controls and procedures as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on that evaluation, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures were effective at a reasonable assurance level as of the end of the period covered by this report.

(b) Changes in internal controls. There were no changes in our internal control over financial reporting that occurred during the three months ended June 30, 2019 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

 27 

 

 

 

PART II - OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS.

 

None.

 

ITEM 1A. RISK FACTORS.

 

Smaller reporting companies are not required to provide this information.

  

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

 

None.

  

ITEM 3. DEFAULTS UPON SENIOR SECURITIES.

 

None.

 

ITEM 4. MINE SAFETY DISCLOSURES.

 

None.

 

ITEM 5. OTHER INFORMATION.

 

None.


 

 28 

 

 

 

ITEM 6. EXHIBITS.

 

EXHIBIT
NUMBER
  DESCRIPTION   LOCATION
         
         
31.1    Certifications of the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002   Filed herewith
31.2   Certification of the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002    Filed herewith
32.1   Certification Pursuant To 18 U.S.C. Section 1350, As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act Of 2002*   Filed herewith
32.2    Certification Pursuant To 18 U.S.C. Section 1350, As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002*   Filed herewith
101. INS   XBRL Instance Document   Filed herewith
         
101. CAL   XBRL Taxonomy Extension Calculation Link base Document   Filed herewith
         
101. DEF   XBRL Taxonomy Extension Definition Link base Document   Filed herewith
         
101. LAB   XBRL Taxonomy Label Link base Document   Filed herewith
         
101. PRE   XBRL Extension Presentation Link base Document   Filed herewith
         
101. SCH   XBRL Taxonomy Extension Scheme Document   Filed herewith

 

 

 29 

 

 

SIGNATURES 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

 

Dated: August 14, 2019 By:   /s/ Philip L. Rose
  Name:   Philip L. Rose
  Title:   Chief Executive Officer
       
Dated: August 14, 2019 By:   /s/ Jacqueline M. Lemke
  Name:   Jacqueline M. Lemke
  Title:   Chief Financial Officer

 

 

 

 30 

EX-31.1 2 e1451_31-1.htm EXHIBIT 31.1

Exhibit 31.1

 

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

PURSUANT TO RULE 13a-14(a) OF THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Philip L. Rose, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of XG Sciences, Inc. for the period ended June 30, 2019;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the consolidated financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The issuer’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f) for the registrant and have:

 

  (a) designed such disclosure controls and procedures, or have caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  (b) designed such internal controls over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of consolidated financial statements for external purposes in accordance with generally accepted accounting principles;

 

  (c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the period covered by this report based on such evaluation; and

 

  (d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The issuer’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent function):

 

  (a) all significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process summarize and report financial information; and

 

  (b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

 

DATE: August 14, 2019

 

  By: /s/ Philip L. Rose
 

Name: Philip L. Rose

Title: Chief Executive Officer

EX-31.2 3 e1451_31-2.htm EXHIBIT 31.2

Exhibit 31.2

 

CERTIFICATION OF FINANCIAL OFFICER

PURSUANT TO RULE 13a-14(a) OF THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Jacqueline M. Lemke, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of XG Sciences, Inc. for the period ended June 30, 2019;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the consolidated financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The issuer’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f) for the registrant and have:

 

  (a) designed such disclosure controls and procedures, or have caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  (b) designed such internal controls over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of consolidated financial statements for external purposes in accordance with generally accepted accounting principles;

 

  (c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the period covered by this report based on such evaluation; and

 

  (d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The issuer’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent function):

 

  (a) all significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process summarize and report financial information; and

 

  (b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

 

DATE: August 14, 2019

 

  By: /s/ Jacqueline M. Lemke
 

Name: Jacqueline M. Lemke

Title: Chief Financial Officer

 

EX-32.1 4 e1451_32-1.htm EXHIBIT 32.1

Exhibit 32.1

 

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the quarterly report of XG Sciences, Inc. (the “Company”) on Form 10-Q for the period ended June 30, 2019 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Philip L. Rose, Principal Executive Officer and Principal Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

 

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

DATE: August 14, 2019

 

  By:/s/ Philip L. Rose
  Name: Philip L. Rose
  Titles: Chief Executive Officer

 

 

EX-32.2 5 e1451_32-2.htm EXHIBIT 32.2

Exhibit 32.2

 

CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the quarterly report of XG Sciences, Inc. (the “Company”) on Form 10-Q for the period ended June 30, 2019 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Jacqueline M. Lemke, Principal Executive Officer and Principal Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

 

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

DATE: August 14, 2019

 

  By:/s/ Jacqueline M. Lemke
  Name: Jacqueline M. Lemke
  Titles: Chief Financial Officer

 

GRAPHIC 6 image_001.jpg GRAPHIC begin 644 image_001.jpg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image_002.jpg GRAPHIC begin 644 image_002.jpg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end GRAPHIC 8 image_003.jpg GRAPHIC begin 644 image_003.jpg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end GRAPHIC 9 image_004.jpg GRAPHIC begin 644 image_004.jpg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end GRAPHIC 10 image_005.jpg GRAPHIC begin 644 image_005.jpg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end EX-101.LAB 11 cik0001435375-20190630_lab.xml XBRL LABEL FILE Product and Service [Axis] Product Sales [Member] Equity Components [Axis] Preferred stock A Common Stock Additional Paid-In Capital Accumulated Deficit Subsequent Event Type [Axis] Subsequent Event [Member] Type of Arrangement and Non-arrangement Transactions [Axis] Draw Loan Note And Agreement [Member] Debt Instrument [Axis] Senior Secured Debt Financing [Member] Legal Entity [Axis] The Dow Chemical Company [Member] Warrant [Member] Warrant 1 [Member] Warrant 2 [Member] Range [Axis] Minimum [Member] Maximum [Member] Warrant 3 [Member] Warrant 4 [Member] Warrant 5 [Member] Warrant 6 [Member] Warrant 7 [Member] Warrant 8 [Member] Warrant 9 [Member] Warrant 10 [Member] Warrant 11 [Member] Sale of Stock [Axis] IPO [Member] Class of Stock [Axis] Series A Convertible Preferred Stock [Member] Plan Name [Axis] 2007 Stock Option Plan [Member] Award Type [Axis] Stock Option [Member] Restricted Common Stock [Member] Related Party [Axis] Directors [Member] Licensing Agreement [Member] Michigan State University (Patents and Pending Patents) [Member] Master Leasing Agreement [Member] Aspen Advance Opportunity Fund, LP [Member] Preferred stock (A) [Member] Document And Entity Information Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Current Fiscal Year End Date Entity File Number Entity Incorporation, State or Country Code Entity a Well-known Seasoned Issuer Entity a Voluntary Filer Entity's Reporting Status Current Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Entity Ex Transition Period Entity Shell Company Entity Common Stock, Shares Outstanding Document Fiscal Period Focus Document Fiscal Year Focus Statement of Financial Position [Abstract] ASSET CURRENT ASSETS Cash Accounts receivable, less allowance for doubtful accounts of $26,000 at June 30, 2019 and $85,000 at December 31, 2018 Inventories Other current assets Total current assets LONG-TERM ASSETS Property, Plant and Equipment, Net Restricted Cash for Letter of Credit Lease Deposit Intangible Assets, Net Right of Use Asset Total Long-Term Assets TOTAL ASSETS LIABILITIES AND STOCKHOLDERS' EQUITY CURRENT LIABILITIES Accounts payable Other current liabilities Deferred revenue Current portion of long-term debt Current portion of lease liabilities Total current liabilities LONG-TERM LIABILITIES Long-term portion of lease liabilities Long term debt Total long-term liabilities TOTAL LIABILITIES STOCKHOLDERS' EQUITY Series A convertible preferred stock, 3,000,000 shares authorized, 1,890,354 shares issued and outstanding, liquidation value of $22,684,248 at June 30, 2019 and December 31, 2018 Common stock, no par value, 25,000,000 shares authorized, 4,011,943 and 3,760,268 shares issued and outstanding at June 30, 2019 and December 31, 2018, respectively Additional paid-in capital Accumulated deficit Total stockholders' equity TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY Allowance for doubtful accounts Series A convertible preferred stock, authorized Series A convertible Preferred stock, issued Series A convertible preferred stock, outstanding Series A convertible preferred stock liquidation value Common stock, no par value (in dollars per share) Common stock, authorized Common stock, issued Common stock, outstanding Statement [Table] Statement [Line Items] REVENUE Total revenue COST OF GOODS SOLD Direct costs Unallocated manufacturing expenses Total cost of goods sold GROSS LOSS OPERATING EXPENSES Research and development Sales, general and administrative Total operating expenses OPERATING LOSS OTHER INCOME (EXPENSE) Interest expense, net Government incentives, net Total other expense NET LOSS WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING - Basic and diluted (in shares) NET LOSS PER SHARE - Basic and diluted (in dollars per share) Increase (Decrease) in Stockholders' Equity [Roll Forward] Balances at beginning Balances at beginning (in shares) Stock issued for cash Stock issued for cash (in shares) Stock issuance fees and expenses Preferred stock issued to pay capital lease obligations Preferred stock issued to pay capital lease obligations (in shares) Transition adjustment for adoption of new lease standard Stock-based compensation Net loss Balances at ending Balances at ending (in shares) Statement of Cash Flows [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES Depreciation Amortization of intangible assets Provision for bad debts Stock-based compensation expense Non-cash interest expense Non-cash equipment rent expense Changes in current assets and liabilities: Accounts receivable Inventory Other current and non-current assets Accounts payable and other liabilities NET CASH USED IN OPERATING ACTIVITIES CASH FLOWS FROM INVESTING ACTIVITIES Purchases of property and equipment Purchases of intangible assets NET CASH USED IN INVESTING ACTIVITIES CASH FLOWS FROM FINANCING ACTIVITIES Repayments of capital lease obligations Repayments of long-term loan debt Proceeds from issuance of common stock Common stock issuance fees and expenses NET CASH PROVIDED BY FINANCING ACTIVITIES NET CHANGE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH CASH, CASH EQUIVALENTS AND RESTRICTED CASH, BEGINNING OF PERIOD CASH, CASH EQUIVALENTS AND RESTRICTED CASH, END OF PERIOD SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION: Cash paid for interest SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES: Value of preferred stock issued for AAOF capital lease obligations Organization, Consolidation and Presentation of Financial Statements [Abstract] NATURE OF BUSINESS AND BASIS OF PRESENTATION Accounting Policies [Abstract] UPDATES TO SIGNIFICANT ACCOUNTING POLICIES Warrants And Financing Agreements FINANCING AGREEMENTS Equity [Abstract] STOCK WARRANTS ACCOUNTED FOR AS EQUITY INSTRUMENTS Stockholders Equity Deficit STOCKHOLDERS' EQUITY (DEFICIT) Share-based Payment Arrangement [Abstract] EQUITY INCENTIVE PLAN Capital Leases of Lessee [Abstract] LEASES Related Party Transactions [Abstract] RELATED PARTY TRANSACTIONS Revenue Recognition Liquidity Inventory Recent Accounting Pronouncements Adoption of Lease Accounting Policy Schedule of inventory Stock Warrants Accounted For As Equity Instruments Tables Schedule of common stock warrants (including the warrants previously accounted for as derivatives) outstanding Schedule of summary of the stock option activity Right of Use Asset and Leased Liability Schedule of Future Minimum Rental Payments Raw materials Consumables Finished goods Total Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Cash on hand Sale of common stock Share price per share Proceeds from sale of stock Amount borrowed Proceeds from secured debt ROU assets Lease liabilities Decrease in retained earnings Face amount Equity capital raise amount Amortization expense of debt Additional equity capital Number of shares purchased (in shares) Exercise price (in dollars per share) Description of conversion terms Unamortized discount Interest rate (in percent) Maturity date Effective intrest rate Non-cash interest expense Amortization from debt discount Repayment of debt Equity capital description Interest payable Statistical Measurement [Axis] Date Issued Expiration Date Indexed stock Exercise Price Number of Warrants Number of shares issued in offering Price per share (in dollars per share) Proceeds from issuance initial public offering Preferred stock, authorized Liquidation (in dollars per share) Description of conversion of stock Conversion price (in dollars per share) Reduction in share price (in dollars per share) Preferred stock, issued Preferred stock, outstanding Number of shares issued Preferred Stock converted into common stock Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Equity Incentive Plan Details Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Options outstanding at beginning of year Changes during the year: Expired New Options Granted - at market price Options outstanding at end of Period Options exercisable at end of Period Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [RollForward] Options outstanding at beginning of year Changes during the year: Expired New Options Granted - at market price Options outstanding at end of Period Options exercisable at end of Period Number of shares awarded (in shares) Number of options granted (in shares) Stock based compensation Unrecognized compensation cost Intrinsic value (in dollars per share) Exercise price (in dollars per share) Vesting period Description of cancellation terms Compensation cost for cancelled stock options Unvested awards, compensation cost Number of shares vested (in shares) Description of vesting terms Aggregate grant date fair value Unrecognized compensation expense period Exercise Price (in dollars per share) Stock Price Expected Term Volatility Risk free interest rate Dividend rate Weighted average fair value of options granted during the year Weighted average remaining contractual term (in months) Right-of-use lease assets- operating at beginning Less: Accumulated amortization Right-of-use lease assets- operating at end Lease liability-operating at beginning Less: Accumulated Amortization Lease liability operating at end Operating lease expense Actual remaining lease payments Present value of remaining payments Operating Leases Details Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases Weighted average remaining lease term- operating leases ( in months) Weighted average discount rate- operating leases (annual) Maturities of leases liabilities Year ending December 31, 2019 (excluding the three months ended March 31, 2019) Year ending December 31, 2020 Year ending December 31, 2021 Year ending December 31, 2022 Total Lease payments Less imputed interest Total Licensing expenses Number of shares issued Government incentives, net. The entire disclosure of liquidity. Amount of noncash equipment rent expense. Amount of restricted cash for letter of credit. Equity impact of the value of preferred stock issued for capita; lease obligations. Represent information about the stock issued during period value for the shares preferred stock issued to pay capital lease obligations. Represent information about the stock issued during period shares preferred stock issued to pay capital lease obligations. Information about agreement. The set of legal entities associated with a report. It represents value of equity capital raise amount. It referse the additional equity capital raise. Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount. Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount. Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount. Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount. Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount. Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount. Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount. Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount. Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount. Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount. Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount. Date the warrants or rights are exercisable, in CCYY-MM-DD format. Date the warrants or rights are exercisable, in CCYY-MM-DD format. Represents as a indexed stock of warrant. Information related to number of warrants issued during period. The price per share of the conversion feature embedded in the debt instrument. The amount of reduction in per share of common stock or unit outstanding during the reporting period. Information by plan name pertaining to equity-based compensation arrangements. Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding. Disclosure about cancellation terms. It represents value of compensation cost for cancelled stock options. It represents value of aggregate grant date fair value. Information by category of arrangement, Information by type of related party. Information about master leasing agreement. Information about legal entity. Assets, Current Assets, Noncurrent Assets Liabilities, Current Liabilities, Noncurrent Liabilities Stockholders' Equity Attributable to Parent Liabilities and Equity Cost of Goods and Services Sold Gross Profit Operating Expenses Operating Income (Loss) Interest Expense Nonoperating Income (Expense) Shares, Outstanding Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs Increase (Decrease) in Accounts Receivable Increase (Decrease) in Inventories Net Cash Provided by (Used in) Operating Activities Payments to Acquire Property, Plant, and Equipment Payments to Acquire Intangible Assets Net Cash Provided by (Used in) Investing Activities Repayments of Long-term Debt Payments of Stock Issuance Costs Net Cash Provided by (Used in) Financing Activities Cash, Period Increase (Decrease) Cash and Cash Equivalents, at Carrying Value Warrant 6 [Member] [Default Label] Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price OperatingLeaseRightOfUseAssets Operating Leases, Future Minimum Payments Due Warrants And Financing Agreements [Default Label] Reclassification of Derivative Liability Warrants to Equity EX-101.PRE 12 cik0001435375-20190630_pre.xml XBRL PRESENTATION FILE EX-101.INS 13 cik0001435375-20190630.xml XBRL INSTANCE FILE 0001435375 2019-01-01 2019-06-30 0001435375 2019-06-30 0001435375 2018-12-31 0001435375 2018-01-01 2018-06-30 0001435375 2019-08-14 0001435375 us-gaap:ProductMember 2019-01-01 2019-06-30 0001435375 us-gaap:ProductMember 2018-01-01 2018-06-30 0001435375 2017-12-31 0001435375 2018-06-30 0001435375 us-gaap:ProductMember 2019-04-01 2019-06-30 0001435375 us-gaap:ProductMember 2018-04-01 2018-06-30 0001435375 2019-04-01 2019-06-30 0001435375 2018-04-01 2018-06-30 0001435375 cik0001435375:PreferredStockAMember 2019-01-01 2019-06-30 0001435375 cik0001435375:PreferredStockAMember 2018-01-01 2018-06-30 0001435375 cik0001435375:PreferredStockAMember 2019-04-01 2019-06-30 0001435375 cik0001435375:PreferredStockAMember 2018-04-01 2018-06-30 0001435375 cik0001435375:PreferredStockAMember 2018-12-31 0001435375 cik0001435375:PreferredStockAMember 2019-06-30 0001435375 cik0001435375:PreferredStockAMember 2017-12-31 0001435375 cik0001435375:PreferredStockAMember 2018-06-30 0001435375 cik0001435375:PreferredStockAMember 2019-03-31 0001435375 cik0001435375:PreferredStockAMember 2018-03-31 0001435375 us-gaap:CommonStockMember 2019-01-01 2019-06-30 0001435375 us-gaap:CommonStockMember 2018-01-01 2018-06-30 0001435375 us-gaap:CommonStockMember 2019-04-01 2019-06-30 0001435375 us-gaap:CommonStockMember 2018-04-01 2018-06-30 0001435375 us-gaap:CommonStockMember 2018-12-31 0001435375 us-gaap:CommonStockMember 2019-06-30 0001435375 us-gaap:CommonStockMember 2017-12-31 0001435375 us-gaap:CommonStockMember 2018-06-30 0001435375 us-gaap:CommonStockMember 2019-03-31 0001435375 us-gaap:CommonStockMember 2018-03-31 0001435375 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-06-30 0001435375 us-gaap:AdditionalPaidInCapitalMember 2018-01-01 2018-06-30 0001435375 us-gaap:AdditionalPaidInCapitalMember 2019-04-01 2019-06-30 0001435375 us-gaap:AdditionalPaidInCapitalMember 2018-04-01 2018-06-30 0001435375 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0001435375 us-gaap:AdditionalPaidInCapitalMember 2019-06-30 0001435375 us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0001435375 us-gaap:AdditionalPaidInCapitalMember 2018-06-30 0001435375 us-gaap:AdditionalPaidInCapitalMember 2019-03-31 0001435375 us-gaap:AdditionalPaidInCapitalMember 2018-03-31 0001435375 us-gaap:RetainedEarningsMember 2019-01-01 2019-06-30 0001435375 us-gaap:RetainedEarningsMember 2018-01-01 2018-06-30 0001435375 us-gaap:RetainedEarningsMember 2019-04-01 2019-06-30 0001435375 us-gaap:RetainedEarningsMember 2018-04-01 2018-06-30 0001435375 us-gaap:RetainedEarningsMember 2018-12-31 0001435375 us-gaap:RetainedEarningsMember 2019-06-30 0001435375 us-gaap:RetainedEarningsMember 2017-12-31 0001435375 us-gaap:RetainedEarningsMember 2018-06-30 0001435375 us-gaap:RetainedEarningsMember 2019-03-31 0001435375 us-gaap:RetainedEarningsMember 2018-03-31 0001435375 2019-03-31 0001435375 2018-03-31 0001435375 us-gaap:SubsequentEventMember 2019-08-12 0001435375 cik0001435375:DrawLoanNoteAndAgreementMember us-gaap:SecuredDebtMember 2019-01-01 2019-06-30 0001435375 2019-04-01 2019-04-12 0001435375 2019-04-12 0001435375 us-gaap:SubsequentEventMember cik0001435375:DrawLoanNoteAndAgreementMember 2019-07-02 2019-07-08 0001435375 cik0001435375:DrawLoanNoteAndAgreementMember us-gaap:SecuredDebtMember cik0001435375:TheDowChemicalCompanyMember 2019-06-30 0001435375 cik0001435375:DrawLoanNoteAndAgreementMember us-gaap:SecuredDebtMember cik0001435375:TheDowChemicalCompanyMember 2019-01-01 2019-06-30 0001435375 cik0001435375:DrawLoanNoteAndAgreementMember us-gaap:SecuredDebtMember cik0001435375:TheDowChemicalCompanyMember 2017-09-21 2017-09-22 0001435375 cik0001435375:DrawLoanNoteAndAgreementMember us-gaap:SecuredDebtMember cik0001435375:TheDowChemicalCompanyMember 2017-07-17 2017-07-18 0001435375 cik0001435375:DrawLoanNoteAndAgreementMember us-gaap:SecuredDebtMember cik0001435375:TheDowChemicalCompanyMember 2016-12-03 2016-12-04 0001435375 cik0001435375:DrawLoanNoteAndAgreementMember us-gaap:SecuredDebtMember cik0001435375:TheDowChemicalCompanyMember 2016-12-02 2016-12-31 0001435375 cik0001435375:DrawLoanNoteAndAgreementMember us-gaap:SecuredDebtMember cik0001435375:TheDowChemicalCompanyMember 2016-12-31 0001435375 cik0001435375:DrawLoanNoteAndAgreementMember us-gaap:SecuredDebtMember cik0001435375:TheDowChemicalCompanyMember 2019-04-02 0001435375 cik0001435375:DrawLoanNoteAndAgreementMember us-gaap:SecuredDebtMember cik0001435375:TheDowChemicalCompanyMember 2019-07-01 0001435375 us-gaap:WarrantMember 2019-01-01 2019-06-30 0001435375 cik0001435375:Warrant1Member 2019-01-01 2019-06-30 0001435375 cik0001435375:Warrant2Member srt:MinimumMember 2019-01-01 2019-06-30 0001435375 cik0001435375:Warrant2Member srt:MaximumMember 2019-01-01 2019-06-30 0001435375 cik0001435375:Warrant3Member srt:MinimumMember 2019-01-01 2019-06-30 0001435375 cik0001435375:Warrant3Member srt:MaximumMember 2019-01-01 2019-06-30 0001435375 cik0001435375:Warrant2Member 2019-01-01 2019-06-30 0001435375 cik0001435375:Warrant3Member 2019-01-01 2019-06-30 0001435375 cik0001435375:Warrant4Member 2019-01-01 2019-06-30 0001435375 cik0001435375:Warrant5Member 2019-01-01 2019-06-30 0001435375 cik0001435375:Warrant6Member 2019-01-01 2019-06-30 0001435375 cik0001435375:Warrant7Member 2019-01-01 2019-06-30 0001435375 cik0001435375:Warrant8Member 2019-01-01 2019-06-30 0001435375 cik0001435375:Warrant9Member 2019-01-01 2019-06-30 0001435375 cik0001435375:Warrant10Member 2019-01-01 2019-06-30 0001435375 cik0001435375:Warrant11Member 2019-01-01 2019-06-30 0001435375 us-gaap:WarrantMember 2019-06-30 0001435375 cik0001435375:Warrant1Member 2019-06-30 0001435375 cik0001435375:Warrant2Member 2019-06-30 0001435375 cik0001435375:Warrant3Member 2019-06-30 0001435375 cik0001435375:Warrant4Member 2019-06-30 0001435375 cik0001435375:Warrant5Member 2019-06-30 0001435375 cik0001435375:Warrant6Member 2019-06-30 0001435375 cik0001435375:Warrant7Member 2019-06-30 0001435375 cik0001435375:Warrant8Member 2019-06-30 0001435375 cik0001435375:Warrant9Member 2019-06-30 0001435375 cik0001435375:Warrant10Member 2019-06-30 0001435375 cik0001435375:Warrant11Member 2019-06-30 0001435375 us-gaap:IPOMember 2019-01-01 2019-06-30 0001435375 us-gaap:IPOMember 2018-01-01 2018-06-30 0001435375 us-gaap:IPOMember 2019-04-01 2019-04-12 0001435375 us-gaap:IPOMember 2019-04-12 0001435375 us-gaap:ConvertiblePreferredStockMember 2015-01-01 2015-12-31 0001435375 us-gaap:ConvertiblePreferredStockMember 2019-01-01 2019-06-30 0001435375 us-gaap:ConvertiblePreferredStockMember 2019-06-30 0001435375 us-gaap:ConvertiblePreferredStockMember 2015-12-31 0001435375 cik0001435375:StockOptionPlan2007Member 2017-06-01 2017-06-24 0001435375 cik0001435375:StockOptionPlan2007Member 2019-06-30 0001435375 cik0001435375:StockOptionPlan2007Member 2019-01-01 2019-06-30 0001435375 us-gaap:EmployeeStockOptionMember 2019-04-01 2019-06-30 0001435375 cik0001435375:StockOptionPlan2007Member us-gaap:RestrictedStockMember cik0001435375:BoardDirectorMember 2019-01-01 2019-06-30 0001435375 srt:MinimumMember 2019-01-01 2019-06-30 0001435375 srt:MaximumMember 2019-01-01 2019-06-30 0001435375 cik0001435375:StockOptionPlan2007Member srt:MaximumMember 2019-06-30 0001435375 cik0001435375:StockOptionPlan2007Member us-gaap:EmployeeStockOptionMember cik0001435375:BoardDirectorMember 2018-09-01 2018-09-30 0001435375 cik0001435375:StockOptionPlan2007Member us-gaap:RestrictedStockMember cik0001435375:BoardDirectorMember 2017-08-09 2017-08-10 0001435375 cik0001435375:LicensingAgreementMember cik0001435375:MichiganStateUniversityMember 2019-04-01 2019-06-30 0001435375 cik0001435375:LicensingAgreementMember cik0001435375:MichiganStateUniversityMember 2018-04-01 2018-06-30 0001435375 cik0001435375:MasterLeasingAgreementMember cik0001435375:AspenAdvanceOpportunityFundLPMember us-gaap:SeriesAPreferredStockMember 2019-04-01 2019-06-30 0001435375 cik0001435375:MasterLeasingAgreementMember cik0001435375:AspenAdvanceOpportunityFundLPMember us-gaap:SeriesAPreferredStockMember 2018-01-01 2018-06-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure XG SCIENCES INC 0001435375 10-Q 2019-06-30 false --12-31 Yes Non-accelerated Filer true true false 4011943 Q2 2019 3000000 3000000 1890354 1890354 1890354 1890354 22684248 22684248 0 0 25000000 25000000 4011943 3760268 4011943 3760268 false Yes 333-209131 MI 1735721 4703834 2680604 2387769 4990719 1097472 1673976 22307480 22307480 21917046 22088389 22307480 22002717 30268476 32301876 19116012 23034814 30682476 20741574 8101923 8280579 7831958 7966189 8190211 7899722 -55687160 -60502166 -47767544 -51415416 -58003655 -49641639 3176512 1002374 26000 85000 -4698687 -3647872 -2498511 -1773776 -4698687 -3647872 -2498511 -1773776 2013400 3945400 1603400 2330000 2013400 3945400 1603400 2330000 20000 66598 4000 56760 20000 66598 4000 56760 171343 85672 171343 85672 218656 174231 110368 86467 40000 40000 20000 20000 178656 134231 90368 66467 1890354 1890354 1857816 1872096 1890354 1864956 3760268 4011943 2353350 2846525 3811518 2555275 251675 493175 200425 291250 0 7140 14280 7140 -116319 -116319 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 1 &#8211; NATURE OF BUSINESS AND BASIS OF PRESENTATION</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">XG Sciences, Inc., a Michigan company located in Lansing, Michigan and its subsidiary, XG Sciences IP, LLC (collectively referred to as &#8220;we&#8221;, &#8220;us&#8221;, &#8220;our&#8221;, or the &#8220;Company&#8221;) manufactures graphene nanoplatelets made from graphite, using two proprietary manufacturing processes to split natural flakes of crystalline graphite into very small and thin particles, which we sell as xGnP<sup>&#174;</sup> graphene nanoplatelets. We sell our nanoplatelets in the form of bulk powders or dispersions to other companies for use as additives to make composite and other materials with specialty engineered characteristics. We also manufacture and sell integrated, value-added products containing these graphene nanoplatelets such as greases, composites, thin sheets, inks and coating formulations that we sell to other companies. Additionally, we have licensed our technology to other companies in exchange for royalties and other fees.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Basis of Presentation</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The accompanying interim condensed consolidated financial statements are unaudited and have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) for interim financial information and the instructions to Form 10-Q and do not include all of the information and footnotes required by GAAP for complete financial statements. All intercompany transactions have been eliminated in consolidation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Certain information and footnote disclosures normally included in our annual audited consolidated financial statements and accompanying notes have been condensed or omitted in these interim condensed consolidated financial statements. Accordingly, the unaudited condensed consolidated financial statements included herein should be read in conjunction with the audited consolidated financial statements for the year ended December 31, 2018, as filed with the Securities and Exchange Commission (&#8220;SEC&#8221;) on Form 10-K/A on April 3, 2019.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The results of operations presented in this quarterly report are not necessarily indicative of the results of operations that may be expected for any future periods. In the opinion of management, these unaudited condensed consolidated financial statements include all adjustments and accruals, consisting only of normal recurring adjustments that are necessary for a fair statement of the results of all interim periods reported herein.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><u>Use of Estimates</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of our condensed consolidated financial statements in conformity with GAAP requires us to make estimates, judgments and assumptions that affect the reported amounts of assets, liabilities, revenue and expenses, together with amounts disclosed in the related notes to the financial statements. Actual results and outcomes may differ from our estimates, judgments and assumptions. Significant estimates, judgments and assumptions used in these condensed consolidated financial statements include, but are not limited to, those related to revenue, accounts receivable and related allowances, inventory valuations, contingencies, useful lives and recovery of long-term assets, including intangible assets, income taxes, and the fair value of stock-based compensation. These estimates, judgments, and assumptions are reviewed periodically and the effects of material revisions in estimates are reflected in the financial statements prospectively from the date of the change in estimate.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 2 &#8211; UPDATES TO SIGNIFICANT ACCOUNTING POLICIES</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><u>Revenue Recognition</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Revenues are recognized at a point in time, typically when control of the promised goods is transferred to customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods. The Company does not recognize revenue in cases where collectability is not probable, and defers the recognition until collection is probable or payment is received.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 10pt">The Company generally expenses sales commissions when incurred because the amortization period would have been one year or less. These costs are recorded within selling, general and administrative expenses. Customer deposits, deferred revenue and other receipts are deferred and recognized when the revenue is realized and earned.</font><font style="font-size: 8pt">&#160;&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Revenue related to licensing agreements is recorded upon substantial performance of the terms of the licensing contract. In the case of licensing arrangements that involve up-front payments, revenue is recorded when management determines that the appropriate terms of the contract have been fulfilled. For example, this may occur when technology has been transferred via written documents or, if training is involved, whenever all contracted training has occurred. In the case of licenses where product delivery is also embedded in the deliverable, a portion of revenue would be recognized when products are delivered.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We have also out-licensed certain intellectual property to licensees under terms and conditions of license agreements that specify the&#160;&#160; intellectual property licensed, the territory, and the type of license. In exchange for these licenses, we have recorded revenues associated with the initial granting of the license and expect to receive royalties based on sales of products produced under these licenses. License revenues are recorded to reflect our performance of requirements under these license agreements. In addition, we record royalty revenues from licensees at the time they are earned.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Grant contract revenue is recognized over the life of the contracts as the services are performed or as milestones are met.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Amounts received in excess of revenues earned are recorded as deferred revenue.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><u>Liquidity</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We have historically incurred recurring losses from operations and we may continue to generate negative cash flows as we implement our business plan. Our consolidated financial statements are prepared using GAAP as applicable to a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of August 12, 2019, we had cash on hand of $2,680,604. We believe our cash is sufficient to fund our operations through August 31, 2020 after taking into account various sources of funding and cash received from continued commercial sales transactions. Our primary means for raising funds since 2016 has been through our offering of shares of common stock at a fixed price of $8.00 per share to the general public in a self-underwritten offering (the &#8220;Offering&#8221; or our &#8220;IPO&#8221;) and under a draw loan note and agreement with The Dow Chemical Company (the &#8220;Dow Facility&#8221;). On April 12, 2019, we completed the Offering, after selling 2,615,425 shares under the Registration Statement at a price of $8.00 per share for total proceeds of $20,923,400. On July 8, 2019 we borrowed $2 million under the draw loan note and agreement with The Dow Chemical Company (the &#8220;Dow Facility&#8221;). We have $3 million of proceeds from the Dow Facility available to us, which we intend to be our primary source of liquidity at this time (See Note 3). &#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 10pt">There has been no public market for our securities and a public market may never develop, or, if any market does develop, it may not be sustained. Our common stock is not currently quoted on or traded on any exchange or on any over-the-counter market. In the event we are unable to fund our operations from existing cash on hand, operating cash flows, additional borrowings or raising equity capital, we may be forced to reduce our expenses, slow down our growth rate, or discontinue operations. Our condensed consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should we be unable to continue as a going concern.</font><font style="font-size: 8pt">&#160;&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;&#160;</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 10pt"><u>Inventory</u></font><font style="font-size: 8pt">&#160;&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt">The following amounts were included in inventory at the end of the period:</td><td>&#160;</td> <td colspan="7" style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td><td style="font-size: 10pt; font-weight: bold">&#160;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center">June 30,</td><td style="font-size: 10pt; font-weight: bold">&#160;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center">December 31,</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2019</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2018</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 68%; font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Raw materials</td><td style="width: 4%; font-size: 10pt">&#160;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 10%; font-size: 10pt; text-align: right">66,395</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 4%; font-size: 10pt">&#160;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 10%; font-size: 10pt; text-align: right">48,371</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-indent: -10pt; padding-left: 10pt">Consumables</td><td style="font-size: 10pt">&#160;</td> <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">160,630</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td> <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">188,764</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 10pt">Finished goods</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">738,553</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">423,082</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 10pt">Total</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">965,578</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">660,217</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Recent Accounting Pronouncements</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 10pt">In February 2016, the FASB issued Accounting Standards Update No. 2016-02, <i>Leases</i> (&#8220;ASU 2016-02&#8221;). The new standard establishes a right-of-use (&#8220;ROU&#8221;) model that requires a lessee to record a ROU asset and a lease liability on the balance sheet for all leases with terms longer than 12 months. Leases will be classified as either finance or operating, with classification affecting the pattern of expense recognition in the income statement. The new standard must be adopted using a modified retrospective transition and requires application of the new guidance at the beginning of the earliest comparative period presented.</font><font style="font-size: 8pt">&#160;&#160;</font><font style="font-size: 10pt">&#160;We adopted ASU 2016-02 as of January 1, 2019.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><font style="font-size: 10pt"><u>Adoption of Lease Accounting Policy</u></font><font style="font-size: 8pt">&#160;&#160;&#160;&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We applied ASU 2016-02 and all related amendments (&#8220;ASC 842&#8221;) using the modified retrospective method by recognizing the cumulative effect of adoption as an adjustment to the opening balance of retained earnings at January 1, 2019. Therefore, the comparative information has not been adjusted and continues to be reported under prior leasing guidance. As a result, in the first quarter of 2019 we recorded ROU assets of $1,871,366. We also recorded lease liabilities of $1,981,795. The decrease to retained earnings was $116,319, reflecting the cumulative impact of the accounting change. The standard did not have a material effect on consolidated net income or cash flows.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Right-of-use assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. As our leases do not provide an implicit rate, we used our incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. Lease expense for lease payments is recognized on a straight-line basis over the lease term.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We do not record a ROU asset or lease liability for leases with an expected term of 12 months or less. The comparative information has not been adjusted and continues to be reported under prior leasing guidance.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 4 &#8211; STOCK WARRANTS ACCOUNTED FOR AS EQUITY INSTRUMENTS</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table summarizes the warrants (including the warrants previously accounted for as derivatives) outstanding at June 30, 2019, which are accounted for as equity instruments, all of which are exercisable:&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td style="white-space: nowrap; vertical-align: bottom; border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>Date&#160;Issued</b></font></td> <td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="white-space: nowrap; vertical-align: bottom; border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>Expiration&#160;Date</b></font></td> <td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: top; border-bottom: black 1pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Indexed</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Stock</b></p></td> <td style="vertical-align: top; text-align: center">&#160;</td> <td colspan="2" style="white-space: nowrap; vertical-align: bottom; border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>Exercise&#160;Price</b></font></td> <td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td colspan="2" style="white-space: nowrap; vertical-align: bottom; border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>Number&#160;of&#160;</b></font><b><br /> <font style="font-size: 10pt">Warrants</font></b></td> <td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 1pt">&#160;</td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: bottom; width: 34%"><font style="font-size: 10pt">07/01/2009</font></td> <td style="vertical-align: bottom; width: 1%">&#160;</td> <td style="vertical-align: bottom; width: 16%"><font style="font-size: 10pt">07/01/2019</font></td> <td style="vertical-align: bottom; width: 1%">&#160;</td> <td style="vertical-align: top; width: 18%; text-align: center"><font style="font-size: 10pt">Common</font></td> <td style="vertical-align: top; width: 1%">&#160;</td> <td style="vertical-align: bottom; width: 1%"><font style="font-size: 10pt">$</font></td> <td style="vertical-align: bottom; width: 10%; text-align: right"><font style="font-size: 10pt">8.00</font></td> <td style="vertical-align: bottom; width: 1%">&#160;</td> <td style="vertical-align: bottom; width: 1%">&#160;</td> <td style="vertical-align: bottom; width: 1%">&#160;</td> <td style="vertical-align: bottom; width: 14%; text-align: right"><font style="font-size: 10pt">6,000</font></td> <td style="vertical-align: bottom; width: 1%">&#160;</td></tr> <tr style="background-color: white"> <td style="vertical-align: bottom; padding-bottom: 1pt"><font style="font-size: 10pt">10/08/2012</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 1pt"><font style="font-size: 10pt">10/08/2027</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: top; text-align: center"><font style="font-size: 10pt">Common</font></td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 1pt"><font style="font-size: 10pt">$</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt; text-align: right"><font style="font-size: 10pt">12.00</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: bottom">&#160;</td> <td style="vertical-align: bottom; text-align: right"><font style="font-size: 10pt">5,000</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: bottom; padding-bottom: 1pt"><font style="font-size: 10pt">01/15/2014 - 12/31/2014</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 1pt"><font style="font-size: 10pt">01/15/2024</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: top; text-align: center"><font style="font-size: 10pt">Series A Convertible Preferred</font></td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 1pt"><font style="font-size: 10pt">$</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt; text-align: right"><font style="font-size: 10pt">6.40</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: bottom">&#160;</td> <td style="vertical-align: bottom; text-align: right"><font style="font-size: 10pt">972,720</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td></tr> <tr style="background-color: white"> <td style="vertical-align: bottom; padding-bottom: 1pt"><font style="font-size: 10pt">04/30/2015- 05/26/2015</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 1pt"><font style="font-size: 10pt">04/30/2022</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: top; text-align: center"><font style="font-size: 10pt">Common</font></td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 1pt"><font style="font-size: 10pt">$</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt; text-align: right"><font style="font-size: 10pt">16.00</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: bottom">&#160;</td> <td style="vertical-align: bottom; text-align: right"><font style="font-size: 10pt">218,334</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: bottom; padding-bottom: 1pt"><font style="font-size: 10pt">06/30/2015</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 1pt"><font style="font-size: 10pt">06/30/2022</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: top; text-align: center"><font style="font-size: 10pt">Common</font></td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 1pt"><font style="font-size: 10pt">$</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt; text-align: right"><font style="font-size: 10pt">16.00</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: bottom">&#160;</td> <td style="vertical-align: bottom; text-align: right"><font style="font-size: 10pt">6,563</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td></tr> <tr style="background-color: white"> <td style="vertical-align: bottom; padding-bottom: 1pt"><font style="font-size: 10pt">12/31/2015</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 1pt"><font style="font-size: 10pt">12/31/2020</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: top; text-align: center"><font style="font-size: 10pt">Common</font></td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 1pt"><font style="font-size: 10pt">$</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt; text-align: right"><font style="font-size: 10pt">8.00</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: bottom">&#160;</td> <td style="vertical-align: bottom; text-align: right"><font style="font-size: 10pt">20,625</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: bottom; padding-bottom: 1pt"><font style="font-size: 10pt">03/31/2016</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 1pt"><font style="font-size: 10pt">03/31/2021</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: top; text-align: center"><font style="font-size: 10pt">Common</font></td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 1pt"><font style="font-size: 10pt">$</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt; text-align: right"><font style="font-size: 10pt">10.00</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: bottom">&#160;</td> <td style="vertical-align: bottom; text-align: right"><font style="font-size: 10pt">10,600</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td></tr> <tr style="background-color: white"> <td style="vertical-align: bottom; padding-bottom: 1pt"><font style="font-size: 10pt">04/30/2016</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 1pt"><font style="font-size: 10pt">04/30/2021</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: top; text-align: center"><font style="font-size: 10pt">Common</font></td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 1pt"><font style="font-size: 10pt">$</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt; text-align: right"><font style="font-size: 10pt">10.00</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: bottom">&#160;</td> <td style="vertical-align: bottom; text-align: right"><font style="font-size: 10pt">895</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: bottom; padding-bottom: 1pt"><font style="font-size: 10pt">12/14/2016</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 1pt"><font style="font-size: 10pt">12/01/2023</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: top; text-align: center"><font style="font-size: 10pt">Common</font></td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 1pt"><font style="font-size: 10pt">$</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt; text-align: right"><font style="font-size: 10pt">8.00</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: bottom">&#160;</td> <td style="vertical-align: bottom; text-align: right"><font style="font-size: 10pt">50,000</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td></tr> <tr style="background-color: white"> <td style="vertical-align: bottom; padding-bottom: 1pt"><font style="font-size: 10pt">07/18/2017</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 1pt"><font style="font-size: 10pt">12/01/2023</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: top; text-align: center"><font style="font-size: 10pt">Common</font></td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 1pt"><font style="font-size: 10pt">$</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt; text-align: right"><font style="font-size: 10pt">8.00</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: bottom">&#160;</td> <td style="vertical-align: bottom; text-align: right"><font style="font-size: 10pt">25,000</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: bottom; padding-bottom: 1pt"><font style="font-size: 10pt">09/22/2017</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 1pt"><font style="font-size: 10pt">12/01/2023</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: top; text-align: center"><font style="font-size: 10pt">Common</font></td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 1pt"><font style="font-size: 10pt">$</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt; text-align: right"><font style="font-size: 10pt">8.00</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: bottom">&#160;</td> <td style="vertical-align: bottom; text-align: right"><font style="font-size: 10pt">25,000</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td></tr> <tr style="background-color: white"> <td style="vertical-align: bottom; padding-bottom: 1pt"><font style="font-size: 10pt">12/04/2017</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 1pt"><font style="font-size: 10pt">12/01/2023</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: top; text-align: center"><font style="font-size: 10pt">Common</font></td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 1pt"><font style="font-size: 10pt">$</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt; text-align: right"><font style="font-size: 10pt">8.00</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: bottom">&#160;</td> <td style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">25,000</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: bottom; padding-bottom: 2.5pt">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 2.5pt">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 2.5pt">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 2.5pt">&#160;</td> <td style="vertical-align: top; text-align: center">&#160;</td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 2.5pt">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 2.5pt; text-align: right">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 2.5pt">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 2.5pt">&#160;</td> <td style="vertical-align: bottom">&#160;</td> <td style="vertical-align: bottom; border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">1,365,737</font></td> <td style="vertical-align: bottom; padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Each warrant indexed to Series A Convertible Preferred Stock is currently exercisable and exchangeable into 1.875 shares of common stock.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 5 &#8211; STOCKHOLDERS&#8217; EQUITY (DEFICIT)</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Common Stock</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company is authorized to issue 25,000,000 shares of common stock, no par value per share of which 4,011,943 and 3,760,268 shares were issued and outstanding as of June 30, 2019 and December 31, 2018, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 10pt">During the six months ended June 30, 2019 the Company issued 251,675 shares of common stock pursuant to the Offering. During the six months ended June 30, 2018 the Company issued 493,175 shares of common stock pursuant to the Offering. Upon its completion on April 12, 2019, the Company had sold 2,615,425 shares of common stock in its IPO at a price of $8.00 per share for gross proceeds of $20,923,400.</font><font style="font-size: 8pt">&#160;&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Potentially dilutive securities consist of shares potentially issuable pursuant to stock options and warrants as well as shares that would result from full conversion of all outstanding convertible securities. These potentially dilutive securities were 3,013,987 and 2,903,987 as of June 30, 2019 and 2018, respectively, and are excluded from diluted net loss per share calculations because they are anti-dilutive.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Series A Convertible Preferred Stock</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company is authorized to issue up to 3,000,000 shares of Series A Convertible Preferred Stock (the &#8220;Series A Preferred&#8221;). Each share of the Series A Preferred, which has a liquidation preference of $12.00 per share, is convertible at any time, at the option of the holder, into one share of common stock at the lower of: (a) $12.00 per share, or (b) 80% of the price at which the Company sells any equity or equity-linked securities in the future. The Series A Preferred also contains typical anti-dilution provisions that provide for adjustment of the conversion price to reflect stock splits, stock dividends, or similar events. The Series A Preferred is subject to mandatory conversion into common stock upon the listing of the Company&#8217;s common stock on a Qualified National Exchange. However, the Series A Preferred is not subject to the mandatory conversion until all outstanding convertible securities are also converted into common stock. The Series A Preferred ranks senior to all other equity or equity equivalent securities of the Company other than those securities which are explicitly senior or pari passu in rights and liquidation preference to the Series A Preferred and pari passu with the Company&#8217;s Series B Preferred Stock.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company issued 1,456,126 shares of Series A Preferred in connection with the conversion of certain convertible notes on December 31, 2015.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In December 2015, the conversion price of the Series A Preferred was reduced from $12.00 to $6.40 (80% of $8.00), and thus, each share of Series A Preferred Stock is convertible into 1.875 shares of common stock. During the period from May 17, 2016 through December 31, 2018 the Company issued shares of Series A Preferred Stock to Aspen Advanced Opportunity Fund, LP (&#8220;AAOF&#8221;) as payment for lease financing obligations under the terms of a Master Leasing Agreement.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of June 30, 2019, and December 31, 2018, the Company had 1,890,354 shares of Series A Preferred Stock issued and outstanding which is currently convertible into 3,544,414 shares of our common stock.</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 10pt"><b>NOTE 6 &#8211; EQUITY INCENTIVE PLAN</b></font><font style="font-size: 8pt">&#160;&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">We previously established the 2007 Stock Option Plan (the &#8220;2007 Plan&#8221;), which was scheduled to expire on October 30, 2017 and under which we granted key employees and directors options to purchase shares of our common stock at not less than fair market value as of the grant date.&#160;On May 4, 2017, the Board approved the 2017 Equity Incentive Plan (the &#8220;2017 Plan&#8221;) to replace the 2007 Plan, which became effective upon the approval of the stockholders holding a majority of the voting power in the Company on July 18, 2017. The 2017 Plan replaces the 2007 Plan and authorizes us to issue awards (stock options and restricted stock) with respect of a maximum of 1,200,000 shares of our common stock, which equals the number of shares authorized under the 2007 Plan. &#160;&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On July 24, 2017, certain stock options from the 2007 Plan were cancelled and replacement stock options were awarded. The replacement stock option awards have an exercise price of $8.00 per share, a seven-year term, are vested 50% on date of grant with the remaining vesting over a 4-year period from the date issued and are subject to certain other terms. Each option holder received options equal to 150% of the number of cancelled stock options. The cancellation and reissuance of the stock options were treated as a modification under ASC 718,&#160;<i>Compensation-Stock Compensation.&#160;</i>Incremental compensation cost of approximately&#160;$1,015,758 was measured as the excess of the fair value of the modified award over the fair value of the original award immediately before the terms were modified. Compensation cost of approximately $501,071 was recorded on the date of cancellation for awards that were vested on the date of the modification. For unvested awards, compensation cost of approximately $514,687 will be recorded over the remaining requisite service period.&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On September 30, 2018 and August 10, 2017, the Company granted each Board member 2,500 stock options and 2,500 shares of restricted stock for their Board services. The options were granted at a price of $8.00 per share and vest ratably over a four-year period beginning on the one-year anniversary. The options had an aggregate grant date fair value of $29,580 and $26,120 on September 30, 2018 and August 10, 2017, respectively. The restricted stock issued to the Board members has an aggregate fair value of $160,000 and vest ratably in arrears over four quarters on the last day of each fiscal quarter following the grant date. As of June 30, 2019, 20,000 of the 20,000 shares of restricted stock issued had vested, resulting in compensation expense of $20,000 for the period ended June 30, 2019.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">During the three months ended June 30, 2019, the Company granted 20,000 employee stock options. The options were granted at a price of $8.00 per share and had an aggregate grant date fair value of $61,644. The options vest ratably over a four-year period beginning on the one-year anniversary. The fair value of the options granted was estimated on the date of grant using the Black Scholes option-pricing model using the following assumptions: Stock price: $8.00, Exercise Price: $8.00, Expected Term: 4.75 years, Volatility: 42.71%, Risk free rate: 1.76%, Dividend rate: 0%.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">All options granted thus far under the 2017 Plan have an exercise price of $8.00 per share and vesting of the options ranges from immediate to 25% per year, with most options vesting 25% per year beginning on the one-year anniversary of the grant date. The options expire seven years from the date of grant.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><font style="font-size: 10pt">Stock-based compensation expense was $110,368 </font><font style="font-size: 8pt">&#160;&#160;&#160;</font><font style="font-size: 10pt">for the three months ended June 30, 2019. As of June 30, 2019, there was approximately $632,744 in unrecognized compensation cost related to the options granted under the 2017 plan. We expect to recognize these costs over the remaining vesting terms, ranging from 3 to 4 years.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">A summary of the stock options available as of June 30, 2019 is as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: justify">&#160;</td><td>&#160;</td> <td colspan="3" style="text-align: center">&#160;</td><td style="font-size: 10pt; font-weight: bold">&#160;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center">Weighted</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify">&#160;</td><td style="font-size: 10pt; font-weight: bold">&#160;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center">Number</td><td style="font-size: 10pt; font-weight: bold">&#160;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center">Average</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify">&#160;</td><td style="font-size: 10pt; font-weight: bold">&#160;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center">Of</td><td style="font-size: 10pt; font-weight: bold">&#160;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center">Exercise</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Options</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Price</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 68%; font-size: 10pt; text-align: justify">Options outstanding at March 31, 2019</td><td style="width: 4%; font-size: 10pt">&#160;</td> <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 10%; font-size: 10pt; text-align: right">805,375</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 4%; font-size: 10pt">&#160;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 10%; font-size: 10pt; text-align: right">8.00</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: justify">Changes during the period:</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: justify">Expired</td><td style="font-size: 10pt">&#160;</td> <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8212;&#160;&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td> <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">8.00</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: justify; padding-bottom: 1pt">New Options Granted &#8211; at market price</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">20,000</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">8.00</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: justify; padding-bottom: 2.5pt">Options outstanding at June 30, 2019</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">825,375</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">8.00</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: justify; padding-bottom: 2.5pt">Options exercisable at June 30, 2019</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">384,025</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">8.00</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 8 &#8211; RELATED PARTY TRANSACTIONS</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We have a licensing agreement for exclusive use of patents and pending patents with Michigan State University (&#8220;MSU&#8221;), a shareholder of the Company via the MSU Foundation. During the three months ended June 30, 2019 and 2018 we recorded licensing expense of $12,500 per quarter.&#160;&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We have also entered into product licensing agreements with certain other shareholders. No royalty revenue or expenses have been recognized related to these agreements during the three and six months ended June 30, 2019 or the three and six months ended June 30, 2018.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the three months ended June 30, 2019 we did not issue any Series A Preferred stock. For the six months ended June 30, 2018, we issued 7,140 shares of Series A Preferred stock to AAOF as payment for lease financing obligations under the terms of the Master Lease Agreement, dated March 18, 2013.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Revenue Recognition</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Revenues are recognized at a point in time, typically when control of the promised goods is transferred to customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods. The Company does not recognize revenue in cases where collectability is not probable, and defers the recognition until collection is probable or payment is received.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 10pt">The Company generally expenses sales commissions when incurred because the amortization period would have been one year or less. These costs are recorded within selling, general and administrative expenses. Customer deposits, deferred revenue and other receipts are deferred and recognized when the revenue is realized and earned.</font><font style="font-size: 8pt">&#160;&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Revenue related to licensing agreements is recorded upon substantial performance of the terms of the licensing contract. In the case of licensing arrangements that involve up-front payments, revenue is recorded when management determines that the appropriate terms of the contract have been fulfilled. For example, this may occur when technology has been transferred via written documents or, if training is involved, whenever all contracted training has occurred. In the case of licenses where product delivery is also embedded in the deliverable, a portion of revenue would be recognized when products are delivered.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We have also out-licensed certain intellectual property to licensees under terms and conditions of license agreements that specify the&#160;&#160; intellectual property licensed, the territory, and the type of license. In exchange for these licenses, we have recorded revenues associated with the initial granting of the license and expect to receive royalties based on sales of products produced under these licenses. License revenues are recorded to reflect our performance of requirements under these license agreements. In addition, we record royalty revenues from licensees at the time they are earned.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Grant contract revenue is recognized over the life of the contracts as the services are performed or as milestones are met.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Amounts received in excess of revenues earned are recorded as deferred revenue.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Liquidity</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We have historically incurred recurring losses from operations and we may continue to generate negative cash flows as we implement our business plan. Our consolidated financial statements are prepared using GAAP as applicable to a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of August 12, 2019, we had cash on hand of $2,680,604. We believe our cash is sufficient to fund our operations through August 31, 2020 after taking into account various sources of funding and cash received from continued commercial sales transactions. Our primary means for raising funds since 2016 has been through our offering of shares of common stock at a fixed price of $8.00 per share to the general public in a self-underwritten offering (the &#8220;Offering&#8221; or our &#8220;IPO&#8221;) and under a draw loan note and agreement with The Dow Chemical Company (the &#8220;Dow Facility&#8221;). On April 12, 2019, we completed the Offering, after selling 2,615,425 shares under the Registration Statement at a price of $8.00 per share for total proceeds of $20,923,400. On July 8, 2019 we borrowed $2 million under the draw loan note and agreement with The Dow Chemical Company (the &#8220;Dow Facility&#8221;). We have $3 million of proceeds from the Dow Facility available to us, which we intend to be our primary source of liquidity at this time (See Note 3). &#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 10pt">There has been no public market for our securities and a public market may never develop, or, if any market does develop, it may not be sustained. Our common stock is not currently quoted on or traded on any exchange or on any over-the-counter market. In the event we are unable to fund our operations from existing cash on hand, operating cash flows, additional borrowings or raising equity capital, we may be forced to reduce our expenses, slow down our growth rate, or discontinue operations. Our condensed consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should we be unable to continue as a going concern.</font><font style="font-size: 8pt">&#160;</font></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 10pt"><u>Inventory</u></font><font style="font-size: 8pt">&#160;&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; text-align: justify">The following amounts were included in inventory at the end of the period:</td><td>&#160;</td> <td colspan="7" style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td><td style="font-size: 10pt; font-weight: bold">&#160;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center">June 30,</td><td style="font-size: 10pt; font-weight: bold">&#160;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center">December 31,</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2019</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2018</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 68%; font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Raw materials</td><td style="width: 4%; font-size: 10pt">&#160;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 10%; font-size: 10pt; text-align: right">66,395</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 4%; font-size: 10pt">&#160;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 10%; font-size: 10pt; text-align: right">48,371</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-indent: -10pt; padding-left: 10pt">Consumables</td><td style="font-size: 10pt">&#160;</td> <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">160,630</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td> <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">188,764</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 10pt">Finished goods</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">738,553</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">423,082</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 10pt">Total</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">965,578</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">660,217</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Recent Accounting Pronouncements</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 10pt">In February 2016, the FASB issued Accounting Standards Update No. 2016-02, <i>Leases</i> (&#8220;ASU 2016-02&#8221;). The new standard establishes a right-of-use (&#8220;ROU&#8221;) model that requires a lessee to record a ROU asset and a lease liability on the balance sheet for all leases with terms longer than 12 months. Leases will be classified as either finance or operating, with classification affecting the pattern of expense recognition in the income statement. The new standard must be adopted using a modified retrospective transition and requires application of the new guidance at the beginning of the earliest comparative period presented.</font><font style="font-size: 8pt">&#160;&#160;</font><font style="font-size: 10pt">&#160;We adopted ASU 2016-02 as of January 1, 2019.</font></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><font style="font-size: 10pt"><u>Adoption of Lease Accounting Policy</u></font><font style="font-size: 8pt">&#160;&#160;&#160;&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We applied ASU 2016-02 and all related amendments (&#8220;ASC 842&#8221;) using the modified retrospective method by recognizing the cumulative effect of adoption as an adjustment to the opening balance of retained earnings at January 1, 2019. Therefore, the comparative information has not been adjusted and continues to be reported under prior leasing guidance. As a result, in the first quarter of 2019 we recorded ROU assets of $1,871,366. We also recorded lease liabilities of $1,981,795. The decrease to retained earnings was $116,319, reflecting the cumulative impact of the accounting change. The standard did not have a material effect on consolidated net income or cash flows.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Right-of-use assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. As our leases do not provide an implicit rate, we used our incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. Lease expense for lease payments is recognized on a straight-line basis over the lease term.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We do not record a ROU asset or lease liability for leases with an expected term of 12 months or less. The comparative information has not been adjusted and continues to be reported under prior leasing guidance.</p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif"><tr style="vertical-align: bottom"><td style="font-size: 10pt; text-align: justify">The following amounts were included in inventory at the end of the period:</td><td>&#160;</td> <td colspan="7" style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td><td style="font-size: 10pt; font-weight: bold">&#160;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center">June 30,</td><td style="font-size: 10pt; font-weight: bold">&#160;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center">December 31,</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2019</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2018</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 68%; font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Raw materials</td><td style="width: 4%; font-size: 10pt">&#160;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 10%; font-size: 10pt; text-align: right">66,395</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 4%; font-size: 10pt">&#160;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 10%; font-size: 10pt; text-align: right">48,371</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-indent: -10pt; padding-left: 10pt">Consumables</td><td style="font-size: 10pt">&#160;</td> <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">160,630</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td> <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">188,764</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 10pt">Finished goods</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">738,553</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">423,082</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 10pt">Total</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">965,578</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">660,217</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table summarizes the warrants (including the warrants previously accounted for as derivatives) outstanding at June 30, 2019, which are accounted for as equity instruments, all of which are exercisable:&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td style="white-space: nowrap; vertical-align: bottom; border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>Date&#160;Issued</b></font></td> <td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="white-space: nowrap; vertical-align: bottom; border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>Expiration&#160;Date</b></font></td> <td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: top; border-bottom: black 1pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Indexed</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Stock</b></p></td> <td style="vertical-align: top; text-align: center">&#160;</td> <td colspan="2" style="white-space: nowrap; vertical-align: bottom; border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>Exercise&#160;Price</b></font></td> <td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td colspan="2" style="white-space: nowrap; vertical-align: bottom; border-bottom: black 1pt solid; text-align: center"><font style="font-size: 10pt"><b>Number&#160;of&#160;</b></font><b><br /> <font style="font-size: 10pt">Warrants</font></b></td> <td style="white-space: nowrap; vertical-align: bottom; padding-bottom: 1pt">&#160;</td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: bottom; width: 34%"><font style="font-size: 10pt">07/01/2009</font></td> <td style="vertical-align: bottom; width: 1%">&#160;</td> <td style="vertical-align: bottom; width: 16%"><font style="font-size: 10pt">07/01/2019</font></td> <td style="vertical-align: bottom; width: 1%">&#160;</td> <td style="vertical-align: top; width: 18%; text-align: center"><font style="font-size: 10pt">Common</font></td> <td style="vertical-align: top; width: 1%">&#160;</td> <td style="vertical-align: bottom; width: 1%"><font style="font-size: 10pt">$</font></td> <td style="vertical-align: bottom; width: 10%; text-align: right"><font style="font-size: 10pt">8.00</font></td> <td style="vertical-align: bottom; width: 1%">&#160;</td> <td style="vertical-align: bottom; width: 1%">&#160;</td> <td style="vertical-align: bottom; width: 1%">&#160;</td> <td style="vertical-align: bottom; width: 14%; text-align: right"><font style="font-size: 10pt">6,000</font></td> <td style="vertical-align: bottom; width: 1%">&#160;</td></tr> <tr style="background-color: white"> <td style="vertical-align: bottom; padding-bottom: 1pt"><font style="font-size: 10pt">10/08/2012</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 1pt"><font style="font-size: 10pt">10/08/2027</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: top; text-align: center"><font style="font-size: 10pt">Common</font></td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 1pt"><font style="font-size: 10pt">$</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt; text-align: right"><font style="font-size: 10pt">12.00</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: bottom">&#160;</td> <td style="vertical-align: bottom; text-align: right"><font style="font-size: 10pt">5,000</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: bottom; padding-bottom: 1pt"><font style="font-size: 10pt">01/15/2014 - 12/31/2014</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 1pt"><font style="font-size: 10pt">01/15/2024</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: top; text-align: center"><font style="font-size: 10pt">Series A Convertible Preferred</font></td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 1pt"><font style="font-size: 10pt">$</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt; text-align: right"><font style="font-size: 10pt">6.40</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: bottom">&#160;</td> <td style="vertical-align: bottom; text-align: right"><font style="font-size: 10pt">972,720</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td></tr> <tr style="background-color: white"> <td style="vertical-align: bottom; padding-bottom: 1pt"><font style="font-size: 10pt">04/30/2015- 05/26/2015</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 1pt"><font style="font-size: 10pt">04/30/2022</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: top; text-align: center"><font style="font-size: 10pt">Common</font></td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 1pt"><font style="font-size: 10pt">$</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt; text-align: right"><font style="font-size: 10pt">16.00</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: bottom">&#160;</td> <td style="vertical-align: bottom; text-align: right"><font style="font-size: 10pt">218,334</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: bottom; padding-bottom: 1pt"><font style="font-size: 10pt">06/30/2015</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 1pt"><font style="font-size: 10pt">06/30/2022</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: top; text-align: center"><font style="font-size: 10pt">Common</font></td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 1pt"><font style="font-size: 10pt">$</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt; text-align: right"><font style="font-size: 10pt">16.00</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: bottom">&#160;</td> <td style="vertical-align: bottom; text-align: right"><font style="font-size: 10pt">6,563</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td></tr> <tr style="background-color: white"> <td style="vertical-align: bottom; padding-bottom: 1pt"><font style="font-size: 10pt">12/31/2015</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 1pt"><font style="font-size: 10pt">12/31/2020</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: top; text-align: center"><font style="font-size: 10pt">Common</font></td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 1pt"><font style="font-size: 10pt">$</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt; text-align: right"><font style="font-size: 10pt">8.00</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: bottom">&#160;</td> <td style="vertical-align: bottom; text-align: right"><font style="font-size: 10pt">20,625</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: bottom; padding-bottom: 1pt"><font style="font-size: 10pt">03/31/2016</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 1pt"><font style="font-size: 10pt">03/31/2021</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: top; text-align: center"><font style="font-size: 10pt">Common</font></td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 1pt"><font style="font-size: 10pt">$</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt; text-align: right"><font style="font-size: 10pt">10.00</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: bottom">&#160;</td> <td style="vertical-align: bottom; text-align: right"><font style="font-size: 10pt">10,600</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td></tr> <tr style="background-color: white"> <td style="vertical-align: bottom; padding-bottom: 1pt"><font style="font-size: 10pt">04/30/2016</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 1pt"><font style="font-size: 10pt">04/30/2021</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: top; text-align: center"><font style="font-size: 10pt">Common</font></td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 1pt"><font style="font-size: 10pt">$</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt; text-align: right"><font style="font-size: 10pt">10.00</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: bottom">&#160;</td> <td style="vertical-align: bottom; text-align: right"><font style="font-size: 10pt">895</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: bottom; padding-bottom: 1pt"><font style="font-size: 10pt">12/14/2016</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 1pt"><font style="font-size: 10pt">12/01/2023</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: top; text-align: center"><font style="font-size: 10pt">Common</font></td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 1pt"><font style="font-size: 10pt">$</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt; text-align: right"><font style="font-size: 10pt">8.00</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: bottom">&#160;</td> <td style="vertical-align: bottom; text-align: right"><font style="font-size: 10pt">50,000</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td></tr> <tr style="background-color: white"> <td style="vertical-align: bottom; padding-bottom: 1pt"><font style="font-size: 10pt">07/18/2017</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 1pt"><font style="font-size: 10pt">12/01/2023</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: top; text-align: center"><font style="font-size: 10pt">Common</font></td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 1pt"><font style="font-size: 10pt">$</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt; text-align: right"><font style="font-size: 10pt">8.00</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: bottom">&#160;</td> <td style="vertical-align: bottom; text-align: right"><font style="font-size: 10pt">25,000</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: bottom; padding-bottom: 1pt"><font style="font-size: 10pt">09/22/2017</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 1pt"><font style="font-size: 10pt">12/01/2023</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: top; text-align: center"><font style="font-size: 10pt">Common</font></td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 1pt"><font style="font-size: 10pt">$</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt; text-align: right"><font style="font-size: 10pt">8.00</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: bottom">&#160;</td> <td style="vertical-align: bottom; text-align: right"><font style="font-size: 10pt">25,000</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td></tr> <tr style="background-color: white"> <td style="vertical-align: bottom; padding-bottom: 1pt"><font style="font-size: 10pt">12/04/2017</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 1pt"><font style="font-size: 10pt">12/01/2023</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: top; text-align: center"><font style="font-size: 10pt">Common</font></td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 1pt"><font style="font-size: 10pt">$</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt; text-align: right"><font style="font-size: 10pt">8.00</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td> <td style="vertical-align: bottom">&#160;</td> <td style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: right"><font style="font-size: 10pt">25,000</font></td> <td style="vertical-align: bottom; padding-bottom: 1pt">&#160;</td></tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: bottom; padding-bottom: 2.5pt">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 2.5pt">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 2.5pt">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 2.5pt">&#160;</td> <td style="vertical-align: top; text-align: center">&#160;</td> <td style="vertical-align: top">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 2.5pt">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 2.5pt; text-align: right">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 2.5pt">&#160;</td> <td style="vertical-align: bottom; padding-bottom: 2.5pt">&#160;</td> <td style="vertical-align: bottom">&#160;</td> <td style="vertical-align: bottom; border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">1,365,737</font></td> <td style="vertical-align: bottom; padding-bottom: 2.5pt">&#160;</td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">A summary of the stock options available as of June 30, 2019 is as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: justify">&#160;</td><td>&#160;</td> <td colspan="3" style="text-align: center">&#160;</td><td style="font-size: 10pt; font-weight: bold">&#160;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center">Weighted</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify">&#160;</td><td style="font-size: 10pt; font-weight: bold">&#160;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center">Number</td><td style="font-size: 10pt; font-weight: bold">&#160;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center">Average</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify">&#160;</td><td style="font-size: 10pt; font-weight: bold">&#160;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center">Of</td><td style="font-size: 10pt; font-weight: bold">&#160;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center">Exercise</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Options</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Price</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 68%; font-size: 10pt; text-align: justify">Options outstanding at March 31, 2019</td><td style="width: 4%; font-size: 10pt">&#160;</td> <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 10%; font-size: 10pt; text-align: right">805,375</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 4%; font-size: 10pt">&#160;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 10%; font-size: 10pt; text-align: right">8.00</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: justify">Changes during the period:</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: justify">Expired</td><td style="font-size: 10pt">&#160;</td> <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#8212;&#160;&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td> <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">8.00</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: justify; padding-bottom: 1pt">New Options Granted &#8211; at market price</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">20,000</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">8.00</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: justify; padding-bottom: 2.5pt">Options outstanding at June 30, 2019</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">825,375</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">8.00</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: justify; padding-bottom: 2.5pt">Options exercisable at June 30, 2019</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">384,025</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">8.00</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Right of Use Asset and Leased Liability:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Estimated Lease Life &#8211; Lease term through December 2022</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; font-size: 10pt; padding-left: 5.4pt"><font style="font: 10pt Times New Roman, Times, Serif">Right-of-use lease assets- operating as of March 31, 2019</font></td><td style="width: 5%; font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="width: 13%; font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,871,366</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><font style="font: 10pt Times New Roman, Times, Serif">Less: Accumulated amortization</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(104,097</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 2.5pt; padding-left: 5.4pt"><font style="font: 10pt Times New Roman, Times, Serif">Right-of-use lease assets- operating as of June 30, 2019</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,767,269</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 5.4pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-left: 5.4pt"><font style="font: 10pt Times New Roman, Times, Serif">Lease liability-operating as of March 31, 2019</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,981,795</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><font style="font: 10pt Times New Roman, Times, Serif">Less: Accumulated Amortization</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(108,443</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 2.5pt; padding-left: 5.4pt"><font style="font: 10pt Times New Roman, Times, Serif">Lease liability operating-as of June 30, 2019</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,873,352</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 5.4pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-left: 5.4pt"><font style="font: 10pt Times New Roman, Times, Serif">Operating lease expense for the three months ended June 30, 2019</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">150,557</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-left: 5.4pt"><font style="font: 10pt Times New Roman, Times, Serif">Actual remaining lease payments</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,214,410</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-left: 5.4pt"><font style="font: 10pt Times New Roman, Times, Serif">Present value of remaining payments</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,</font><font style="font-family: Times New Roman, Times, Serif">873,352</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr></table> 66395 48371 160630 188764 738553 423082 2615425 251675 493175 2615425 8.00 8.00 8.00 20923400 2000000 3000000 1000000 1000000 1000000 2000000 116319 4323953 10000000 163919 125000 8.00 8.00 12.00 6.40 16.00 16.00 8.00 10.00 10.00 8.00 8.00 8.00 8.00 8.00 Dow received warrant coverage of one share of common stock for each $40 in loans received by us, equating to 20% warrant coverage, with an exercise price of $8.00 per share for the warrants issued at closing of the initial $2 million draw. 372372 0.05 2021-12-01 0.0767 124335 39584 816710 Equity capital exceeding $15 million, we are required to prepay an amount equal to 30% of the amount raised over $15 million, but less than $25 million. 64626 59709 2009-07-01 2012-10-08 2014-01-15 2014-12-31 2015-04-30 2015-05-26 2015-06-30 2015-12-31 2016-03-31 2016-04-30 2016-12-14 2017-07-18 2017-09-22 2017-12-04 2019-07-01 2027-10-08 2024-01-15 2022-04-30 2022-06-30 2020-12-31 2021-03-31 2021-04-30 2023-12-01 2023-12-01 2023-12-01 2023-12-01 Common Common Series A Convertible Preferred Common Common Common Common Common Common Common Common Common 1365737 6000 5000 972720 218334 6563 20625 10600 895 50000 25000 25000 25000 20923400 12.00 Series A Preferred was reduced from $12.00 to $6.40 (80% of $8.00), and thus, each share of Series A Preferred Stock is convertible into 1.875 shares of common stock. One share of common stock at the lower of: (a) $12.00 per share, or (b) 80% of the price at which the Company sells any equity or equity-linked securities in the future. 12.00 6.40 3544414 1456126 3013987 2903987 825375 805375 20000 20000 2500 2500 384025 8.00 8.00 8.00 8.00 8.00 8.00 8.00 8.00 8.00 1200000 110368 1015758 20000 632744 P4Y Each option holder received options equal to 150% of the number of cancelled stock options. 501071 514687 20000 The options vest ratably over a four-year period beginning on the one-year anniversary. The options vest ratably over a four-year period beginning on the one-year anniversary. The options vest ratably over a four-year period beginning on the one-year anniversary. 61644 160000 29580 26120 P3Y P4Y 8.00 8.00 P4Y9M 0.4271 0.0176 0.00 8.00 P7Y 154903 P40M 0.0998 309806 622878 638178 643547 12500 12500 1871366 269539 859054 965578 660217 110937 114453 3081775 6337558 4123286 4223650 190140 59440 20156 733056 690646 1767269 6683051 5124592 9764826 11462150 666718 1102910 513034 429573 832 196723 461603 3613 1641355 1733651 1411749 11914 4323953 4725866 5735702 4737780 7377057 6471431 22307480 22307480 32301876 30268476 8280579 8101923 -60502166 -55687160 9764826 11462150 1104346 1737191 1104346 1737191 247069 850854 247069 850854 877564 1031451 196411 563260 1093214 1289272 599745 542689 1970778 2320723 796156 1105949 -866432 -583532 -549087 -255095 770013 564146 384767 287082 2907301 2334473 1486380 1147794 3677314 2898619 1871147 1434876 -4543746 -3482151 -2420234 -1689971 154941 168974 78277 83805 3253 -154941 -165721 -78277 -83805 3883053 2549943 3990038 2644522 -1.21 -1.43 -0.63 -0.67 388110 442231 31716 26434 26000 5000 218656 174231 39584 170311 106164 -563515 207620 305361 72173 -46002 -101249 -353563 755506 -4136032 -2349037 287746 1707364 74127 72731 -361873 -1780095 -15528 -10661 638220 2013400 3945400 20000 66598 1339652 3868141 -3158253 -260991 1735721 4893974 3041590 2780599 64626 430 171343 1767269 1871366 -104097 1873352 1981795 -108443 150557 1873352 2214409 341057 1873352 2214410 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>NOTE 3 &#8211;FINANCING AGREEMENT</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><u>Dow Facility</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In December 2016,&#160;we entered into the Dow Facility which provides us with up to $10 million of secured debt financing at an interest rate of 5% per year, drawable at our request under certain conditions. We received $2 million at closing and an additional $1 million on July 18, 2017, September 22, 2017 and December 4, 2017, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Dow Facility is senior to our other debt and is secured by all of our assets. It matures on December 1, 2021 (subject to certain mandatory prepayments based on our equity financing activities). When we raise a cumulative amount of equity capital exceeding $15 million, we are required to prepay an amount equal to 30% of the amount raised over $15 million, but less than $25 million. We began these prepayments on equity raised as of September 10, 2018. Interest was payable beginning January 1, 2017, although we had elected, per the Dow facility, to capitalize the interest as part of the outstanding debt through January 1, 2019. Beginning April 1, 2019, current interest is payable in cash on the first day of each quarter, and accordingly, has been paid on April 1, 2019 and July 1, 2019 in the amounts of $64,626 and $59,709, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Dow received warrant coverage of one share of common stock for each $40 in loans received by us, equating to 20% warrant coverage, with an exercise price of $8.00 per share for the warrants issued at closing of the initial $2 million draw. After the initial closing, the strike price of future warrants issued is subject to adjustment if we sell shares of common stock at a lower price. As of June 30, 2019, we had issued 125,000 warrants to Dow, which are exercisable on or before the expiration date of December 1, 2023.&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-size: 10pt">The aforementioned warrants meet the criteria for classification within stockholders&#8217; equity. Proceeds were allocated between the debt and the warrants at their relative fair value. The total debt discount on the Dow Facility was approximately $372,372. The debt discount is being amortized to interest expense using the effective interest method over the term of the loans using an average effective interest rate of 7.67%. During the six months ended June 30, 2019, we recognized $163,919 of amortization expense consisting of $124,335 interest expense</font><font style="font-size: 8pt">&#160;</font><font style="font-size: 10pt">and $39,584 of amortization from debt discount accretion related to the Dow Facility. We have repaid $816,710 of outstanding principal on the debt, resulting in a carrying value of $4,323,953 for the Dow Facility as of June 30, 2019.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Dow Facility entitles Dow to appoint an observer to our Board. Dow will maintain this observation right until the later of December 1, 2019 or when the amount of principal and interest outstanding under the Dow Facility is less than $5 million.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>NOTE 7 &#8211; LEASES</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Right of Use Asset and Leased Liability:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Estimated Lease Life &#8211; Lease term through December 2022</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; font-size: 10pt; padding-left: 5.4pt"><font style="font: 10pt Times New Roman, Times, Serif">Right-of-use lease assets- operating as of March 31, 2019</font></td><td style="width: 5%; font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="width: 13%; font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,871,366</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><font style="font: 10pt Times New Roman, Times, Serif">Less: Accumulated amortization</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(104,097</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 2.5pt; padding-left: 5.4pt"><font style="font: 10pt Times New Roman, Times, Serif">Right-of-use lease assets- operating as of June 30, 2019</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,767,269</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 5.4pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-left: 5.4pt"><font style="font: 10pt Times New Roman, Times, Serif">Lease liability-operating as of March 31, 2019</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,981,795</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><font style="font: 10pt Times New Roman, Times, Serif">Less: Accumulated Amortization</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(108,443</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 2.5pt; padding-left: 5.4pt"><font style="font: 10pt Times New Roman, Times, Serif">Lease liability operating-as of June 30, 2019</font></td><td style="font-size: 10pt; padding-bottom: 2.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,873,352</font></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 5.4pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-left: 5.4pt"><font style="font: 10pt Times New Roman, Times, Serif">Operating lease expense for the three months ended June 30, 2019</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">150,557</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-left: 5.4pt"><font style="font: 10pt Times New Roman, Times, Serif">Actual remaining lease payments</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,214,410</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-left: 5.4pt"><font style="font: 10pt Times New Roman, Times, Serif">Present value of remaining payments</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,</font><font style="font-family: Times New Roman, Times, Serif">873,352</font></td><td style="font-size: 10pt; text-align: left"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">Supplemental cash flow information related to leases:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Leases</font></td></tr> <tr style="vertical-align: bottom"> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Three months</font></td></tr> <tr style="vertical-align: bottom"> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">ended</font></td></tr> <tr style="vertical-align: bottom"> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">June 30, 2019</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Cash paid for amounts included in the measurement of lease liabilities:</font></td><td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 80%; font-size: 10pt; text-align: left; padding-left: 5.4pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;Operating cash flows from operating leases</font></td><td style="width: 5%; font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="width: 13%; font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">154,903</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-left: 5.4pt"><font style="font: 10pt Times New Roman, Times, Serif">Weighted average remaining lease term- operating leases (in months)</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">40</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-left: 5.4pt"><font style="font: 10pt Times New Roman, Times, Serif">Weighted average discount rate- operating leases (annual)</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">9.98</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-left: 5.4pt"><font style="font: 10pt Times New Roman, Times, Serif">Maturities of leases liabilities were as follows:</font></td><td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-left: 5.4pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;Year ending December 31, 2019 (excluding the three months ended June 30, 2019)</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">309,806</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-left: 5.4pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;Year ending December 31, 2020</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">622,878</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-left: 5.4pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;Year ending December 31, 2021</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">638,178</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 1pt; padding-left: 5.4pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;Year ending December 31, 2022</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">643,547</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-left: 5.4pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total Lease payments</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,214,409</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><font style="font: 10pt Times New Roman, Times, Serif">Less imputed interest</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(341,057</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-bottom: 2.5pt; padding-left: 5.4pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;Total</font></td><td style="padding-bottom: 2.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,873,352</font></td><td style="padding-bottom: 2.5pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">With the exception of the standards discussed above, we believe there have been no new accounting pronouncements issued that would have a material impact, to our Consolidated Financial Statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">Supplemental cash flow information related to leases:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Leases</font></td></tr> <tr style="vertical-align: bottom"> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Three months</font></td></tr> <tr style="vertical-align: bottom"> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">ended</font></td></tr> <tr style="vertical-align: bottom"> <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td colspan="3" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">June 30, 2019</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Cash paid for amounts included in the measurement of lease liabilities:</font></td><td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 80%; font-size: 10pt; text-align: left; padding-left: 5.4pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;Operating cash flows from operating leases</font></td><td style="width: 5%; font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 1%; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="width: 13%; font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">154,903</font></td><td style="width: 1%; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-left: 5.4pt"><font style="font: 10pt Times New Roman, Times, Serif">Weighted average remaining lease term- operating leases (in months)</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">40</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-left: 5.4pt"><font style="font: 10pt Times New Roman, Times, Serif">Weighted average discount rate- operating leases (annual)</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">9.98</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-left: 5.4pt"><font style="font: 10pt Times New Roman, Times, Serif">Maturities of leases liabilities were as follows:</font></td><td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-left: 5.4pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;Year ending December 31, 2019 (excluding the three months ended June 30, 2019)</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">309,806</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-left: 5.4pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;Year ending December 31, 2020</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">622,878</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-left: 5.4pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;Year ending December 31, 2021</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">638,178</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 1pt; padding-left: 5.4pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;Year ending December 31, 2022</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">643,547</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-left: 5.4pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total Lease payments</font></td><td style="font-size: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,214,409</font></td><td style="font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><font style="font: 10pt Times New Roman, Times, Serif">Less imputed interest</font></td><td style="font-size: 10pt; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(341,057</font></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-bottom: 2.5pt; padding-left: 5.4pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;Total</font></td><td style="padding-bottom: 2.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,873,352</font></td><td style="padding-bottom: 2.5pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr></table> EX-101.SCH 14 cik0001435375-20190630.xsd XBRL SCHEMA FILE 00000001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited) link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - NATURE OF BUSINESS AND BASIS OF PRESENTATION link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - UPDATES TO SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - FINANCING AGREEMENTS link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - STOCK WARRANTS ACCOUNTED FOR AS EQUITY INSTRUMENTS link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - STOCKHOLDERS' EQUITY (DEFICIT) link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - EQUITY INCENTIVE PLAN link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - LEASES link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - RELATED PARTY TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - UPDATES TO SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - UPDATES TO SIGNIFICANT ACCOUNTING POLICIES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - STOCK WARRANTS ACCOUNTED FOR AS EQUITY INSTRUMENTS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - EQUITY INCENTIVE PLAN (Tables) link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - LEASES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - UPDATES TO SIGNIFICANT ACCOUNTING POLICIES (Details) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - UPDATES TO SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - FINANCING AGREEMENTS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - STOCK WARRANTS ACCOUNTED FOR AS EQUITY INSTRUMENTS (Details) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - STOCKHOLDERS' EQUITY (DEFICIT) (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - EQUITY INCENTIVE PLAN (Details) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - EQUITY INCENTIVE PLAN (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - LEASES (Details) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - LEASES (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - RELATED PARTY TRANSACTIONS AND COMMITMENTS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 15 cik0001435375-20190630_cal.xml XBRL CALCULATION FILE EX-101.DEF 16 cik0001435375-20190630_def.xml XBRL DEFINITION FILE XML 17 R1.htm IDEA: XBRL DOCUMENT v3.19.2
Document and Entity Information - shares
6 Months Ended
Jun. 30, 2019
Aug. 14, 2019
Document And Entity Information    
Entity Registrant Name XG SCIENCES INC  
Entity Central Index Key 0001435375  
Document Type 10-Q  
Document Period End Date Jun. 30, 2019  
Amendment Flag false  
Current Fiscal Year End Date --12-31  
Entity File Number 333-209131  
Entity Incorporation, State or Country Code MI  
Entity's Reporting Status Current Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company true  
Entity Ex Transition Period false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   4,011,943
Document Fiscal Period Focus Q2  
Document Fiscal Year Focus 2019  
XML 18 R2.htm IDEA: XBRL DOCUMENT v3.19.2
CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited) - USD ($)
Jun. 30, 2019
Dec. 31, 2018
CURRENT ASSETS    
Cash $ 1,735,721 $ 4,703,834
Accounts receivable, less allowance for doubtful accounts of $26,000 at June 30, 2019 and $85,000 at December 31, 2018 269,539 859,054
Inventories 965,578 660,217
Other current assets 110,937 114,453
Total current assets 3,081,775 6,337,558
LONG-TERM ASSETS    
Property, Plant and Equipment, Net 4,123,286 4,223,650
Restricted Cash for Letter of Credit 190,140
Lease Deposit 59,440 20,156
Intangible Assets, Net 733,056 690,646
Right of Use Asset 1,767,269
Total Long-Term Assets 6,683,051 5,124,592
TOTAL ASSETS 9,764,826 11,462,150
CURRENT LIABILITIES    
Accounts payable 666,718 1,102,910
Other current liabilities 513,034 429,573
Deferred revenue 832
Current portion of long-term debt 196,723
Current portion of lease liabilities 461,603 3,613
Total current liabilities 1,641,355 1,733,651
LONG-TERM LIABILITIES    
Long-term portion of lease liabilities 1,411,749 11,914
Long term debt 4,323,953 4,725,866
Total long-term liabilities 5,735,702 4,737,780
TOTAL LIABILITIES 7,377,057 6,471,431
STOCKHOLDERS' EQUITY    
Series A convertible preferred stock, 3,000,000 shares authorized, 1,890,354 shares issued and outstanding, liquidation value of $22,684,248 at June 30, 2019 and December 31, 2018 22,307,480 22,307,480
Common stock, no par value, 25,000,000 shares authorized, 4,011,943 and 3,760,268 shares issued and outstanding at June 30, 2019 and December 31, 2018, respectively 32,301,876 30,268,476
Additional paid-in capital 8,280,579 8,101,923
Accumulated deficit (60,502,166) (55,687,160)
Total stockholders' equity 2,387,769 4,990,719
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 9,764,826 $ 11,462,150
XML 19 R3.htm IDEA: XBRL DOCUMENT v3.19.2
CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited) (Parenthetical) - USD ($)
Jun. 30, 2019
Dec. 31, 2018
Statement of Financial Position [Abstract]    
Allowance for doubtful accounts $ 26,000 $ 85,000
Series A convertible preferred stock, authorized 3,000,000 3,000,000
Series A convertible Preferred stock, issued 1,890,354 1,890,354
Series A convertible preferred stock, outstanding 1,890,354 1,890,354
Series A convertible preferred stock liquidation value $ 22,684,248 $ 22,684,248
Common stock, no par value (in dollars per share) $ 0 $ 0
Common stock, authorized 25,000,000 25,000,000
Common stock, issued 4,011,943 3,760,268
Common stock, outstanding 4,011,943 3,760,268
XML 20 R4.htm IDEA: XBRL DOCUMENT v3.19.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
REVENUE        
Total revenue $ 247,069 $ 850,854 $ 1,104,346 $ 1,737,191
COST OF GOODS SOLD        
Direct costs 196,411 563,260 877,564 1,031,451
Unallocated manufacturing expenses 599,745 542,689 1,093,214 1,289,272
Total cost of goods sold 796,156 1,105,949 1,970,778 2,320,723
GROSS LOSS (549,087) (255,095) (866,432) (583,532)
OPERATING EXPENSES        
Research and development 384,767 287,082 770,013 564,146
Sales, general and administrative 1,486,380 1,147,794 2,907,301 2,334,473
Total operating expenses 1,871,147 1,434,876 3,677,314 2,898,619
OPERATING LOSS (2,420,234) (1,689,971) (4,543,746) (3,482,151)
OTHER INCOME (EXPENSE)        
Interest expense, net (78,277) (83,805) (154,941) (168,974)
Government incentives, net 3,253
Total other expense (78,277) (83,805) (154,941) (165,721)
NET LOSS $ (2,498,511) $ (1,773,776) $ (4,698,687) $ (3,647,872)
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING - Basic and diluted (in shares) 3,990,038 2,644,522 3,883,053 2,549,943
NET LOSS PER SHARE - Basic and diluted (in dollars per share) $ (0.63) $ (0.67) $ (1.21) $ (1.43)
Product Sales [Member]        
REVENUE        
Total revenue $ 247,069 $ 850,854 $ 1,104,346 $ 1,737,191
XML 21 R5.htm IDEA: XBRL DOCUMENT v3.19.2
CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
Preferred stock A
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Balances at beginning at Dec. 31, 2017 $ 21,917,046 $ 19,116,012 $ 7,831,958 $ (47,767,544) $ 1,097,472
Balances at beginning (in shares) at Dec. 31, 2017 1,857,816 2,353,350      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock issued for cash $ 3,945,400 3,945,400
Stock issued for cash (in shares) 493,175      
Stock issuance fees and expenses $ (66,598) (66,598)
Preferred stock issued to pay capital lease obligations $ 171,343 171,343
Preferred stock issued to pay capital lease obligations (in shares) 14,280      
Stock-based compensation $ 40,000 134,231 174,231
Net loss (3,647,872) (3,647,872)
Balances at ending at Jun. 30, 2018 $ 22,088,389 $ 23,034,814 7,966,189 (51,415,416) 1,673,976
Balances at ending (in shares) at Jun. 30, 2018 1,872,096 2,846,525      
Balances at beginning at Mar. 31, 2018 $ 22,002,717 $ 20,741,574 7,899,722 (49,641,639) 1,002,374
Balances at beginning (in shares) at Mar. 31, 2018 1,864,956 2,555,275      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock issued for cash $ 2,330,000 2,330,000
Stock issued for cash (in shares) 291,250      
Stock issuance fees and expenses $ (56,760) (56,760)
Preferred stock issued to pay capital lease obligations $ 85,672 85,672
Preferred stock issued to pay capital lease obligations (in shares) 7,140      
Stock-based compensation $ 20,000 66,467 86,467
Net loss (1,773,776) (1,773,776)
Balances at ending at Jun. 30, 2018 $ 22,088,389 $ 23,034,814 7,966,189 (51,415,416) 1,673,976
Balances at ending (in shares) at Jun. 30, 2018 1,872,096 2,846,525      
Balances at beginning at Dec. 31, 2018 $ 22,307,480 $ 30,268,476 8,101,923 (55,687,160) 4,990,719
Balances at beginning (in shares) at Dec. 31, 2018 1,890,354 3,760,268      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock issued for cash $ 2,013,400 2,013,400
Stock issued for cash (in shares) 251,675      
Stock issuance fees and expenses $ (20,000) (20,000)
Transition adjustment for adoption of new lease standard (116,319) (116,319)
Stock-based compensation 40,000 178,656 218,656
Net loss (4,698,687) (4,698,687)
Balances at ending at Jun. 30, 2019 $ 22,307,480 $ 32,301,876 8,280,579 (60,502,166) 2,387,769
Balances at ending (in shares) at Jun. 30, 2019 1,890,354 4,011,943      
Balances at beginning at Mar. 31, 2019 $ 22,307,480 $ 30,682,476 8,190,211 (58,003,655) 3,176,512
Balances at beginning (in shares) at Mar. 31, 2019 1,890,354 3,811,518      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock issued for cash $ 1,603,400 1,603,400
Stock issued for cash (in shares) 200,425      
Stock issuance fees and expenses $ (4,000) (4,000)
Stock-based compensation 20,000 90,368 110,368
Net loss (2,498,511) (2,498,511)
Balances at ending at Jun. 30, 2019 $ 22,307,480 $ 32,301,876 $ 8,280,579 $ (60,502,166) $ 2,387,769
Balances at ending (in shares) at Jun. 30, 2019 1,890,354 4,011,943      
XML 22 R6.htm IDEA: XBRL DOCUMENT v3.19.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) - USD ($)
6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
CASH FLOWS FROM OPERATING ACTIVITIES    
Net loss $ (4,698,687) $ (3,647,872)
Depreciation 388,110 442,231
Amortization of intangible assets 31,716 26,434
Provision for bad debts 26,000 5,000
Stock-based compensation expense 218,656 174,231
Non-cash interest expense 39,584 170,311
Non-cash equipment rent expense 106,164
Changes in current assets and liabilities:    
Accounts receivable 563,515 (207,620)
Inventory (305,361) (72,173)
Other current and non-current assets (46,002) (101,249)
Accounts payable and other liabilities (353,563) 755,506
NET CASH USED IN OPERATING ACTIVITIES (4,136,032) (2,349,037)
CASH FLOWS FROM INVESTING ACTIVITIES    
Purchases of property and equipment (287,746) (1,707,364)
Purchases of intangible assets (74,127) (72,731)
NET CASH USED IN INVESTING ACTIVITIES (361,873) (1,780,095)
CASH FLOWS FROM FINANCING ACTIVITIES    
Repayments of capital lease obligations (15,528) (10,661)
Repayments of long-term loan debt (638,220)
Proceeds from issuance of common stock 2,013,400 3,945,400
Common stock issuance fees and expenses (20,000) (66,598)
NET CASH PROVIDED BY FINANCING ACTIVITIES 1,339,652 3,868,141
NET CHANGE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH (3,158,253) (260,991)
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, BEGINNING OF PERIOD 4,893,974 3,041,590
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, END OF PERIOD 1,735,721 2,780,599
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:    
Cash paid for interest 64,626 430
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:    
Value of preferred stock issued for AAOF capital lease obligations $ 171,343
XML 23 R7.htm IDEA: XBRL DOCUMENT v3.19.2
NATURE OF BUSINESS AND BASIS OF PRESENTATION
6 Months Ended
Jun. 30, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
NATURE OF BUSINESS AND BASIS OF PRESENTATION

NOTE 1 – NATURE OF BUSINESS AND BASIS OF PRESENTATION

 

XG Sciences, Inc., a Michigan company located in Lansing, Michigan and its subsidiary, XG Sciences IP, LLC (collectively referred to as “we”, “us”, “our”, or the “Company”) manufactures graphene nanoplatelets made from graphite, using two proprietary manufacturing processes to split natural flakes of crystalline graphite into very small and thin particles, which we sell as xGnP® graphene nanoplatelets. We sell our nanoplatelets in the form of bulk powders or dispersions to other companies for use as additives to make composite and other materials with specialty engineered characteristics. We also manufacture and sell integrated, value-added products containing these graphene nanoplatelets such as greases, composites, thin sheets, inks and coating formulations that we sell to other companies. Additionally, we have licensed our technology to other companies in exchange for royalties and other fees.

 

Basis of Presentation

 

The accompanying interim condensed consolidated financial statements are unaudited and have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and the instructions to Form 10-Q and do not include all of the information and footnotes required by GAAP for complete financial statements. All intercompany transactions have been eliminated in consolidation.

 

Certain information and footnote disclosures normally included in our annual audited consolidated financial statements and accompanying notes have been condensed or omitted in these interim condensed consolidated financial statements. Accordingly, the unaudited condensed consolidated financial statements included herein should be read in conjunction with the audited consolidated financial statements for the year ended December 31, 2018, as filed with the Securities and Exchange Commission (“SEC”) on Form 10-K/A on April 3, 2019.

 

The results of operations presented in this quarterly report are not necessarily indicative of the results of operations that may be expected for any future periods. In the opinion of management, these unaudited condensed consolidated financial statements include all adjustments and accruals, consisting only of normal recurring adjustments that are necessary for a fair statement of the results of all interim periods reported herein.

 

Use of Estimates

 

The preparation of our condensed consolidated financial statements in conformity with GAAP requires us to make estimates, judgments and assumptions that affect the reported amounts of assets, liabilities, revenue and expenses, together with amounts disclosed in the related notes to the financial statements. Actual results and outcomes may differ from our estimates, judgments and assumptions. Significant estimates, judgments and assumptions used in these condensed consolidated financial statements include, but are not limited to, those related to revenue, accounts receivable and related allowances, inventory valuations, contingencies, useful lives and recovery of long-term assets, including intangible assets, income taxes, and the fair value of stock-based compensation. These estimates, judgments, and assumptions are reviewed periodically and the effects of material revisions in estimates are reflected in the financial statements prospectively from the date of the change in estimate.

XML 24 R8.htm IDEA: XBRL DOCUMENT v3.19.2
UPDATES TO SIGNIFICANT ACCOUNTING POLICIES
6 Months Ended
Jun. 30, 2019
Accounting Policies [Abstract]  
UPDATES TO SIGNIFICANT ACCOUNTING POLICIES

NOTE 2 – UPDATES TO SIGNIFICANT ACCOUNTING POLICIES

 

Revenue Recognition

 

Revenues are recognized at a point in time, typically when control of the promised goods is transferred to customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods. The Company does not recognize revenue in cases where collectability is not probable, and defers the recognition until collection is probable or payment is received.

 

The Company generally expenses sales commissions when incurred because the amortization period would have been one year or less. These costs are recorded within selling, general and administrative expenses. Customer deposits, deferred revenue and other receipts are deferred and recognized when the revenue is realized and earned.  

 

Revenue related to licensing agreements is recorded upon substantial performance of the terms of the licensing contract. In the case of licensing arrangements that involve up-front payments, revenue is recorded when management determines that the appropriate terms of the contract have been fulfilled. For example, this may occur when technology has been transferred via written documents or, if training is involved, whenever all contracted training has occurred. In the case of licenses where product delivery is also embedded in the deliverable, a portion of revenue would be recognized when products are delivered.

 

We have also out-licensed certain intellectual property to licensees under terms and conditions of license agreements that specify the   intellectual property licensed, the territory, and the type of license. In exchange for these licenses, we have recorded revenues associated with the initial granting of the license and expect to receive royalties based on sales of products produced under these licenses. License revenues are recorded to reflect our performance of requirements under these license agreements. In addition, we record royalty revenues from licensees at the time they are earned.

 

Grant contract revenue is recognized over the life of the contracts as the services are performed or as milestones are met.

 

Amounts received in excess of revenues earned are recorded as deferred revenue.

  

Liquidity

 

We have historically incurred recurring losses from operations and we may continue to generate negative cash flows as we implement our business plan. Our consolidated financial statements are prepared using GAAP as applicable to a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business.

  

As of August 12, 2019, we had cash on hand of $2,680,604. We believe our cash is sufficient to fund our operations through August 31, 2020 after taking into account various sources of funding and cash received from continued commercial sales transactions. Our primary means for raising funds since 2016 has been through our offering of shares of common stock at a fixed price of $8.00 per share to the general public in a self-underwritten offering (the “Offering” or our “IPO”) and under a draw loan note and agreement with The Dow Chemical Company (the “Dow Facility”). On April 12, 2019, we completed the Offering, after selling 2,615,425 shares under the Registration Statement at a price of $8.00 per share for total proceeds of $20,923,400. On July 8, 2019 we borrowed $2 million under the draw loan note and agreement with The Dow Chemical Company (the “Dow Facility”). We have $3 million of proceeds from the Dow Facility available to us, which we intend to be our primary source of liquidity at this time (See Note 3).  

 

There has been no public market for our securities and a public market may never develop, or, if any market does develop, it may not be sustained. Our common stock is not currently quoted on or traded on any exchange or on any over-the-counter market. In the event we are unable to fund our operations from existing cash on hand, operating cash flows, additional borrowings or raising equity capital, we may be forced to reduce our expenses, slow down our growth rate, or discontinue operations. Our condensed consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should we be unable to continue as a going concern.  

  

Inventory  

 

The following amounts were included in inventory at the end of the period:   
   June 30,  December 31,
   2019  2018
Raw materials  $66,395   $48,371 
Consumables   160,630    188,764 
Finished goods   738,553    423,082 
Total  $965,578   $660,217 

 

Recent Accounting Pronouncements

 

In February 2016, the FASB issued Accounting Standards Update No. 2016-02, Leases (“ASU 2016-02”). The new standard establishes a right-of-use (“ROU”) model that requires a lessee to record a ROU asset and a lease liability on the balance sheet for all leases with terms longer than 12 months. Leases will be classified as either finance or operating, with classification affecting the pattern of expense recognition in the income statement. The new standard must be adopted using a modified retrospective transition and requires application of the new guidance at the beginning of the earliest comparative period presented.   We adopted ASU 2016-02 as of January 1, 2019.

 

Adoption of Lease Accounting Policy    

 

We applied ASU 2016-02 and all related amendments (“ASC 842”) using the modified retrospective method by recognizing the cumulative effect of adoption as an adjustment to the opening balance of retained earnings at January 1, 2019. Therefore, the comparative information has not been adjusted and continues to be reported under prior leasing guidance. As a result, in the first quarter of 2019 we recorded ROU assets of $1,871,366. We also recorded lease liabilities of $1,981,795. The decrease to retained earnings was $116,319, reflecting the cumulative impact of the accounting change. The standard did not have a material effect on consolidated net income or cash flows.

 

Right-of-use assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. As our leases do not provide an implicit rate, we used our incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. Lease expense for lease payments is recognized on a straight-line basis over the lease term.

 

We do not record a ROU asset or lease liability for leases with an expected term of 12 months or less. The comparative information has not been adjusted and continues to be reported under prior leasing guidance.

XML 25 R9.htm IDEA: XBRL DOCUMENT v3.19.2
FINANCING AGREEMENTS
6 Months Ended
Jun. 30, 2019
Warrants And Financing Agreements  
FINANCING AGREEMENTS

NOTE 3 –FINANCING AGREEMENT

 

Dow Facility

 

In December 2016, we entered into the Dow Facility which provides us with up to $10 million of secured debt financing at an interest rate of 5% per year, drawable at our request under certain conditions. We received $2 million at closing and an additional $1 million on July 18, 2017, September 22, 2017 and December 4, 2017, respectively.

 

The Dow Facility is senior to our other debt and is secured by all of our assets. It matures on December 1, 2021 (subject to certain mandatory prepayments based on our equity financing activities). When we raise a cumulative amount of equity capital exceeding $15 million, we are required to prepay an amount equal to 30% of the amount raised over $15 million, but less than $25 million. We began these prepayments on equity raised as of September 10, 2018. Interest was payable beginning January 1, 2017, although we had elected, per the Dow facility, to capitalize the interest as part of the outstanding debt through January 1, 2019. Beginning April 1, 2019, current interest is payable in cash on the first day of each quarter, and accordingly, has been paid on April 1, 2019 and July 1, 2019 in the amounts of $64,626 and $59,709, respectively.

 

Dow received warrant coverage of one share of common stock for each $40 in loans received by us, equating to 20% warrant coverage, with an exercise price of $8.00 per share for the warrants issued at closing of the initial $2 million draw. After the initial closing, the strike price of future warrants issued is subject to adjustment if we sell shares of common stock at a lower price. As of June 30, 2019, we had issued 125,000 warrants to Dow, which are exercisable on or before the expiration date of December 1, 2023. 

 

The aforementioned warrants meet the criteria for classification within stockholders’ equity. Proceeds were allocated between the debt and the warrants at their relative fair value. The total debt discount on the Dow Facility was approximately $372,372. The debt discount is being amortized to interest expense using the effective interest method over the term of the loans using an average effective interest rate of 7.67%. During the six months ended June 30, 2019, we recognized $163,919 of amortization expense consisting of $124,335 interest expense and $39,584 of amortization from debt discount accretion related to the Dow Facility. We have repaid $816,710 of outstanding principal on the debt, resulting in a carrying value of $4,323,953 for the Dow Facility as of June 30, 2019.

 

The Dow Facility entitles Dow to appoint an observer to our Board. Dow will maintain this observation right until the later of December 1, 2019 or when the amount of principal and interest outstanding under the Dow Facility is less than $5 million.

XML 26 R10.htm IDEA: XBRL DOCUMENT v3.19.2
STOCK WARRANTS ACCOUNTED FOR AS EQUITY INSTRUMENTS
6 Months Ended
Jun. 30, 2019
Equity [Abstract]  
STOCK WARRANTS ACCOUNTED FOR AS EQUITY INSTRUMENTS

NOTE 4 – STOCK WARRANTS ACCOUNTED FOR AS EQUITY INSTRUMENTS

 

The following table summarizes the warrants (including the warrants previously accounted for as derivatives) outstanding at June 30, 2019, which are accounted for as equity instruments, all of which are exercisable: 

 

Date Issued   Expiration Date  

Indexed

Stock

  Exercise Price     Number of 
Warrants
 
07/01/2009   07/01/2019   Common   $ 8.00       6,000  
10/08/2012   10/08/2027   Common   $ 12.00       5,000  
01/15/2014 - 12/31/2014   01/15/2024   Series A Convertible Preferred   $ 6.40       972,720  
04/30/2015- 05/26/2015   04/30/2022   Common   $ 16.00       218,334  
06/30/2015   06/30/2022   Common   $ 16.00       6,563  
12/31/2015   12/31/2020   Common   $ 8.00       20,625  
03/31/2016   03/31/2021   Common   $ 10.00       10,600  
04/30/2016   04/30/2021   Common   $ 10.00       895  
12/14/2016   12/01/2023   Common   $ 8.00       50,000  
07/18/2017   12/01/2023   Common   $ 8.00       25,000  
09/22/2017   12/01/2023   Common   $ 8.00       25,000  
12/04/2017   12/01/2023   Common   $ 8.00       25,000  
                      1,365,737  

  

Each warrant indexed to Series A Convertible Preferred Stock is currently exercisable and exchangeable into 1.875 shares of common stock.

XML 27 R11.htm IDEA: XBRL DOCUMENT v3.19.2
STOCKHOLDERS' EQUITY (DEFICIT)
6 Months Ended
Jun. 30, 2019
Stockholders Equity Deficit  
STOCKHOLDERS' EQUITY (DEFICIT)

NOTE 5 – STOCKHOLDERS’ EQUITY (DEFICIT)

 

Common Stock

 

The Company is authorized to issue 25,000,000 shares of common stock, no par value per share of which 4,011,943 and 3,760,268 shares were issued and outstanding as of June 30, 2019 and December 31, 2018, respectively.

 

During the six months ended June 30, 2019 the Company issued 251,675 shares of common stock pursuant to the Offering. During the six months ended June 30, 2018 the Company issued 493,175 shares of common stock pursuant to the Offering. Upon its completion on April 12, 2019, the Company had sold 2,615,425 shares of common stock in its IPO at a price of $8.00 per share for gross proceeds of $20,923,400.  

 

Potentially dilutive securities consist of shares potentially issuable pursuant to stock options and warrants as well as shares that would result from full conversion of all outstanding convertible securities. These potentially dilutive securities were 3,013,987 and 2,903,987 as of June 30, 2019 and 2018, respectively, and are excluded from diluted net loss per share calculations because they are anti-dilutive.

 

Series A Convertible Preferred Stock

 

The Company is authorized to issue up to 3,000,000 shares of Series A Convertible Preferred Stock (the “Series A Preferred”). Each share of the Series A Preferred, which has a liquidation preference of $12.00 per share, is convertible at any time, at the option of the holder, into one share of common stock at the lower of: (a) $12.00 per share, or (b) 80% of the price at which the Company sells any equity or equity-linked securities in the future. The Series A Preferred also contains typical anti-dilution provisions that provide for adjustment of the conversion price to reflect stock splits, stock dividends, or similar events. The Series A Preferred is subject to mandatory conversion into common stock upon the listing of the Company’s common stock on a Qualified National Exchange. However, the Series A Preferred is not subject to the mandatory conversion until all outstanding convertible securities are also converted into common stock. The Series A Preferred ranks senior to all other equity or equity equivalent securities of the Company other than those securities which are explicitly senior or pari passu in rights and liquidation preference to the Series A Preferred and pari passu with the Company’s Series B Preferred Stock.

 

The Company issued 1,456,126 shares of Series A Preferred in connection with the conversion of certain convertible notes on December 31, 2015.

 

In December 2015, the conversion price of the Series A Preferred was reduced from $12.00 to $6.40 (80% of $8.00), and thus, each share of Series A Preferred Stock is convertible into 1.875 shares of common stock. During the period from May 17, 2016 through December 31, 2018 the Company issued shares of Series A Preferred Stock to Aspen Advanced Opportunity Fund, LP (“AAOF”) as payment for lease financing obligations under the terms of a Master Leasing Agreement.

 

As of June 30, 2019, and December 31, 2018, the Company had 1,890,354 shares of Series A Preferred Stock issued and outstanding which is currently convertible into 3,544,414 shares of our common stock.

XML 28 R12.htm IDEA: XBRL DOCUMENT v3.19.2
EQUITY INCENTIVE PLAN
6 Months Ended
Jun. 30, 2019
Share-based Payment Arrangement [Abstract]  
EQUITY INCENTIVE PLAN

NOTE 6 – EQUITY INCENTIVE PLAN  

 

We previously established the 2007 Stock Option Plan (the “2007 Plan”), which was scheduled to expire on October 30, 2017 and under which we granted key employees and directors options to purchase shares of our common stock at not less than fair market value as of the grant date. On May 4, 2017, the Board approved the 2017 Equity Incentive Plan (the “2017 Plan”) to replace the 2007 Plan, which became effective upon the approval of the stockholders holding a majority of the voting power in the Company on July 18, 2017. The 2017 Plan replaces the 2007 Plan and authorizes us to issue awards (stock options and restricted stock) with respect of a maximum of 1,200,000 shares of our common stock, which equals the number of shares authorized under the 2007 Plan.   

 

On July 24, 2017, certain stock options from the 2007 Plan were cancelled and replacement stock options were awarded. The replacement stock option awards have an exercise price of $8.00 per share, a seven-year term, are vested 50% on date of grant with the remaining vesting over a 4-year period from the date issued and are subject to certain other terms. Each option holder received options equal to 150% of the number of cancelled stock options. The cancellation and reissuance of the stock options were treated as a modification under ASC 718, Compensation-Stock Compensation. Incremental compensation cost of approximately $1,015,758 was measured as the excess of the fair value of the modified award over the fair value of the original award immediately before the terms were modified. Compensation cost of approximately $501,071 was recorded on the date of cancellation for awards that were vested on the date of the modification. For unvested awards, compensation cost of approximately $514,687 will be recorded over the remaining requisite service period. 

 

On September 30, 2018 and August 10, 2017, the Company granted each Board member 2,500 stock options and 2,500 shares of restricted stock for their Board services. The options were granted at a price of $8.00 per share and vest ratably over a four-year period beginning on the one-year anniversary. The options had an aggregate grant date fair value of $29,580 and $26,120 on September 30, 2018 and August 10, 2017, respectively. The restricted stock issued to the Board members has an aggregate fair value of $160,000 and vest ratably in arrears over four quarters on the last day of each fiscal quarter following the grant date. As of June 30, 2019, 20,000 of the 20,000 shares of restricted stock issued had vested, resulting in compensation expense of $20,000 for the period ended June 30, 2019.

 

During the three months ended June 30, 2019, the Company granted 20,000 employee stock options. The options were granted at a price of $8.00 per share and had an aggregate grant date fair value of $61,644. The options vest ratably over a four-year period beginning on the one-year anniversary. The fair value of the options granted was estimated on the date of grant using the Black Scholes option-pricing model using the following assumptions: Stock price: $8.00, Exercise Price: $8.00, Expected Term: 4.75 years, Volatility: 42.71%, Risk free rate: 1.76%, Dividend rate: 0%.

 

All options granted thus far under the 2017 Plan have an exercise price of $8.00 per share and vesting of the options ranges from immediate to 25% per year, with most options vesting 25% per year beginning on the one-year anniversary of the grant date. The options expire seven years from the date of grant.

 

Stock-based compensation expense was $110,368    for the three months ended June 30, 2019. As of June 30, 2019, there was approximately $632,744 in unrecognized compensation cost related to the options granted under the 2017 plan. We expect to recognize these costs over the remaining vesting terms, ranging from 3 to 4 years.

 

A summary of the stock options available as of June 30, 2019 is as follows:

 

      Weighted
   Number  Average
   Of  Exercise
   Options  Price
Options outstanding at March 31, 2019   805,375   $8.00 
Changes during the period:          
Expired   —      8.00 
New Options Granted – at market price   20,000    8.00 
Options outstanding at June 30, 2019   825,375   $8.00 
Options exercisable at June 30, 2019   384,025   $8.00 
XML 29 R13.htm IDEA: XBRL DOCUMENT v3.19.2
LEASES
6 Months Ended
Jun. 30, 2019
Capital Leases of Lessee [Abstract]  
LEASES

NOTE 7 – LEASES

 

Right of Use Asset and Leased Liability:

 

Estimated Lease Life – Lease term through December 2022

 

Right-of-use lease assets- operating as of March 31, 2019  $1,871,366 
Less: Accumulated amortization   (104,097)
Right-of-use lease assets- operating as of June 30, 2019  $1,767,269 
      
Lease liability-operating as of March 31, 2019  $1,981,795 
Less: Accumulated Amortization   (108,443)
Lease liability operating-as of June 30, 2019  $1,873,352 
      
Operating lease expense for the three months ended June 30, 2019  $150,557 
Actual remaining lease payments  $2,214,410 
Present value of remaining payments  $1,873,352 

  

Supplemental cash flow information related to leases:

 

   Leases
   Three months
   ended
   June 30, 2019
Cash paid for amounts included in the measurement of lease liabilities:     
    Operating cash flows from operating leases  $154,903 
Weighted average remaining lease term- operating leases (in months)   40 
Weighted average discount rate- operating leases (annual)   9.98%
Maturities of leases liabilities were as follows:     
  Year ending December 31, 2019 (excluding the three months ended June 30, 2019)  $309,806 
  Year ending December 31, 2020   622,878 
  Year ending December 31, 2021   638,178 
  Year ending December 31, 2022   643,547 
       Total Lease payments   2,214,409 
Less imputed interest   (341,057)
    Total  $1,873,352 

 

With the exception of the standards discussed above, we believe there have been no new accounting pronouncements issued that would have a material impact, to our Consolidated Financial Statements.

XML 30 R14.htm IDEA: XBRL DOCUMENT v3.19.2
RELATED PARTY TRANSACTIONS
6 Months Ended
Jun. 30, 2019
Related Party Transactions [Abstract]  
RELATED PARTY TRANSACTIONS

NOTE 8 – RELATED PARTY TRANSACTIONS

 

We have a licensing agreement for exclusive use of patents and pending patents with Michigan State University (“MSU”), a shareholder of the Company via the MSU Foundation. During the three months ended June 30, 2019 and 2018 we recorded licensing expense of $12,500 per quarter.  

 

We have also entered into product licensing agreements with certain other shareholders. No royalty revenue or expenses have been recognized related to these agreements during the three and six months ended June 30, 2019 or the three and six months ended June 30, 2018.

 

During the three months ended June 30, 2019 we did not issue any Series A Preferred stock. For the six months ended June 30, 2018, we issued 7,140 shares of Series A Preferred stock to AAOF as payment for lease financing obligations under the terms of the Master Lease Agreement, dated March 18, 2013.

XML 31 R15.htm IDEA: XBRL DOCUMENT v3.19.2
UPDATES TO SIGNIFICANT ACCOUNTING POLICIES (Policies)
6 Months Ended
Jun. 30, 2019
Accounting Policies [Abstract]  
Revenue Recognition

Revenue Recognition

 

Revenues are recognized at a point in time, typically when control of the promised goods is transferred to customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods. The Company does not recognize revenue in cases where collectability is not probable, and defers the recognition until collection is probable or payment is received.

 

The Company generally expenses sales commissions when incurred because the amortization period would have been one year or less. These costs are recorded within selling, general and administrative expenses. Customer deposits, deferred revenue and other receipts are deferred and recognized when the revenue is realized and earned.  

 

Revenue related to licensing agreements is recorded upon substantial performance of the terms of the licensing contract. In the case of licensing arrangements that involve up-front payments, revenue is recorded when management determines that the appropriate terms of the contract have been fulfilled. For example, this may occur when technology has been transferred via written documents or, if training is involved, whenever all contracted training has occurred. In the case of licenses where product delivery is also embedded in the deliverable, a portion of revenue would be recognized when products are delivered.

 

We have also out-licensed certain intellectual property to licensees under terms and conditions of license agreements that specify the   intellectual property licensed, the territory, and the type of license. In exchange for these licenses, we have recorded revenues associated with the initial granting of the license and expect to receive royalties based on sales of products produced under these licenses. License revenues are recorded to reflect our performance of requirements under these license agreements. In addition, we record royalty revenues from licensees at the time they are earned.

 

Grant contract revenue is recognized over the life of the contracts as the services are performed or as milestones are met.

 

Amounts received in excess of revenues earned are recorded as deferred revenue.

Liquidity

Liquidity

 

We have historically incurred recurring losses from operations and we may continue to generate negative cash flows as we implement our business plan. Our consolidated financial statements are prepared using GAAP as applicable to a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business.

  

As of August 12, 2019, we had cash on hand of $2,680,604. We believe our cash is sufficient to fund our operations through August 31, 2020 after taking into account various sources of funding and cash received from continued commercial sales transactions. Our primary means for raising funds since 2016 has been through our offering of shares of common stock at a fixed price of $8.00 per share to the general public in a self-underwritten offering (the “Offering” or our “IPO”) and under a draw loan note and agreement with The Dow Chemical Company (the “Dow Facility”). On April 12, 2019, we completed the Offering, after selling 2,615,425 shares under the Registration Statement at a price of $8.00 per share for total proceeds of $20,923,400. On July 8, 2019 we borrowed $2 million under the draw loan note and agreement with The Dow Chemical Company (the “Dow Facility”). We have $3 million of proceeds from the Dow Facility available to us, which we intend to be our primary source of liquidity at this time (See Note 3).  

 

There has been no public market for our securities and a public market may never develop, or, if any market does develop, it may not be sustained. Our common stock is not currently quoted on or traded on any exchange or on any over-the-counter market. In the event we are unable to fund our operations from existing cash on hand, operating cash flows, additional borrowings or raising equity capital, we may be forced to reduce our expenses, slow down our growth rate, or discontinue operations. Our condensed consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should we be unable to continue as a going concern. 

Inventory

Inventory  

 

The following amounts were included in inventory at the end of the period:   
   June 30,  December 31,
   2019  2018
Raw materials  $66,395   $48,371 
Consumables   160,630    188,764 
Finished goods   738,553    423,082 
Total  $965,578   $660,217 

Recent Accounting Pronouncements

Recent Accounting Pronouncements

 

In February 2016, the FASB issued Accounting Standards Update No. 2016-02, Leases (“ASU 2016-02”). The new standard establishes a right-of-use (“ROU”) model that requires a lessee to record a ROU asset and a lease liability on the balance sheet for all leases with terms longer than 12 months. Leases will be classified as either finance or operating, with classification affecting the pattern of expense recognition in the income statement. The new standard must be adopted using a modified retrospective transition and requires application of the new guidance at the beginning of the earliest comparative period presented.   We adopted ASU 2016-02 as of January 1, 2019.

Adoption of Lease Accounting Policy

Adoption of Lease Accounting Policy    

 

We applied ASU 2016-02 and all related amendments (“ASC 842”) using the modified retrospective method by recognizing the cumulative effect of adoption as an adjustment to the opening balance of retained earnings at January 1, 2019. Therefore, the comparative information has not been adjusted and continues to be reported under prior leasing guidance. As a result, in the first quarter of 2019 we recorded ROU assets of $1,871,366. We also recorded lease liabilities of $1,981,795. The decrease to retained earnings was $116,319, reflecting the cumulative impact of the accounting change. The standard did not have a material effect on consolidated net income or cash flows.

 

Right-of-use assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. As our leases do not provide an implicit rate, we used our incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. Lease expense for lease payments is recognized on a straight-line basis over the lease term.

 

We do not record a ROU asset or lease liability for leases with an expected term of 12 months or less. The comparative information has not been adjusted and continues to be reported under prior leasing guidance.

XML 32 R16.htm IDEA: XBRL DOCUMENT v3.19.2
UPDATES TO SIGNIFICANT ACCOUNTING POLICIES (Tables)
6 Months Ended
Jun. 30, 2019
Accounting Policies [Abstract]  
Schedule of inventory
The following amounts were included in inventory at the end of the period:   
   June 30,  December 31,
   2019  2018
Raw materials  $66,395   $48,371 
Consumables   160,630    188,764 
Finished goods   738,553    423,082 
Total  $965,578   $660,217 
XML 33 R17.htm IDEA: XBRL DOCUMENT v3.19.2
STOCK WARRANTS ACCOUNTED FOR AS EQUITY INSTRUMENTS (Tables)
6 Months Ended
Jun. 30, 2019
Stock Warrants Accounted For As Equity Instruments Tables  
Schedule of common stock warrants (including the warrants previously accounted for as derivatives) outstanding

The following table summarizes the warrants (including the warrants previously accounted for as derivatives) outstanding at June 30, 2019, which are accounted for as equity instruments, all of which are exercisable: 

 

Date Issued   Expiration Date  

Indexed

Stock

  Exercise Price     Number of 
Warrants
 
07/01/2009   07/01/2019   Common   $ 8.00       6,000  
10/08/2012   10/08/2027   Common   $ 12.00       5,000  
01/15/2014 - 12/31/2014   01/15/2024   Series A Convertible Preferred   $ 6.40       972,720  
04/30/2015- 05/26/2015   04/30/2022   Common   $ 16.00       218,334  
06/30/2015   06/30/2022   Common   $ 16.00       6,563  
12/31/2015   12/31/2020   Common   $ 8.00       20,625  
03/31/2016   03/31/2021   Common   $ 10.00       10,600  
04/30/2016   04/30/2021   Common   $ 10.00       895  
12/14/2016   12/01/2023   Common   $ 8.00       50,000  
07/18/2017   12/01/2023   Common   $ 8.00       25,000  
09/22/2017   12/01/2023   Common   $ 8.00       25,000  
12/04/2017   12/01/2023   Common   $ 8.00       25,000  
                      1,365,737  
XML 34 R18.htm IDEA: XBRL DOCUMENT v3.19.2
EQUITY INCENTIVE PLAN (Tables)
6 Months Ended
Jun. 30, 2019
Share-based Payment Arrangement [Abstract]  
Schedule of summary of the stock option activity

A summary of the stock options available as of June 30, 2019 is as follows:

 

      Weighted
   Number  Average
   Of  Exercise
   Options  Price
Options outstanding at March 31, 2019   805,375   $8.00 
Changes during the period:          
Expired   —      8.00 
New Options Granted – at market price   20,000    8.00 
Options outstanding at June 30, 2019   825,375   $8.00 
Options exercisable at June 30, 2019   384,025   $8.00 
XML 35 R19.htm IDEA: XBRL DOCUMENT v3.19.2
LEASES (Tables)
6 Months Ended
Jun. 30, 2019
Capital Leases of Lessee [Abstract]  
Right of Use Asset and Leased Liability

Right of Use Asset and Leased Liability:

 

Estimated Lease Life – Lease term through December 2022

 

Right-of-use lease assets- operating as of March 31, 2019  $1,871,366 
Less: Accumulated amortization   (104,097)
Right-of-use lease assets- operating as of June 30, 2019  $1,767,269 
      
Lease liability-operating as of March 31, 2019  $1,981,795 
Less: Accumulated Amortization   (108,443)
Lease liability operating-as of June 30, 2019  $1,873,352 
      
Operating lease expense for the three months ended June 30, 2019  $150,557 
Actual remaining lease payments  $2,214,410 
Present value of remaining payments  $1,873,352 
Schedule of Future Minimum Rental Payments

Supplemental cash flow information related to leases:

 

   Leases
   Three months
   ended
   June 30, 2019
Cash paid for amounts included in the measurement of lease liabilities:     
    Operating cash flows from operating leases  $154,903 
Weighted average remaining lease term- operating leases (in months)   40 
Weighted average discount rate- operating leases (annual)   9.98%
Maturities of leases liabilities were as follows:     
  Year ending December 31, 2019 (excluding the three months ended June 30, 2019)  $309,806 
  Year ending December 31, 2020   622,878 
  Year ending December 31, 2021   638,178 
  Year ending December 31, 2022   643,547 
       Total Lease payments   2,214,409 
Less imputed interest   (341,057)
    Total  $1,873,352 
XML 36 R20.htm IDEA: XBRL DOCUMENT v3.19.2
UPDATES TO SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)
Jun. 30, 2019
Dec. 31, 2018
Accounting Policies [Abstract]    
Raw materials $ 66,395 $ 48,371
Consumables 160,630 188,764
Finished goods 738,553 423,082
Total $ 965,578 $ 660,217
XML 37 R21.htm IDEA: XBRL DOCUMENT v3.19.2
UPDATES TO SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
6 Months Ended
Jul. 08, 2019
Apr. 12, 2019
Jun. 30, 2019
Aug. 12, 2019
Dec. 31, 2018
Cash on hand     $ 1,735,721   $ 4,703,834
Sale of common stock   2,615,425      
Share price per share   $ 8.00 $ 8.00    
Proceeds from sale of stock   $ 20,923,400      
ROU assets     $ 1,871,366    
Lease liabilities     1,873,352   $ 1,981,795
Decrease in retained earnings     116,319    
Draw Loan Note And Agreement [Member] | Senior Secured Debt Financing [Member]          
Proceeds from secured debt     $ 3,000,000    
Subsequent Event [Member]          
Cash on hand       $ 2,680,604  
Subsequent Event [Member] | Draw Loan Note And Agreement [Member]          
Amount borrowed $ 2,000,000        
XML 38 R22.htm IDEA: XBRL DOCUMENT v3.19.2
FINANCING AGREEMENTS (Details Narrative) - Senior Secured Debt Financing [Member] - Draw Loan Note And Agreement [Member] - USD ($)
1 Months Ended 6 Months Ended
Sep. 22, 2017
Jul. 18, 2017
Dec. 04, 2016
Dec. 31, 2016
Jun. 30, 2019
Jul. 01, 2019
Apr. 02, 2019
Proceeds from secured debt         $ 3,000,000    
The Dow Chemical Company [Member]              
Face amount       $ 10,000,000 4,323,953    
Proceeds from secured debt $ 1,000,000 $ 1,000,000 $ 1,000,000 $ 2,000,000      
Amortization expense of debt         $ 163,919    
Number of shares purchased (in shares)         125,000    
Exercise price (in dollars per share)         $ 8.00    
Description of conversion terms         Dow received warrant coverage of one share of common stock for each $40 in loans received by us, equating to 20% warrant coverage, with an exercise price of $8.00 per share for the warrants issued at closing of the initial $2 million draw.    
Unamortized discount         $ 372,372    
Interest rate (in percent)       5.00%      
Maturity date         Dec. 01, 2021    
Effective intrest rate         7.67%    
Non-cash interest expense         $ 124,335    
Amortization from debt discount         39,584    
Repayment of debt         $ 816,710    
Equity capital description         Equity capital exceeding $15 million, we are required to prepay an amount equal to 30% of the amount raised over $15 million, but less than $25 million.    
Interest payable           $ 59,709 $ 64,626
XML 39 R23.htm IDEA: XBRL DOCUMENT v3.19.2
STOCK WARRANTS ACCOUNTED FOR AS EQUITY INSTRUMENTS (Details)
6 Months Ended
Jun. 30, 2019
$ / shares
shares
Number of Warrants 1,365,737
Warrant [Member]  
Date Issued Jul. 01, 2009
Expiration Date Jul. 01, 2019
Indexed stock Common
Exercise Price | $ / shares $ 8.00
Number of Warrants 6,000
Warrant 1 [Member]  
Date Issued Oct. 08, 2012
Expiration Date Oct. 08, 2027
Indexed stock Common
Exercise Price | $ / shares $ 12.00
Number of Warrants 5,000
Warrant 2 [Member]  
Expiration Date Jan. 15, 2024
Indexed stock Series A Convertible Preferred
Exercise Price | $ / shares $ 6.40
Number of Warrants 972,720
Warrant 3 [Member]  
Expiration Date Apr. 30, 2022
Indexed stock Common
Exercise Price | $ / shares $ 16.00
Number of Warrants 218,334
Warrant 4 [Member]  
Date Issued Jun. 30, 2015
Expiration Date Jun. 30, 2022
Indexed stock Common
Exercise Price | $ / shares $ 16.00
Number of Warrants 6,563
Warrant 5 [Member]  
Date Issued Dec. 31, 2015
Expiration Date Dec. 31, 2020
Indexed stock Common
Exercise Price | $ / shares $ 8.00
Number of Warrants 20,625
Warrant 6 [Member]  
Date Issued Mar. 31, 2016
Expiration Date Mar. 31, 2021
Indexed stock Common
Exercise Price | $ / shares $ 10.00
Number of Warrants 10,600
Warrant 7 [Member]  
Date Issued Apr. 30, 2016
Expiration Date Apr. 30, 2021
Indexed stock Common
Exercise Price | $ / shares $ 10.00
Number of Warrants 895
Warrant 8 [Member]  
Date Issued Dec. 14, 2016
Expiration Date Dec. 01, 2023
Indexed stock Common
Exercise Price | $ / shares $ 8.00
Number of Warrants 50,000
Warrant 9 [Member]  
Date Issued Jul. 18, 2017
Expiration Date Dec. 01, 2023
Indexed stock Common
Exercise Price | $ / shares $ 8.00
Number of Warrants 25,000
Warrant 10 [Member]  
Date Issued Sep. 22, 2017
Expiration Date Dec. 01, 2023
Indexed stock Common
Exercise Price | $ / shares $ 8.00
Number of Warrants 25,000
Warrant 11 [Member]  
Date Issued Dec. 04, 2017
Expiration Date Dec. 01, 2023
Indexed stock Common
Exercise Price | $ / shares $ 8.00
Number of Warrants 25,000
Minimum [Member] | Warrant 2 [Member]  
Date Issued Jan. 15, 2014
Minimum [Member] | Warrant 3 [Member]  
Date Issued Apr. 30, 2015
Maximum [Member] | Warrant 2 [Member]  
Date Issued Dec. 31, 2014
Maximum [Member] | Warrant 3 [Member]  
Date Issued May 26, 2015
XML 40 R24.htm IDEA: XBRL DOCUMENT v3.19.2
STOCKHOLDERS' EQUITY (DEFICIT) (Details Narrative) - USD ($)
6 Months Ended 12 Months Ended
Apr. 12, 2019
Jun. 30, 2019
Jun. 30, 2018
Dec. 31, 2015
Dec. 31, 2018
Common stock, authorized   25,000,000     25,000,000
Common stock, issued   4,011,943     3,760,268
Common stock, outstanding   4,011,943     3,760,268
Number of shares issued in offering 2,615,425        
Price per share (in dollars per share) $ 8.00 $ 8.00      
Preferred stock, authorized   3,000,000     3,000,000
Preferred stock, issued   1,890,354     1,890,354
Preferred stock, outstanding   1,890,354     1,890,354
Number of shares issued   3,544,414      
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount   3,013,987 2,903,987    
IPO [Member]          
Number of shares issued in offering 2,615,425 251,675 493,175    
Price per share (in dollars per share) $ 8.00        
Proceeds from issuance initial public offering $ 20,923,400        
Series A Convertible Preferred Stock [Member]          
Liquidation (in dollars per share)   $ 12.00      
Description of conversion of stock   One share of common stock at the lower of: (a) $12.00 per share, or (b) 80% of the price at which the Company sells any equity or equity-linked securities in the future.   Series A Preferred was reduced from $12.00 to $6.40 (80% of $8.00), and thus, each share of Series A Preferred Stock is convertible into 1.875 shares of common stock.  
Conversion price (in dollars per share)   $ 12.00      
Reduction in share price (in dollars per share)       $ 6.40  
Exercise price (in dollars per share)       $ 8.00  
Number of shares issued       1,456,126  
XML 41 R25.htm IDEA: XBRL DOCUMENT v3.19.2
EQUITY INCENTIVE PLAN (Details)
6 Months Ended
Jun. 30, 2019
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]  
Options outstanding at beginning of year | shares 805,375
Changes during the year:  
Expired | shares
New Options Granted - at market price | shares 20,000
Options outstanding at end of Period | shares 825,375
Options exercisable at end of Period | shares 384,025
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [RollForward]  
Options outstanding at beginning of year | $ / shares $ 8.00
Changes during the year:  
Expired | $ / shares 8.00
New Options Granted - at market price | $ / shares 8.00
Options outstanding at end of Period | $ / shares 8.00
Options exercisable at end of Period | $ / shares $ 8.00
XML 42 R26.htm IDEA: XBRL DOCUMENT v3.19.2
EQUITY INCENTIVE PLAN (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended
Aug. 10, 2017
Sep. 30, 2018
Jun. 24, 2017
Jun. 30, 2019
Jun. 30, 2019
Number of options granted (in shares)         20,000
Stock based compensation       $ 110,368  
Exercise price (in dollars per share)         $ 8.00
Exercise Price (in dollars per share)       $ 8.00 8.00
Stock Price       $ 8.00 $ 8.00
Expected Term         4 years 9 months
Volatility         42.71%
Risk free interest rate         1.76%
Dividend rate         0.00%
Minimum [Member]          
Unrecognized compensation expense period         3 years
Maximum [Member]          
Unrecognized compensation expense period         4 years
Stock Option [Member]          
Number of options granted (in shares)       20,000  
Exercise price (in dollars per share)       $ 8.00  
Description of vesting terms       The options vest ratably over a four-year period beginning on the one-year anniversary.  
Aggregate grant date fair value       $ 61,644  
2007 Stock Option Plan [Member]          
Stock based compensation     $ 1,015,758    
Unrecognized compensation cost       $ 632,744 $ 632,744
Exercise price (in dollars per share)     $ 8.00    
Vesting period     4 years    
Description of cancellation terms     Each option holder received options equal to 150% of the number of cancelled stock options.    
Compensation cost for cancelled stock options     $ 501,071    
Weighted average fair value of options granted during the year         $ 8.00
Weighted average remaining contractual term (in months)         7 years
2007 Stock Option Plan [Member] | Maximum [Member]          
Number of shares awarded (in shares)       1,200,000 1,200,000
Unvested awards, compensation cost       $ 514,687 $ 514,687
2007 Stock Option Plan [Member] | Stock Option [Member] | Directors [Member]          
Number of options granted (in shares)   2,500      
Exercise price (in dollars per share)   $ 8.00      
Description of vesting terms   The options vest ratably over a four-year period beginning on the one-year anniversary.      
Aggregate grant date fair value   $ 29,580      
2007 Stock Option Plan [Member] | Restricted Common Stock [Member] | Directors [Member]          
Number of options granted (in shares) 2,500        
Stock based compensation         $ 20,000
Exercise price (in dollars per share) $ 8.00        
Number of shares vested (in shares)         20,000
Description of vesting terms The options vest ratably over a four-year period beginning on the one-year anniversary.        
Aggregate grant date fair value $ 26,120       $ 160,000
XML 43 R27.htm IDEA: XBRL DOCUMENT v3.19.2
LEASES (Details)
6 Months Ended
Jun. 30, 2019
USD ($)
Capital Leases of Lessee [Abstract]  
Right-of-use lease assets- operating at beginning $ 1,871,366
Less: Accumulated amortization (104,097)
Right-of-use lease assets- operating at end 1,767,269
Lease liability-operating at beginning 1,981,795
Less: Accumulated Amortization (108,443)
Lease liability operating at end 1,873,352
Operating lease expense 150,557
Actual remaining lease payments 2,214,410
Present value of remaining payments $ 1,873,352
XML 44 R28.htm IDEA: XBRL DOCUMENT v3.19.2
LEASES (Details 1)
6 Months Ended
Jun. 30, 2019
USD ($)
Cash paid for amounts included in the measurement of lease liabilities:  
Operating cash flows from operating leases $ 154,903
Weighted average remaining lease term- operating leases ( in months) 40 months
Weighted average discount rate- operating leases (annual) 9.98%
Maturities of leases liabilities  
Year ending December 31, 2019 (excluding the three months ended March 31, 2019) $ 309,806
Year ending December 31, 2020 622,878
Year ending December 31, 2021 638,178
Year ending December 31, 2022 643,547
Total Lease payments 2,214,409
Less imputed interest (341,057)
Total $ 1,873,352
XML 45 R29.htm IDEA: XBRL DOCUMENT v3.19.2
RELATED PARTY TRANSACTIONS AND COMMITMENTS (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2018
Licensing Agreement [Member] | Michigan State University (Patents and Pending Patents) [Member]      
Licensing expenses $ 12,500 $ 12,500  
Master Leasing Agreement [Member] | Aspen Advance Opportunity Fund, LP [Member] | Preferred stock (A) [Member]      
Number of shares issued 0   7,140
EXCEL 46 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 48 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 49 FilingSummary.xml IDEA: XBRL DOCUMENT 3.19.2 html 119 278 1 false 34 0 false 4 false false R1.htm 00000001 - Document - Document and Entity Information Sheet http://xgsciences.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited) Sheet http://xgsciences.com/role/CondensedConsolidatedBalanceSheets CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited) Statements 2 false false R3.htm 00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited) (Parenthetical) Sheet http://xgsciences.com/role/CondensedConsolidatedBalanceSheetsParenthetical CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited) (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited) Sheet http://xgsciences.com/role/CondensedConsolidatedStatementsOfOperations CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited) Statements 4 false false R5.htm 00000005 - Statement - CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited) Sheet http://xgsciences.com/role/CondensedConsolidatedStatementOfChangesInStockholdersEquity CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited) Statements 5 false false R6.htm 00000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) Sheet http://xgsciences.com/role/CondensedConsolidatedStatementsOfCashFlows CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) Statements 6 false false R7.htm 00000007 - Disclosure - NATURE OF BUSINESS AND BASIS OF PRESENTATION Sheet http://xgsciences.com/role/NatureOfBusinessAndBasisOfPresentation NATURE OF BUSINESS AND BASIS OF PRESENTATION Notes 7 false false R8.htm 00000008 - Disclosure - UPDATES TO SIGNIFICANT ACCOUNTING POLICIES Sheet http://xgsciences.com/role/UpdatesToSignificantAccountingPolicies UPDATES TO SIGNIFICANT ACCOUNTING POLICIES Notes 8 false false R9.htm 00000009 - Disclosure - FINANCING AGREEMENTS Sheet http://xgsciences.com/role/FinancingAgreements FINANCING AGREEMENTS Notes 9 false false R10.htm 00000010 - Disclosure - STOCK WARRANTS ACCOUNTED FOR AS EQUITY INSTRUMENTS Sheet http://xgsciences.com/role/StockWarrantsAccountedForAsEquityInstruments STOCK WARRANTS ACCOUNTED FOR AS EQUITY INSTRUMENTS Notes 10 false false R11.htm 00000011 - Disclosure - STOCKHOLDERS' EQUITY (DEFICIT) Sheet http://xgsciences.com/role/StockholdersEquityDeficit STOCKHOLDERS' EQUITY (DEFICIT) Notes 11 false false R12.htm 00000012 - Disclosure - EQUITY INCENTIVE PLAN Sheet http://xgsciences.com/role/EquityIncentivePlan EQUITY INCENTIVE PLAN Notes 12 false false R13.htm 00000013 - Disclosure - LEASES Sheet http://xgsciences.com/role/Leases LEASES Notes 13 false false R14.htm 00000014 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://xgsciences.com/role/RelatedPartyTransactions RELATED PARTY TRANSACTIONS Notes 14 false false R15.htm 00000015 - Disclosure - UPDATES TO SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://xgsciences.com/role/UpdatesToSignificantAccountingPoliciesPolicies UPDATES TO SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 15 false false R16.htm 00000016 - Disclosure - UPDATES TO SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://xgsciences.com/role/UpdatesToSignificantAccountingPoliciesTables UPDATES TO SIGNIFICANT ACCOUNTING POLICIES (Tables) Tables http://xgsciences.com/role/UpdatesToSignificantAccountingPolicies 16 false false R17.htm 00000017 - Disclosure - STOCK WARRANTS ACCOUNTED FOR AS EQUITY INSTRUMENTS (Tables) Sheet http://xgsciences.com/role/StockWarrantsAccountedForAsEquityInstrumentsTables STOCK WARRANTS ACCOUNTED FOR AS EQUITY INSTRUMENTS (Tables) Tables http://xgsciences.com/role/StockWarrantsAccountedForAsEquityInstruments 17 false false R18.htm 00000018 - Disclosure - EQUITY INCENTIVE PLAN (Tables) Sheet http://xgsciences.com/role/EquityIncentivePlanTables EQUITY INCENTIVE PLAN (Tables) Tables http://xgsciences.com/role/EquityIncentivePlan 18 false false R19.htm 00000019 - Disclosure - LEASES (Tables) Sheet http://xgsciences.com/role/LeasesTables LEASES (Tables) Tables http://xgsciences.com/role/Leases 19 false false R20.htm 00000020 - Disclosure - UPDATES TO SIGNIFICANT ACCOUNTING POLICIES (Details) Sheet http://xgsciences.com/role/UpdatesToSignificantAccountingPoliciesDetails UPDATES TO SIGNIFICANT ACCOUNTING POLICIES (Details) Details http://xgsciences.com/role/UpdatesToSignificantAccountingPoliciesTables 20 false false R21.htm 00000021 - Disclosure - UPDATES TO SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Sheet http://xgsciences.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative UPDATES TO SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Details http://xgsciences.com/role/UpdatesToSignificantAccountingPoliciesTables 21 false false R22.htm 00000022 - Disclosure - FINANCING AGREEMENTS (Details Narrative) Sheet http://xgsciences.com/role/FinancingAgreementsDetailsNarrative FINANCING AGREEMENTS (Details Narrative) Details http://xgsciences.com/role/FinancingAgreements 22 false false R23.htm 00000023 - Disclosure - STOCK WARRANTS ACCOUNTED FOR AS EQUITY INSTRUMENTS (Details) Sheet http://xgsciences.com/role/StockWarrantsAccountedForAsEquityInstrumentsDetails STOCK WARRANTS ACCOUNTED FOR AS EQUITY INSTRUMENTS (Details) Details http://xgsciences.com/role/StockWarrantsAccountedForAsEquityInstrumentsTables 23 false false R24.htm 00000024 - Disclosure - STOCKHOLDERS' EQUITY (DEFICIT) (Details Narrative) Sheet http://xgsciences.com/role/StockholdersEquityDeficitDetailsNarrative STOCKHOLDERS' EQUITY (DEFICIT) (Details Narrative) Details http://xgsciences.com/role/StockholdersEquityDeficit 24 false false R25.htm 00000025 - Disclosure - EQUITY INCENTIVE PLAN (Details) Sheet http://xgsciences.com/role/EquityIncentivePlanDetails EQUITY INCENTIVE PLAN (Details) Details http://xgsciences.com/role/EquityIncentivePlanTables 25 false false R26.htm 00000026 - Disclosure - EQUITY INCENTIVE PLAN (Details Narrative) Sheet http://xgsciences.com/role/EquityIncentivePlanDetailsNarrative EQUITY INCENTIVE PLAN (Details Narrative) Details http://xgsciences.com/role/EquityIncentivePlanTables 26 false false R27.htm 00000027 - Disclosure - LEASES (Details) Sheet http://xgsciences.com/role/LeasesDetails LEASES (Details) Details http://xgsciences.com/role/LeasesTables 27 false false R28.htm 00000028 - Disclosure - LEASES (Details 1) Sheet http://xgsciences.com/role/LeasesDetails1 LEASES (Details 1) Details http://xgsciences.com/role/LeasesTables 28 false false R29.htm 00000029 - Disclosure - RELATED PARTY TRANSACTIONS AND COMMITMENTS (Details Narrative) Sheet http://xgsciences.com/role/RelatedPartyTransactionsAndCommitmentsDetailsNarrative RELATED PARTY TRANSACTIONS AND COMMITMENTS (Details Narrative) Details 29 false false All Reports Book All Reports cik0001435375-20190630.xml cik0001435375-20190630.xsd cik0001435375-20190630_cal.xml cik0001435375-20190630_def.xml cik0001435375-20190630_lab.xml cik0001435375-20190630_pre.xml http://fasb.org/us-gaap/2019-01-31 http://xbrl.sec.gov/dei/2019-01-31 http://fasb.org/srt/2019-01-31 true true ZIP 51 0001731122-19-000476-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001731122-19-000476-xbrl.zip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end